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Resumen 
El reconocimiento molecular está presente en numerosos procesos vitales y relevantes para la 
salud y la enfermedad. El conocimiento de la comunicación intermolecular a nivel estructural 
es de especial interés para el entendimiento de numerosos procesos biológicos. De entre la 
gran variedad de técnicas aplicadas al reconocimiento molecular, la Resonancia Magnética 
Nuclear (RMN) proporciona información valiosa a diferentes niveles de los bio-complejos 
formados. 
Desde el comienzo, la RMN ha sido explotada hasta alcanzar límites insospechados. En esta 
tesis, diferentes técnicas, métodos y protocolos basados en RMN se han aplicado 
extensamente para estudiar una variedad de procesos de reconocimiento molecular de 
diferentes niveles de complejidad. En particular, esta aplicación de la RMN ha permitido 
recopilar información sobre las características del reconocimiento molecular de estos eventos 
abordado desde las perspectivas del ligando y/o receptor. Se ha hecho especial hincapié en 
desentrañar los fenómenos de interacción en los que intervienen los carbohidratos. De 
manera paralela, también se han utilizado métodos de RMN análogos en el campo de la 
dinámica de proteínas así como para cribar mezclas de ligandos mediante un enfoque de 
química dinámica combinatoria guiada por RMN. 
Introducción 
Este capítulo introduce las bases de la RMN aplicada al reconocimiento molecular y describe el 
fondo bioquímico de los sistemas biológicos estudiados. Las perspectivas de ligando y receptor 
basadas en RMN se presentan como alternativas para obtener acceso a información 
complementaria de la interacción ligando-receptor. 
Desde el punto de vista del ligando, los experimentos de RMN están enfocados en la 
observación de las señales del ligando revelando información clave sobre el epitopo de unión 
del ligando así como de su conformación en el estado unido. Los experimentos de RMN más 
relevantes dentro de esta clase (STD-NMR) se basan en la transferencia de saturación de la 
magnetización para un sistema en intercambio químico (del estado libre al unido y viceversa). 
Por otro lado, los experimentos de RMN desde el punto de vista del receptor, proporcionan 
información a nivel atómico valiosa sobre receptor y permiten definir con mayor precisión 
rasgos clave del evento de reconocimiento (ej. amino ácidos del sitio de unión). Estos últimos 
métodos, generalmente implican la observación de las señales del receptor en experimentos 
de correlación heteronuclear en ausencia y en presencia del ligando.  
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También, se describen las principales interacciones intermoleculares esenciales para el 
reconocimiento molecular y se introducen los principales actores bioquímicos (proteínas, 
carbohidratos, ADN) involucrados en los procesos de reconocimiento. 
Objetivos generales 
El objetivo general de la tesis es la aplicación de métodos basados en RMN desde el punto 
vista del ligando y del receptor para el estudio de interacciones de ligandos de diversa 
naturaleza química con receptores de interés biológico y/o biomédico. 
Aplicaciones de la RMN al reconocimiento molecular de carbohidratos 
Este capítulo se encuentra enfocado a la obtención de información clave del reconocimiento 
de carbohidratos para aplicaciones biomédicas. Durante mucho tiempo, los carbohidratos 
fueron considerados como la principal fuente de energía de los seres vivos. Hoy en día, resulta 
evidente que los carbohidratos desempeñan un papel importante en numerosos procesos 
biológicos y que son capaces de transmitir ingente cantidad de información biológica 
importante. Los carbohidratos situados en la superficie de las células y su entorno  se 
encuentran a menudo implicados en importantes procesos de reconocimiento molecular 
estableciendo interacciones con anticuerpos, proteínas, virus, células, bacterias… que 
desencadenar una variedad de procesos intra e inter celulares de interés fisiológico y 
patológico. 
En esta sección,  mediante la aplicación de estrategias basadas en RMN tanto del punto vista 
del ligando como del receptor, se ha estudiado diferentes sistemas biológicos carbohidrato-
receptor: i) El análisis de las características de reconocimiento de los miméticos sintéticos de 
antígeno Tn reveló un modo de unión similar al modelo de referencia del Tn antígeno (-
OMeGalNAc) hacia diferentes lectinas; ii) Se ha demostrado el carácter bifuncional de un 
glicano ramificado sintético unido covalentemente a un inhibidor de proteasa y su capacidad 
para dirigir simultáneamente diferentes proteínas. iii) La especificidad de la interacción de 
anticuerpos monoclonales dirigidos al xenoantígeno basado en carbohidratos se ha deducido 
por STD-NMR, mostrando también la existencia de diferentes afinidades para el xenoantígeno 
-gal y una serie de anticuerpos. En particular, también se ha mostrado la especificidad 
anomérica de la interacción del antígeno de ácido N-glicolilneuramínico (Neu5Gc) con 
diferentes anticuerpos. iv) El modo de unión de diferentes cepas de hemaglutininas (HA) del 
Resumen                                             
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virus de la gripe hacia los epítopos del ácido siálico presentes en los N-glicanos también ha sido 
elucidado por STD-NMR. Los datos experimentales, combinados con los cálculos de docking, 
han puesto de manifiesto la existencia de distintos modos de unión, dependiendo de la 
regioquímica del enlace Neu5Ac 
Aplicaciones de RMN a otros sistemas y sistemas dinámicos 
Los procesos biológicos son  inherentemente dinámicos ya que ligandos y proteínas son 
capaces de ensamblarse en multitud de conformaciones. El entendimiento de este ambiente 
dinámico intrínseco es de suma importancia para monitorizar, explicar y modular los eventos 
de unión y reconocimiento molecular. En este contexto, los métodos de RMN proporcionan 
una diversidad de estrategias experimentales basadas en parámetros de relajación y / o 
interacciones dipolares para obtener información sobre el comportamiento conformacional de 
ligandos y receptores en sus estados libres y enlazados. Además, la RMN también puede 
aplicarse en sistemas químicos dinámicos, incluyendo la deconvolución de la interacción de 
bibliotecas combinatorias dinámicas con receptores, un proceso en el que se producen 
reacciones múltiples reversibles. 
En este capítulo se describen diferentes ejemplos de aplicación de métodos de RMN al estudio 
de las características estructurales, conformacionales y dinámicas de sistemas de naturaleza 
química diversa e interés biológico. En particular, i) se han aplicado métodos de RMN para 
estudiar el grado de orden de dominios de proteínas mediante el análisis de los parámetros 
dinámicos de RMN de un fragmento del factor de transcripción CHOP. ii) Se ha realizado 
análisis conformacional por RMN basado en experimentos tr-NOESY de un derivado sintético 
de epotilona unido a tubulina revelando un modo de unión similar al descrito para la 
epotilona-A. iii) La interacción de una familia de moléculas con el surco menor del ADN se ha 
caracterizado mediante RMN mostrando su especificidad por regiones ricas en A / T. iv) Por 
último, la aplicación de métodos de RMN al estudio de una química combinatoria dinámica en 
presencia de una proteína determinada (Frequenin-2) ha permitido la identificación directa no 
ambigua de nuevos ligandos 
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Abstract 
Molecular recognition is at heart of life processes relevant to health and disease. Deciphering 
the code of the intermolecular communication at structural level is enormous interest for the 
understanding of many biological events. Among the variety of techniques applied in this field, 
NMR may provide valuable information, at different levels, on the formed bio-complexes. 
NMR has been continuously exploited to reach unexpected limits a few years ago. In this 
thesis, different NMR techniques, methods and protocols have been extensively applied to 
study a variety molecular recognition processes at diverse levels of complexity.  In particular, 
these applications of NMR have permitted gathering information on the molecular recognition 
features of these events, from the ligand and/or receptor perspectives. Special emphasis has 
been paid to unravel interaction phenomena where carbohydrates are involved. In a parallel 
manner, analogous NMR methods have also been used in the field of protein dynamics as well 
as for screening ligand mixtures through a NMR-guided dynamic combinatorial chemistry 
approach.  
Introduction 
The initial section of this thesis outlines the basic concepts for applying NMR methods to study 
molecular recognition events and describes the biochemical background of the employed 
systems. The NMR-based ligand and receptor perspectives are presented as alternatives to 
gain access to complementary information of the ligand-receptor interaction. 
The ligand-point-of-view NMR experiments, focused on the observation of the ligand NMR 
signals, reveal key information on the interacting epitope and ligand conformation. The most 
relevant NMR experiments within this class (STD-NMR) are based on the detection of simple 
saturation transfer phenomena for a system in chemical exchange (free to bound and 
viceversa). Conversely, the receptor point of view NMR experiments provide atomic level 
information on the receptor and permit to define more precisely key features of the 
recognition event (i.e. amino acids at the binding pocket). The NMR experiments from the 
receptor perspective, generally, involve the observation of receptor signals in heteronuclear 
NMR experiments before and after the addition of the ligand.  
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In addition, we also introduce the intermolecular interactions important for molecular 
recognition and the biochemical players (i.e. carbohydrates, proteins, DNA) that are involved in 
the interacting process.  
General objective 
The general objective of the thesis is to apply ligand- and receptor-based NMR methods to 
study the interaction of a variety of ligands of diverse chemical nature with receptors of 
biological and/or biomedical interest.  
NMR applications to carbohydrate recognition 
This part is focused on gathering key information of carbohydrate recognition relevant for 
biomedical applications. During long time, carbohydrates were mainly considered as the 
source of energy for living organisms. It is evident today that carbohydrates play additional 
important roles in numerous life processes and also transmit important biological information. 
Carbohydrates located at the surface and cellular surroundings are involved in molecular 
recognition processes by establishing interactions with antibodies, proteins, viruses, cells, 
bacteria… which trigger a variety of intracellular and extracellular processes of special 
physiological and pathological interest. 
Herein, by applying NMR strategies that rely on ligand and/or receptor observation, we have 
studied different carbohydrate-based biological systems: i) The analysis of the recognition 
features of synthetic tryciclic Tn antigen mimetics revealed a similar binding mode as that of 
the Tn reference model (-OMeGalNAc) towards different lectins. ii) The bifunctional 
character of a synthetic branched glycan covalently connected to a protease inhibitor and its 
capacity for targeting simultaneously different proteins has been demonstrated. iii) The 
specificity of the interaction of monoclonal antibodies targeting the carbohydrate-based 
xenoantigen has been deduced by STD-NMR, also showing the existence of different affinities 
for the -gal xenoantigen and derivatives thereof to a series of antibodies. In particular, the 
anomeric specificity of the interaction of the N-glycolylneuraminic acid (Neu5Gc) antigen 
towards different antibodies has also been shown. iv)  The binding mode of the hemagglutinins 
(HA) from influenza virus strains towards the sialic acid epitopes present in N-glycans has also 
been elucidated by STD-NMR. The experimental data, combined with docking calculations, 
Abstract 
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have revealed the existence of distinct binding modes, depending on the regiochemistry of the 
Neu5Ac linkage.  
NMR applications to dynamic processes and other systems 
Biological processes are inherently dynamic since proteins and ligands can sample a vast 
ensemble of conformations. The understanding of the intrinsic dynamic features of the system 
under study is of paramount importance to monitor, explain and modulate the associated 
binding events. In this context, NMR provides a diversity of experimental strategies based on 
relaxation parameters and/or dipolar interactions to get insights into the conformational 
behavior of ligands and receptors in their free and bound states. Moreover, NMR can also be 
applied in chemical dynamic systems, including the deconvolution of the interaction of 
dynamic combinatorial libraries with receptors, a process where multiple reversible reactions 
take place. 
In this chapter, we describe different examples of the application of NMR methods to the 
study of the structural, conformational and dynamics features of systems of diverse chemical 
nature and biological interest. In particular, i) NMR methods have been applied to study the 
degree of ordering of protein domains by the analysis of NMR dynamic parameters (R1, R2 and 
hetNOE) of a fragment of the CHOP transcription factor. ii) In a parallel manner, the NMR-
based conformational analysis (tr-NOESY experiments) of a synthetic epothilone derivative 
bound to tubulin revealed the presence of a similar binding mode to that described for natural 
epothilone-A. iii) The interaction of a family of molecules with the DNA minor groove has been 
also characterized by other NMR methods, allowing to deduce their specificity towards the A/T 
rich regions as well as the structure of their complexes. iv) Finally, the application of NMR 
methods to the study of a dynamic combinatorial chemistry in the presence of a given protein 
target (Frequenin-2) has permitted the direct non-ambiguous identification of new binders. 
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1.1. Molecular recognition and NMR 
Molecular recognition is at heart of life processes relevant in health and diseases. The 
deciphering of the code of the intermolecular communication at structural level has been 
revealed of enormous interest for the understanding of many biological processes such as 
biochemical cascades, enzymatic reactions, metabolism, fertilization, immune reactions, 
pathogen infection, and tumor metastasis among others. Over the years numerous techniques 
(isothermal calorimetry (ITC),1–3 quartz crystal microbalance (QCM),4,5 surface Plasmon 
resonance (SPR),6,7 X-ray crystallography,8,9 nuclear magnetic resonance (NMR)10–14…) have 
been developed for the study of these interactions. 
From a pharmaceutical point of view, the deep knowledge of the key interactions is of special 
importance for the rational design of proper drugs for therapeutic targets. Thus, the study of 
the molecular recognition has experienced a large development. The future perspective of 
molecular recognition is promising given the fast development of the technologies and the 
new information that will continuously be generated. As example of that, the supramolecular 
chemistry field has matured in the last years passing from the fundamental molecular 
recognition research that studied the formation of supramolecular complexes by non-covalent 
forces between species to the generation of molecular machines, awarded with the Nobel 
Prize in Chemistry in 2016.  
The structure of biomolecules and its dynamic behavior, in the context of the cellular medium, 
have a key role in molecular recognition events and hence in the biological activity. Therefore, 
the study of molecular recognition in solution is of central importance.  
Among the variety of techniques applied in molecular recognition studies, NMR provides 
valuable information at atomic level of the formed bio-complexes upon molecular recognition 
events in solution. This approach nicely complements the constraint environments required 
for other alternatives as X-ray crystallography.  
1.1.1. NMR in molecular recognition 
Since the first observation of the nuclear magnetic resonance (NMR) in the mid-1940s by 
Purcell and Bloch (awarded with Nobel prize in 1952), NMR has demonstrated to be a 
disruptive methodology in science endorsed by three additional Nobel prizes (Richard E. Ernst, 
1991; Kurt Wüthrich, 2002 and Paul C. Lauterbur and Peter Mansfield, 2003). NMR 
spectroscopy was firstly employed in organic chemistry for structural elucidation of synthetic 
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compounds, but numerous additional applications have been developed concerning other 
fields such as biochemistry15–17 or inorganic chemistry.18,19 However, over the years NMR 
(figure 1) has experienced a significant revolution with three major achievements because of 
technology improvement: 1. The early introduction of the Fourier transformation that 
decrease the acquisition times compare with the previous continuous wave method, 2. The 
development of multidimensional NMR, and 3. The introduction of cryo-technology that 
increase significantly the magnetic fields. The generalization of other breaking methods, such 
as Dynamic Nuclear Polarization is still under development.  
 
Figure 1. NMR timeline of the last 70 years. NMR hits are annotated. 
NMR20,21 is based in the intrinsic magnetic properties of several atomic nuclei that possess non-
zero nuclear spin quantum number, I. The property of nuclear spin is necessary for the 
resonance phenomenon. Therefore, the spinning nuclei possess angular momentum, P, with a 
concomitant magnetic momentum, . P is directly related with  by the magnetogyric ratio, , 
which is characteristic of each atomic nucleus (equation 1).  
𝜇 = 𝛾𝑃 
Equation 1. Relationship between the angular momentum and the magnetic momentum of a nuclear spin. 
According with the quantum rules, the magnetic momentum and the angular momentum are 
quantified. Thus, for a spin quantum number I, exist 2I+1 possible spin sub-states comprising 
from -I to +I values, for instance for a spin I=½ such as 1H, 13C or 15N, there are two possible 
degenerated energy levels ½ and –½ dubbed as  and . In the presence of an external 
magnetic field, B0, the degeneracy disappears splitting into two different energy levels. The 
energy difference between the two states is directly proportional to the strength of the 
magnetic field, B0, and is given by equation 2. 
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∆𝐸 = 𝛾ℏ𝐵0 
Equation 2. Energy between spin levels when applied a magnetic field, B0. 
The occupancy of the  and  energy levels is driven by the Boltzmann distribution (equation 
3). 
𝑁𝑙𝑜𝑤
𝑁𝑢𝑝𝑝
= 𝑒
−∆𝐸
𝑘𝑇  
Equation 3. Boltzmann distribution of the populations of the spin levels. 
The asymmetric distribution of the nuclear spin in the two states,  and , in the presence of 
an external magnetic field is the basis of the observation of NMR signals. When the radiation 
frequency matches with the energy gap between levels, it stimulates a transition from the 
fundamental state to the state of higher energy taking place the resonance condition. 
Noteworthy, the Boltzmann distribution is temperature dependent and the E between spin 
states is rather low even at high magnetic fields. Thus, the populations difference are similarly 
small being NMR very insensitive relative to other spectroscopies such as IR o UV. Every energy 
quantum is described by E= h,which in NMR is transformed into = B0 where  is the 
rotation frequency that the nucleus precesses (figure 2) with a circular path about the applied 
magnetic field, Larmor frequency.  
 
Figure 2. Diagram of the energy levels of a nucleus of spin I=1/2 when an external magnetic field is applied. 
Therefore, the Larmor frequency of each nucleus depends directly on the magnetogyric ratio 
and the strength of the magnetic field. However, in a molecule, the effective magnetic field, 
Beff, experienced by the nuclei of different atoms is affected by the nearby electrons of the 
chemical bonds and the chemical environment due to the shielding or de-shielding. 
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Consequently, the different nuclei of a molecule precess with a particular Larmor frequency 
depending on their chemical environment (equation 4). 
𝜔 = 𝛾𝐵𝑒𝑓𝑓 
Equation 4. Larmour frequency () of an atomic nucleus in the presence of a magnetic field, Beff. 
Hence, the Larmor frequencies are translated into terms of chemical shifts, , by equation 5. 
𝛿 (𝑝𝑝𝑚) = (
𝜔 − 𝜔𝑟𝑒𝑓
𝜔𝑟𝑒𝑓
) 106 
Equation 5. Definition of chemical shift. 
Where  is the Larmor frequency of the nucleus and ref is the reference Larmor frequency of 
a reference compound. 
From the beginning, NMR has been exploited to unexpected limits being in numerous cases 
preferred to other spectroscopic techniques even though its insensitivity. The great 
development of the NMR in the last decades has allowed the transition of the NMR from the 
structural organic chemistry to the biochemistry fields arising as a powerful and versatile 
technique for the study of biochemical processes thanks to the development of an immense 
variety of experiments able to extract detailed information at atomic level. 
1.1.2. Molecular recognition: Chemical equilibrium and kinetics exchange22 
Binding events are defined according to thermodynamics as an equilibrium between the free 
species and the bound complex. For a 1:1 ligand:receptor complex, the equilibrium is given by 
equation 6. 
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Equation 6. Equilibrium at the binding event. 
Where [R] is the receptor concentration, [L] the ligand concentration, kon is the rate constant 
to form the RL complex while koff is the rate constant for complex dissociation, which is 
inversely proportional to the lifetime of the bound complex. Therefore, the binding affinity is 
described by the dissociation constant (KD) as: 
𝐾𝐷 =
[𝑅] [𝐿] 
[𝑅𝐿]
=
𝑘𝑜𝑓𝑓
𝑘𝑜𝑛
 
Equation 7. Expression of the dissociation constant (KD). 
Thus, a strong binder (high affinity) with a long complex lifetime and concomitant low koff has a 
small KD whereas weak binder (low affinity) displays larger KD. As a consequence, strong 
ligands with small KD values saturate receptor sites at lower concentrations than weaker 
ligands. Under these conditions, any observed NMR parameter tends towards its endpoint, RL 
complex formation, very rapidly. Conversely, weak ligands have to be present in significant 
excess over the receptor to achieve significant populations of the bound complex and, hence, 
to induce an observable change on the NMR parameter. Experimentally, these considerations 
relative to the different KD limits are important for detection of ligands with different affinity.  
Most of the NMR observables used for the molecular recognition involved a change of NMR 
parameters as a result of receptor-ligand association. However, the kinetics of the binding and 
the residence time of the ligand at the binding pocket usually determine de final observable 
value of the NMR parameter. Consequently, if the observed NMR species are in rapid on-off 
exchange, the observed NMR parameter value may be, then, described by the molar fraction-
weighted contributions of the different species, free and bound, present in the binding 
equilibrium. For a two states system, equation 8 can be applied. 
𝑀𝑜𝑏𝑠𝑒𝑟𝑣𝑒𝑑 =  𝜒𝑓𝑟𝑒𝑒𝑀𝑓𝑟𝑒𝑒 + 𝜒𝑏𝑜𝑢𝑛𝑑𝑀𝑏𝑜𝑢𝑛𝑑 
Equation 8. Observed NMR value in a rapid exchange equilibrium for a two-states system. 
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Where M is the observable NMR parameter and χ is molar fraction. Thus, the bound 
population must be sufficient to induce a variation on the NMR observable parameter. This 
situation is very important for the case of chemical shift; in the fast-exchange regime, one 
unique signal will be observed, located at the molar fraction-weighted average between both 
end states (equation 8). 
In the case of slow on-off exchange, the chemical shift will display different values for each 
possible form. In this case, their signal intensities will be proportional to the corresponding 
molar fractions (equation 9). 
𝑀𝑜𝑏𝑠𝑒𝑟𝑣𝑒𝑑 1 =  𝜒𝑓𝑟𝑒𝑒𝑀𝑓𝑟𝑒𝑒  
𝑀𝑜𝑏𝑠𝑒𝑟𝑣𝑒𝑑 2 =  𝜒𝑏𝑜𝑢𝑛𝑑𝑀𝑏𝑜𝑢𝑛𝑑 
Equation 9. Observed NMR values in a slow exchange equilibrium. 
However, in the intermediate on-off exchange, a new component related to the exchange 
kinetics contributes to the final shape and intensity of the NMR observed parameter. A 
complex function results from the contributions of the bound and free forms and their 
exchange kinetics (equation 10). 
𝑀𝑜𝑏𝑠𝑒𝑟𝑣𝑒𝑑 = 𝑓(𝜒𝑓𝑟𝑒𝑒𝑀𝑓𝑟𝑒𝑒; 𝜒𝑏𝑜𝑢𝑛𝑑𝑀𝑏𝑜𝑢𝑛𝑑; 𝑘𝑒𝑥𝑐ℎ𝑎𝑛𝑔𝑒) 
Equation 10. Observed NMR values in an intermediate exchange equilibrium. 
1.1.3. NMR parameters in the context of intermolecular complex, equilibrium, dynamics, 
structure and size 
Different NMR observables are useful to monitor binding events. As already mentioned, the 
value of the NMR observable depends on the equilibrium exchange rate. Below, we described 
some of the most common NMR observables used for analyzing molecular recognition 
processes. 
1.1.3.1. Chemical Shift 
The chemical shift is very sensitive to the chemical environment of the observed nuclei. Thus, if 
a ligand binds, its own chemical environment as well as that of the receptor binding pocket, 
changes. This fact induces perturbations in the chemical shift of the nuclei of both binding 
partners. Indeed, the observation of changes in the chemical shift in one binding partner upon 
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addition of the other may be observed in either monodimensional spectra or 2D NMR spectra. 
Due to the different on-off exchange rates in ligand binding, different chemical shift 
perturbation effects (figure 3) may be described, depending on the presence of fast, slow or 
intermediate exchange (equations 8-10). 
  
Figure 3. Scheme of the chemical shift variation depending on the exchange rate. 
However, changes in the chemical shifts may be also caused by changes in the solvent 
environment (pH, ionic strength of the buffer or temperature) or intrinsic ligand and/or 
receptor conformation. Thus, a precise sample handling helps in the discrimination of the 
chemical shift perturbations of relevance for the binding event over those due to changes in 
the solvent environment. 
1.1.3.2. Relaxation rates 
After any perturbation of an external force, the perturbed system takes time to return to its 
equilibrium state. In NMR experiments, two main time-dependent magnitudes, relaxation 
modes, are of interest depending on the orientation where the magnetization of the observed 
nuclei is located with respect to the static magnetic field of the spectrometer. Thus, 
longitudinal relaxation (R1=1/T1) and transverse relaxation (R2=1/T2) rates are described 
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corresponding to the evolution of the magnetization when parallel to the external field (z-axis) 
or orthogonal to it (x,y plane)  respectively.  
The relaxation rates of nuclear spins depend on the global rotational correlation time (c) of 
the molecule, directly related with the molecular size in solution, and hence on the molecular 
weight. Thus, ligands with low molecular weight display large T1 (small R1) and large T2 (small 
R2) with a concomitant slow longitudinal and transverse relaxation rates. In contrast, receptors 
with large molecular weight display large T1 (small R1) and small T2 (large R2) with a 
concomitant slow longitudinal relaxation and fast transverse relaxation rates (figure 4). 
 
Equation 11. Representation of the relaxation times evolution with c. 
In the molecular recognition event, the bound ligand adopts the relaxation properties of the 
receptor and transiently retains these properties after dissociation, depending on its relaxation 
rates. The observation of the change of the ligand NMR properties is often used as indicative 
of binding. 
 
Figure 4. Relaxation properties of the species in the binding equilibrium. 
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1.1.3.3. Dipolar interactions: Nuclear Overhauser Effect (NOE) 
The nuclear Overhauser effect (NOE) has been largely exploited in NMR for conformational 
analysis studies. The NOE is based in the dipolar coupling of the nuclear spins through the 
space. Dipolar coupling or dipole-dipole interaction occurs via cross-relaxation, a process 
through which an excited nuclear spin reverts to its equilibrium populations affecting other 
closer spins by dipole-dipole interaction. Since cross-relaxation has a strong dependency with 
the distance, the NOE intensity is actually proportional to r-6. Thus, the inter-nuclei distance is 
critical for the observation of NOE, which provides information on the 3D structure and 
conformation. Furthermore, the NOE intensity sign depends on the global rotational 
correlation time (c) of the molecule. Thus, small molecules with a short c display positive 
NOE, while large molecules with large c have opposite sign (figure 5). 
  
Figure 5. NOE dependency with the total correlation time (c) and spectrometer frequency (). 
Based on the characteristics of the NOE, in addition of its extensive use in conformational 
analysis, it has been used for the identification of molecular recognition events. For instance, 
the transferred NOESY experiment (tr-NOESY) applies the simple observation of sign change in 
ligand NOESY cross peaks (figure 6). 
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Figure 6. NOEs of the  interacting species in the binding equilibrium. 
1.1.3.4. Hydrodynamic diffusion coefficient: Diffusion ordered spectroscopy (DOSY)23 
With the development of reliable gradient technology for NMR the investigations of diffusion 
processes by pulsed-field gradient (PFG) became possible. Diffusion can be either investigated 
by analysis of the relaxation data or by PFG.24 However, the PFG based experiments are 
sensitive to motions at the ms to s time-scale, matching with the molecular recognition time-
scale. Diffusion ordered spectroscopy (DOSY) is a PFG based experiment that facilitates the 
study of mixtures by the different diffusion properties of the components. DOSY has been 
further applied to study binding of low-molecular weight ligands to large receptors.25–28 The 
main concern is that the ligand has to reside significant time in the binding pocket to detect 
significant changes in the diffusion coefficient since the observed diffusion coefficient consists 
in the linear average of the diffusion constant of the ligand in the free and bound state 
(equation 6). 
𝐷𝑜𝑏𝑠𝑒𝑟𝑣𝑒𝑑 =  𝜒𝑓𝑟𝑒𝑒𝐷𝑓𝑟𝑒𝑒 + 𝜒𝑏𝑜𝑢𝑛𝑑𝐷𝑏𝑜𝑢𝑛𝑑 
Equation 12. Diffusion coefficient observed of a binder in DOSY experiments. 
Where D is the translational diffusion coefficient. 
The diffusion coefficient is defined by the Stokes-Einstein equation being inversely 
proportional to the hydrodynamic radius of the molecule (equation 13). 
𝐷 ∝
1
𝑟
 
Equation 13. Relation between the hydrodynamic radius (r) and the diffusion coefficient (D). 
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Therefore, recognition by the receptor strongly affects the hydrodynamic behavior of the 
ligand inducing changes on its diffusion coefficient. This fact is observable by the decrease of 
the diffusion coefficient in the DOSY experiment. Obviously, receptor diffusion coefficient is 
also affected but the much smaller diffusion coefficient of the receptor, Dfree, makes the 
contribution of the bound ligand, Dbound, insignificant.  
1.1.3.5. Different time-scale processes observable by NMR 
One of the advantages that have favored NMR to establish as a versatile tool to study dynamic 
systems is its large time-scale window. The NMR time scale rangs from the ps to s. Many key 
biochemical processes such as protein motions, ligand binding, or enzyme kinetics occur at 
these times.  Thus, different NMR parameters provide essential information for these studies. 
 
Figure 7. NMR parameters and molecular motions at the NMR time scale. 
1.1.4. NMR experiments in molecular recognition 
The study of molecular recognition events can be addressed from different perspectives. A 
variety of NMR experiments can be applied for gathering the required information. Two 
perspectives are commonly employed to describe the recognition phenomenon between 
partners. The first one involves the observation of the ligand properties. The second one, the 
observation of the receptor properties. Both perspectives are widely used and provide 
complementary information of the molecular recognition event.  
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1.1.4.1. The ligand point of view29,30 
The ligand NMR perspective is often used for the study of weakly binding ligands. Normally, 
ligands are small molecular weight molecules whose characteristic NMR properties change 
with the association to large molecular weight macromolecules, proteins or DNA fragments. As 
already mentioned, small molecules, due to their size, display a fast Brownian motion, 
associated with a rapid tumbling rate, a concomitant fast rotational motion correlation time, 
and slow relaxation. Opposite properties, slow Brownian motion, slow tumbling, and large 
rotational motion correlation times, associated with fast transverse relaxation, are 
characteristic of macromolecules. Therefore, binding of ligands to macromolecules may be 
detected by the observation of increased transverse relaxation rates in the presence of the 
receptor. Qualitatively, these relaxation changes are easily observed by monitoring the line 
width of ligand signals in the free-state and in the presence of the receptor. In fact, the 
observed linewidth is inversely proportional to T2. Thus, the observation of an increase of the 
line width in a simple 1H NMR 1D spectrum is the first indication of binding (figure 8). 
 
Figure 8. Example of line broadening as diagnostic of binding. On the top: 
1
H spectrum of a ligand (Mw=1750 Da) 
in the presence of its receptor (Mw=30 KDa). On the bottom: 
1
H spectrum of the ligand in absence of receptor. 
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Furthermore, changes in the chemical shifts may be observed in the simple 1H NMR spectrum, 
which are also indicative of binding. 
1.1.4.1.1. Saturation transfer experiments 
Additionally, other methods based in a selective transfer of magnetization during the ligand 
residence time at the receptor binding pocket are frequently employed in ligand-based NMR 
methods. The saturation transfer experiments take advantage of the selective transfer of 
magnetization from one of the partners in the binding event (the receptor in this case) to the 
other partner (the ligand). This transfer perturbs its populations of the  and  states and can 
be easily detected in the NMR signals. 
1.1.4.1.1.1. Saturation transfer difference NMR (STD-NMR) 
The STD-NMR experiment is a robust and powerful experiment for identifying ligand-receptor 
interactions. It has been widely used for molecular recognition and it is suitable for NMR 
screening of ligand libraries. Indeed, it is of special relevance in the pharmaceutic industry for 
screening and fragment based drug discovery (FBDD),31–34 since STD-NMR allows from one 
side, the direct observation of the bound ligand filtering the NMR signals for those non-
binders. Moreover, it provides epitope information. 
STD-NMR35,36 is based on the transfer of magnetization between the receptor, which is 
selectively irradiated by a train of radiofrequency pulses, and any ligands bound to it. The STD 
spectrum, as its name indicates, is a difference of two 1D 1H NMR spectra: the on-resonance 
spectrum, in which the saturation pulse is applied selectively on the receptor signals, and the 
off-resonance spectrum, in which this pulse is applied away from any receptor and ligand 
signals. Typically, in the case of protein receptors, the on-resonance irradiation pulse is set 
around the aliphatic region (from −1 to 1 ppm) or alternatively around the aromatic region 
(usually 6–8 ppm) if the ligand has no aromatic signals.28 The saturation quickly propagates 
along the macromolecule via spin diffusion (dipolar cross relaxation mechanism), and then 
from the macromolecule to the ligand’s nuclei in close contact with the macromolecule (r < 4–
5 Å). The dissociation of the ligand, according to binding exchange kinetics, allows saturated 
ligand molecules to accumulate, and when the NMR spectrum is recorded, the saturated nuclei 
give rise to attenuated signals due to the inversion of the spin populations induced by the 
transferred saturation (figure 9). As blank, off-resonance spectrum is acquired. In the off-
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resonance spectrum, the saturation pulse is set at a frequency where no signals of either 
receptor or ligands appear (e.g. 100 ppm). The subtraction of the on-resonance from the off-
resonance spectra gives a difference spectrum showing the signals of those nuclei of the ligand 
that had received magnetization during their binding to the macromolecule. Analysis of these 
signals not only permits the identification of binding ligands among a mixture of compounds 
challenging the receptor, but also provides information of their binding epitope (figure 10), 
since nuclei of complex ligands, which are closer to the protein, become more saturated than 
those that do not participate directly in the binding.37 
 
Figure 9. Scheme of the STD experiment for binder identification. Panel A: Selective transfer of magnetization 
from the irradiated protein to a bound ligand (red triangles). Panel B: Simulated STD spectrum, in which 
saturation of the bound molecule leads to a decrease of its NMR signals in the on-resonance spectrum. The STD-
difference spectrum reveals only the NMR signals of saturated molecules. 
 
Figure 10. Scheme of the STD information for epitope mapping. Closer nuclei receive higher saturation from the 
receptor while nuclei far from the receptor are not affected. 
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Typically, STD-NMR experiments require small concentrations of receptor (low micromolar) in 
the presence of a large excess of ligand (50 to 100 fold excess), making this technique very 
convenient in terms of protein economy. From the information given, bound ligands may be 
efficiently detected and epitope mapping inferred and, in favorable cases, the binding affinities 
can be quantitatively estimated from initial saturation rates measured by ligand titration at 
different saturation times.38,39 However, STD-NMR presents limitations. Due to its intrinsic 
dependency on fast exchange, STD-NMR is only useful for systems with KD in the 10
−8 to 10−3 M 
range, thus hampering the direct observation of high affinity ligands. Nevertheless, these 
ligands may be detected by means of competitions experiments with weaker and observable 
ligands. In addition, STD-NMR based competition studies with a well-known ligand not only 
permits the elucidation of the binding site, in the case of a competitive inhibition, but also the 
estimation of apparent binding affinities of other ligands by competitive titrations.  
1.1.4.1.1.2. Water-LOGSY 
In the Water-LOGSY NMR experiment the saturated entities are the bulk water molecules.40,41 
Water molecules at the surface of the receptor’s binding pocket display similar characteristics 
to those of large molecules, whereas solvation water molecules of ligands behave like small 
molecules. Since the nuclear Overhauser effect (NOE) is related to the global rotational 
correlation time of the system, solvating water molecules adopt similar NOE properties than 
the solvated molecule, receptor or ligand, and display negative or positive intermolecular 
NOEs, respectively.  
The WaterLOGSY experiment takes profit of the transfer of magnetization of bulk water 
molecules via different pathways. One pathway involves 1H–1H cross-relaxation mechanisms 
between the bound ligand and the water molecules of the binding pocket. A second pathway 
occurs via cross-relaxation with exchangeable protons of the receptor (i.e. of amino (NH) or 
hydroxyl (OH) groups), which propagate inverted magnetization to bound ligand protons.42 
These pathways of magnetization transfer act constructively. In all cases, inverted 
magnetization is transferred during the mixing time from the water molecules at the binding 
pocket to the bound ligands, yielding a change of sign of their NOEs to negative, characteristic 
of large molecules. In contrast, non-binders maintain the positive sign of their NOEs. The 
resulting spectrum displays signals of one sign for bound ligands that have received saturation 
during the mixing time and signals of the alternative one for non-binders. 
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The experimental requirements are similar to those of STD, i.e. small amounts of protein and 
excesses of ligand (up to 50-fold excess). However, the samples must be prepared in non-
deuterated water. Information obtained through WaterLOGSY experiments is comparable to 
that obtained through STD-NMR. In contrast with STD-NMR, WaterLOGSY is less dependent on 
spin diffusion, being the preferred method when studying receptors of low proton densities, 
such as nucleic acids.41 
1.1.4.1.2. Transferred NOESY (tr-NOESY) 
Since its introduction by Bothner-By in the early seventies, tr-NOE NMR spectroscopy43,44 has 
been thoroughly used to study receptor–ligand interactions. This technique focuses on the 
change of sign in the ligand NOE peaks upon binding to the receptor. This is due to the 
dependence of the NOE sign on the global motion rotational correlation time of the molecule, 
which in turn, is related to its molecular size. As in any NOE-based experiment, transferred 
NOEs provide information on the conformation of the ligands, now in their bound states. The 
tr-NOESY experiment is a regular 2D NOESY experiment in which the cross-peaks of the ligand 
change their NOE sign by virtue of the fact that, in the bound state, they adopt the motional 
properties of the macromolecule. As a result, non-binders show no NOE sign change upon the 
presence of receptor and their NOEs remain positive, while binders show negative NOE cross-
peaks. Of note, the observed NOE is a contribution of both the free (positive NOE) and the 
bound ligand (negative NOE), but the cross-relaxation rate of the bound ligand is much larger 
than that in the free-state. Thus, the observed NOEs show a predominance of the contribution 
arisen by the bound form, even for low populations of the complex. Thus, the tr-NOESY 
experiment not only helps to detect interactions, but also provides geometrical information of 
the conformation of the ligand in the bound state. 
1.1.4.1.3. Other Nuclei 
Biochemically, few nuclei are of interest apart from proton, oxygen, carbon or nitrogen which 
are present in almost all biomolecules. Unfortunately, only 1H is the natural abundant isotope 
with nuclear spin I= ½ and high magnetogyric ratio. However, carbon and nitrogen have NMR 
active isotopes with I=½, 13C and 15N respectively, even though their abundance is immensely 
low (1% for 13C and less than 0.5% for 15N). Nevertheless, they are useful observables for 15N-
labeled protein NMR and direct 13C NMR detection methods.  
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However, other minor nuclei of particular interest have been explored such as 31P or 19F, both 
NMR active with a nuclear spin of I= ½ and natural abundant. Nevertheless, 31P-NMR is rather 
limited to clinical applications i.e. to assess metabolites.45 On the other hand, 19F has been 
exploited extensively in medicinal chemistry and is present in numerous bioactive drugs and 
carbohydrates mimetics.46–49 Thus, its importance in the pharmaceutic industry has enhanced 
19F NMR development.50,51  
19F NMR displays similar sensitivity to that observed for 1H due to their similar magnetogyric 
ratios. The large spectral width allows the simultaneous screening of complex mixtures of 
molecules with minor signal overlapping. Additionally, the large chemical shift anisotropy of 19F 
makes it very sensitive to binding to a receptor. From the ligand perspective, 19F show 
additional advantages to those already mentioned, simplifying the interpretation of the 
spectra, since biomolecules does not incorporate fluorine. Thus, only signals of the ligand are 
observed without the introduction of any filter to remove the undesirable receptor signals. 19F 
relaxation based experiments52 and 19F STD-NMR experiments53 have also been introduced for 
studying ligand binding. 
1.1.4.2. The receptor point of view 
As mentioned before, although the ligand NMR point of view offers a variety of procedures for 
understanding the ligand behavior in the bound state, no direct information of the receptor 
may be extracted. In addition, the adoption of a ligand point of view NMR approach is 
desirable for weakly bound ligands. The gained information fades away for stronger affinities. 
Thus, the molecular recognition process can also be addressed from the NMR receptor 
perspective. It is well established and has been applied to proteins and large receptors since 
the early 1990s. Normally, the receptor point of view methodologies involve 2D NMR with 
isotopically 15N and/or 13C labeling of the receptor due to the complexity of handling the huge 
number of resonances in the 1H NMR spectra. Therefore, it can be used for gathering 
information on conformational changes, binding pocket residues, affinity constants or other 
related receptor features.  
1.1.4.2.1. Chemical Shift Perturbations. 1H-15N HSQC experiments 
The current advances in protein expression have permitted the development of 1H-15N 
heteronuclear spectroscopy to assess information of the backbone amino acids changes upon 
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ligand binding. The chemical shift perturbation (CSP) analysis has emerged as the most 
frequently used method to study molecular recognition events from the receptor perspective. 
However, different challenges related with protein expression and the assignment of the 
amino acid resonances, which is very time-consuming and expensive, should be previously 
overcome. Protein labeling strategies and protein NMR have allowed the detailed study of 
domains up to 40 KDa.28,54 However, partially labeled domains of larger proteins are also 
feasible and enough to extract the information of interest even though the limits are pushing 
further.30  
The monitoring of the CSP of the protein resonances in a 1H-15N HSQC spectrum, as a result of 
a change in the chemical environment of the amino acids induced by ligand binding, provides 
information of the amino acids involved in the molecular recognition event. This methodology 
involves the acquisition of two protein 1H-15N HSQC spectra, before and after ligand addition. 
The simple monitoring of the resonances shows up the amino acid comprising the binding 
pocket but also KD could be extracted by titration with the ligand. The observed CSPs could be 
quantified as an average of the perturbed nuclei (1H and 15N) with a correction factor due to 
the different magnetogyric ratios. 
In comparison with the already ligand-observed described procedures, protein 1H-15N HSQC 
CSPs provide information of the receptor binding pocket but in contrast it is more time- and 
material-consuming and, due to the requirement of isotopically labeled proteins, it is also 
more expensive. Experimentally, this procedure is applicable to proteins of moderate size (up 
to 40 KDa) not only because of 15N labeling limits but also due to unfavorable relaxation 
properties of larger macromolecules and its concomitant signal linewidth. Nevertheless, it 
allows the study of a wider range of ligand affinities. 
1.1.4.2.2. Chemical Shift Perturbations. NOESY/TOCSY experiments 
In its simple version, the interaction between ligands and small-peptides or short nucleic acids 
sequences, may also be studied from the receptor’s perspective by monitoring their 1H CSPs in 
standard two-dimensional experiments (TOCSY, NOESY) using an unlabeled receptor. In such 
cases, the assignment of the receptor’s 1H NMR signals can be achieved with the standard 
strategies used for spectral assignment of small ligands, using a combination of TOCSY and 
NOESY experiments. Once again, for CSP analysis, two spectra, before and after ligand addition 
should be recorded.  
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Obviously, the NOESY spectra also provide information on the conformation and the 3D 
arrangement of the receptor in both states, free and bound, allowing the observation of 
conformational changes at the molecular recognition event, if any, and the possible 
intermolecular contacts. 
1.1.4.2.3. Relaxation 
As mentioned before, relaxation properties are characteristic of each type of molecule and 
depend on the global motion rotational correlation time. However, in biomacromolecules, due 
to the different local dynamics (folding-unfolding, loops, amino acids side chain mobility), local 
differences may appear that affect their relaxation behavior. 
The Lipari and Szabo model, also dubbed model free approach, was developed in the 80s to 
correlate NMR relaxation data to protein mobility and has been widely accepted. The 
assumptions of the model free approach are consistent to describe the dynamics of globular 
isotropic proteins.21 The employed NMR parameters with dynamic information are the 
longitudinal relaxation rate (R1), the transversal relaxation rate (R2) and the heteronuclear NOE 
effect (hetNOE).  The tendency of these NMR parameters over time is employed for the 
qualitative interpretation of the protein motions. These parameters describe the mobility of 
each N-H vector of the amino acids of the backbone. The protein regions with a high mobility 
are encoded by small R1 (R1=1/T1) and R2 (R2=1/T2) values and negative hetNOE while motion 
restricted amino acids display positive hetNOE, large R2 and small R1.  
 
Figure 11. Representation of the variation of T1 (1/R1), T2 (1/R2) and hetNOE. 
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Experimentally, the dynamic study of a protein is expensive. It is a material-consuming 
process, with a high cost because of the need of 15N labeled protein. It is also time-consuming, 
since NMR relaxation experiments require long time for the acquisition of long sets of spectra 
for the case of R1 and R2. In addition, for an efficient analysis of the protein dynamics, the NMR 
relaxation data should be acquired at different magnetic fields, thus increasing the 
experimental time.  
1.2. Key interactions in molecular recognition events 
The nature of molecular recognition of biomolecules, such as proteins, carbohydrates or DNA, 
resides in the existence of weak intermolecular forces between the species. In fact, two major 
sets of intermolecular forces have been described: polar and non-polar interactions. 
Nevertheless, other mediated intermolecular interactions may happen. 
1.2.1. Polar interactions: Hydrogen bonding55,56 
The formation of a hydrogen bond (HB), in general, involves the presence of a hydrogen bond 
donor, characterized by the presence of a hydrogen covalently bonded to an electronegative 
atom, and a hydrogen acceptor, also usually an electronegative atom. This atom provides a 
lone pair of electrons to be shared with the donated hydrogen that accommodates the 
electron density on its valency layer. Frequently, electronegative atoms like O or N atoms may 
act on both sides of the hydrogen bond, as hydrogen donors when they have covalently 
bonded hydrogen. Together with fluorine, they may also act as acceptors when they provide a 
lone pair of electrons to be shared with the donated proton. 
Because of the prevalence of these atoms (O, N and H) in biological systems, HB plays an 
important role in molecular recognition contributing not only to affinity but also to selectivity. 
HB is the most evident in carbohydrate recognition by proteins due to the presence of 
numerous –OH groups in saccharides with simultaneous behavior as donor and acceptor that 
may establish HB with amines and carbonyl groups from the protein backbone and side chains 
of polar residues (figure 11).  
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Figure 12. Hydrogen bonding representation in carbohydrate recognition. Adapted from Gabius et al.
56
 
1.2.2. Non-polar interactions55–57 
Apart from hydrogen bonding, non-polar interactions also contribute to the molecular 
recognition between biochemical species. They are of special interest when aromatic protein 
residues are involved in the recognition event. For instance, the non-polar CH groups of a 
ligand tend to pack with adjacent aromatic rings establishing CH-pi interactions. The geometry 
condition for CH-pi interactions requires the presence of CH groups perpendicular to the 
aromatic ring where the CH-pi system stabilize the complex formation by entropic and 
enthalpic contributions. Since the stabilizing energy of one CH-pi interaction is rather low, (CH-
pi interaction ca.= 1 kcal/mol), the simultaneous CH-pi interaction of various CH groups could 
finally drive the molecular recognition. Indeed, CH-pi interactions have been deeply described 
in carbohydrate recognition58,59 (figure 12). 
 
Figure 13. CH-pi interaction representation in carbohydrate recognition. Adapted from Gabius et al.
56
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1.2.3. Other interactions55,56 
Due to the complexity of the biochemical systems in molecular recognition, other polar and 
non-polar intermolecular interactions may take place. Some of them involve third partners, 
such as ions or water molecules.  Water mediated interactions take place when a water 
molecule establishes HB simultaneously with both partners, ligand and receptor. The nature of 
this interaction resides in the presence of solvating water molecules in the binding pocket that 
enhances the ligand binding mediating as a “bridge” between the ligand and receptor.  
Similarly, ion mediated intermolecular interactions take the advantage of electrostatic forces 
established between both partners and one ion present at or close to the binding site. As 
water mediated interactions, the ion may act as a bridge between the partners and/or to 
stabilize the amino acid side chains in the proper orientations to bind the ligand (figure 13). 
 
Figure 14. Ion mediated interaction in carbohydrate recognition. Adapted from Gabius et al.
56
 
In summary, molecular recognition involves the cooperative contributions of several 
intermolecular forces to form stable supramolecular receptor-ligand complexes.  
1.3. Ligands and receptors 
All types of molecules of biological interest, proteins, nucleic acids, carbohydrates, vitamins, 
drugs, etc., participate in one way or another as recognition partners. Therefore, the study of 
these processes at atomic molecular level is of paramount importance for understanding their 
mechanism and functionality and the pathological consequences derived of their malfunction. 
In a further step, this knowledge would drive the basis for drug design strategies to control and 
modulate such processes in a therapeutic context. In the present thesis, some examples of 
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ligand-receptor partners, carbohydrates and their protein receptors as lectins and antibodies, 
natural products that bind tubulin, an essential protein of cell cytoskeleton, synthetic 
compounds and peptides  that can bind to nucleic acids or control its transcription, have been 
studied by the NMR methodologies introduced above. 
 1.3.1. Carbohydrates 
During long time, carbohydrates (glycans, sugars, saccharides) were exclusively considered as 
the first source of energy for living organisms while the study of further capabilities was not 
relevant. Large efforts have been put on the last decades to understand transcriptional and 
translational processes. However, little attention was initially paid to post-transcriptional 
processes. Nevertheless, after the observation of carbohydrate in membranes, other aspects 
started to be scrutinized. Therefore, the discovery of the glycocalyx has motivated the study of 
their biological functions, thus boosting advances in glycosciences including glycomics. 
It is evident today that carbohydrates, when conjugated as glycoproteins or glycolipids at the 
glycocalix, play an important role in numerous life processes and also transmit important 
biological information. Carbohydrates at the glycocalix are involved in molecular recognition 
processes by establishing interactions with antibodies, proteins, viruses, cells, bacteria… (figure 
14) that trigger a variety of intracellular and extracellular processes of special physiological and 
pathological interest. 
 
Figure 15. Cell membrane carbohydrates and their interaction with antibodies, bacteria, proteins, virus and cells. 
 Chapter 1. Introduction 
26 
 
1.3.1.1. Monosaccharides 
Carbohydrates constitute a large group of biomolecules built by monosaccharides. In nature, 
different monosaccharides exist with different number of carbon atoms. All of them share 
similar structural features. Monosaccharides are composed by poly-hydroxylated carbon 
chains, usually from five to seven carbon atoms, with a carbonyl group ketone (ketoses) or 
aldehyde (aldoses). The high diversity and complexity of carbohydrates may be even noticed at 
the monosaccharide level due to the vast number of possible monosaccharides. However, this 
structural variability is even increased when the monosaccharide is studied in solution because 
of their cyclization event. 
For the case of hexoses, for instance glucose (Glc), two different heterocycles could be formed 
in solution: 5-membered ring (furanose) or 6-membered ring (pyranose) (figure 15). Moreover, 
the cyclization introduces a new source of variability of special interest in pyranoses related 
with the flexibility of the 6-membered ring and the spatial orientation of the functional groups 
in either axial or equatorial orientation.60,61 Therefore different conformation may be adopted 
in fast equilibrium among them. In the case of Glc,62 the most populated conformation is the 
chair form 4C1 since the all the hydroxyl groups are in equatorial minimizing the steric 
hindrance with axial hydrogens (figure 16). The molecular recognition features of 
carbohydrates have been largely explored and sugar conformation was found critical for the 
complex formation.63 
Even though, in a 6-membered ring, the minimum of energy is acquired by the accommodation 
of bulky groups in equatorial orientation, pyranoses experienced a stabilization of the axial 
orientation of the hydroxyl of the hemiacetalic moiety at the anomeric position (carbon 1 in 
the Glc example in figure 17) dubbed anomeric effect. 
 
Figure 16. Schematic representation of glucose (Glc). On the left: open chain form. On the right: possible 
cyclizations in solution. 
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Figure 17. Conformational equilibrium of glucopyranose (Glcp). 
1.3.1.2. The anomeric effect64–68 
The anomeric effect was firstly postulated in the 1950s by Edward69 and Lemieux and it has 
remained a controversial topic in science. The anomeric effect describes the stabilization of the 
axial electronegative substituent at the anomeric position due to orbital and electronic factors 
produced by the presence of a cyclic oxygen atom. The tendency of the anomeric -OH or 
electronegative substituent to adopt axial orientation (-anomer) rather than equatorial (-
anomer) is in contrast to what would be expected based on steric factors (figure 18). However, 
modelling and computational approaches have permitted the understanding of this 
phenomenon.70,71  
The stabilization of the -anomer is produced by the hyperconjugative effect between the 
lone pair orbitals from the endocyclic oxygen and the s* orbital of the C-X bond with the 
exocyclic substituent. In the axial configuration, this antibonding orbital displays the proper 
orientation to accommodate lone pair of electrons from the endocyclic oxygen.66 This orbital 
conjugation is not possible in the equatorial configuration of the -anomer. 
 
Figure 18. Equilibrium between Glcp anomers. The intermediate open form is not represented. 
1.3.1.3. Oligo and polysaccharides 
The association between monosaccharides (glycosylation) results in more complex 
biomolecules, oligo- and polysaccharides. The linkage between two monosaccharide units 
receives the name of glycosidic linkage and present several features that make it unique. The 
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different conformations adopted around the glycosidic linkage are defined by the torsion 
angles  and . Additionally in the case of 1-6 linkages there is one additional torsion,  
(figure 19). The geometry of the glycosidic linkage has also steric, electronic and orbital factors 
(the exo-anomeric effect)68,72,73 that favors the adoption of certain range of angles.74 
 
Figure 19. Representation of the glycosidic linkage angles. 
If the variability of monosaccharides is enormous, the variability of oligosaccharides is much 
higher and increases exponentially with the number of units.  From the linear disaccharide, an 
additional third unit could result in a branched or linear trisaccharide with its concomitant 
level of complexity. Therefore, over other biomolecules, the number of possible combinations 
of oligosaccharides gives to carbohydrates the ability to encode huge biological information 
with few monosaccharide units.75 Moreover, carbohydrate modifications have been also 
observed in nature with critical consequences. For instance, blood group A and B (figure 20) 
compatibility is driven by a single modification on the oligosaccharide, the presence or absence 
of a N-acetyl group in the terminal galactose (Gal)  results in the rejection of the blood 
type.76,77 
 
Figure 20. Chemical structures of the oligosaccharides of blood group types A and B. 
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In addition, carbohydrates, from monosaccharide units to polysaccharides, may be also 
conjugated with other biomolecules such lipids or proteins. Actually, more than half of human 
proteins display glycosylation in post-translational modifications constituting glycoproteins. 
Glycosylated lipids form glycolipids.78,79 
1.3.2. Proteins 
Proteins are the most common receptors in the biological molecular recognition processes. 
Carbohydrates and ligands are recognized by biochemical partners belonging to different 
protein families such as enzymes, lectins, antibodies or others.  
Enzymes are a class of proteins involved in biochemical transformations. In fact, the main 
metabolic transformations of sugars are mediated by enzymes that transfer monosaccharides 
to different scaffolds (glycotransferases) or destroy glycosidic linkages to obtain carbohydrate 
subunits (glycosidases).80 Additionally, a great variety of other types of enzymes 
(oxidoreductases, isomerases, kinases, acylases, etc) are responsible of further chemical 
modifications of the monosaccharide units. One of the key principles of the enzymes is their 
precise substrate selectivity and conversion efficiency that has been exploited in-vitro in 
carbohydrate synthesis facilitating the chemo-enzymatic synthesis of complex oligosaccharide 
structures.81–85  
Lectins are a large family of proteins from different sources that specifically recognize 
carbohydrates without producing any transformation on them. Historically, the term “lectin” 
derives from the latin verb “legere” that means “to select” and was proposed by W. C. Boyd in 
195486 for naming some specific blood agglutinins from vegetal seeds and specific of blood 
groups. Nowadays, “lectin” is applied, in general, to proteins (excluding antibodies and 
enzymes) that interacts reversibly with saccharides.87 
 Finally, antibodies consist in proteins from the immune system important in the defense of 
the organism against pathogens and other external aggressions and distinguish “self” from 
“non-self” structures. Many pathogens and aberrant cells present characteristic oligo- or 
polysaccharide structures in their cellular envelopes.88,89 The immune system is able to 
interpret carbohydrate structures as cell signatures and, hence, to synthesize specific 
antibodies against non-self-structures to protect the organism.90,91 Interestingly, as mention 
above, a recognition process of special relevance for human species is the identifications of 
blood groups ABO (figure 20) that is mediated by carbohydrate-antibody interactions.76,77,92 
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Proteins are the main executors of life processes. An alteration of the protein function often 
triggers pathological disorders, misfunction or over- or under-expression. However, different 
therapeutic approaches based on ligand binding to these therapeutics targets have been 
developed to inhibit or promote protein activity or to inhibit or promote protein expression. 
Thus, proteins are, in essence, the main concern in the molecular recognition applied to 
medicinal chemistry. The further knowledge of the protein molecular recognition features and 
structure led to the better design of inhibitor and binders. In this context, other proteins that 
are involved in important cell and life processes such the case of tubulin, which plays a main 
role in mitosis, has been validated as antitumor therapeutic target.93  
1.3.2.1. Lectins 
As mentioned above, lectins belong to a carbohydrate binding protein family distinct from 
antibodies and enzymes. Lectins are glycan specific receptors that present a structural diversity 
and are ubiquitous in nature. Indeed, lectins are present in virus and microbes, plants, animals 
and humans (figure 21). Due to the diversity of the lectins, many different classifications 
attending to carbohydrate specificity, structure or functions have been proposed. 
 
Figure 21. Lectin distribution over different species. 
Among the lectin family, certain amino acids have been found at the carbohydrate binding site 
that drives carbohydrate specificity. This applies to aromatic residues that establish CH-pi 
interactions with the hydrophobic face of the sugar and arginine, aspartate and glutamate 
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residues which may establish bidentate HB interactions with hydroxyl groups of the 
saccharide.94 
Galectins, a family of 15 lectins with affinity to -galactose95,96 containing oligosaccharides and 
a basic structural -sandwich fold, display a conserved carbohydrate recognition domain (CRD) 
of around 130 amino acids where a central tryptophan (Trp) residue is the key feature for 
carbohydrate interaction.97 These structural features differentiate galectins from other -
sandwich lectins such as calnexin or pentraxins. In galectins, the CRD may be found in three 
types of structural contexts, proto- (non-covalent association of CRDs), chimera- (CRD 
connected to an N-terminal tail) and tandem repeat type (CRDs linked by a peptidic sequence) 
arrangements.98–100  Remarkably, all galectins are confined in proto- and tandem repeat type 
except for galectin 3 (gal-3) which is the unique chimera type galectin. Galectins often exists as 
oligomers of CRDs so they are multivalent proteins able to bind to several carbohydrate 
epitopes, for instance, gal-3  forms pentamers in the presence of multivalent glycan 
ligands.101,102 In addition, galectin functions are related to their tendency to dimerize or 
oligomerize comprising a large number of cellular activities such as cell-cell interaction, cell-
pathogen interaction or signal transduction through receptor clustering (figure 22).102–105 
 
Figure 22. Intra- and extra- cellular functions of galectins. Adapted from Vasta 
106
 
Moreover, many galectins exhibit dual localization107 in the cell being found in both 
intracellular and extracellular matrix displaying different activities. Gal-3 is present in the 
nucleus and cytoplasm of the cell as well as in the extracellular matrix. Depending on the 
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cellular localization gal-3 displays different activities most of them related with cell 
proliferation in the immune and inflammatory responses. Of note, gal-3 induces apoptosis in T 
cells108 but anti apoptotic activity has been reported in macrophages109 and neutrophils.110 
Thus, endogenous gal-3 in T cells is anti-apoptotic, but extracellular gal-3 secreted by other 
cells may kill T cells through binding to T cell surface glycoproteins. Overall, current 
information suggest that inhibitors of gal-3 may be useful for treatment of inflammatory 
diseases.111  
Viral lectins are involved at the early infection events by recognizing oligosaccharides at the 
surface of their targeted cells. In fact, that is the case of the hemagglutinin (HA) of the 
influenza virus directly involved in influenza infection. The influenza HA consists in a family of 
16 structural related lectins specific for terminal sialic acid glyconjugates. The HA is built by the 
association of three identical monomers with a carbohydrate binding site in each monomer; 
therefore, the HA unit (trimer) presents mulitvalency towards sialic acid. The carbohydrate 
binding site displays a number of conserved amino acids as well as three conserved elements 
of secondary structure, the 130- and 220- loops and the 190--helix (figure 23). 
 
Figure 23. Carbohydrate binding site of the influenza hemagglutinin H1. 
Since influenza viruses may affect different species such as avians and mammals, including 
humans, structural and specificity insights have been obtained for a better understanding of 
the infection. Indeed, the glycosidic linkage of the terminal sialic acid to the glycoconjugate 
determines the infection of particular specie. While avian influenza HA strains display binding 
towards (2-3) sialic acid linked to galactose, the human HA strain is specific of (2-6).  These 
subtle differences are the key of the transfection between species. The affinity of the HA, as 
occurs in most of lectins, is rather low. Consequently the tight binding of the HA towards sialic 
acid is mediated by its multivalency with the simultaneous binding of sialosides.112,113 The 
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influence of the cooperativity on effective binding affinity has encouraged studies of the 
inhibition of receptor binding by modified sialosides presented as polyvalent inhibitors.114–116 
1.3.2.2. Antibodies 
Antibodies are a large class of proteins directly involved in the immune response against 
antigens. The antibody’s activity comprises the binding to their specific target antigens and the 
activation of the other immune cells and molecules triggering the immune response. The 
exquisite specificity and high affinity of the antibodies is the key for immunity and has been 
exploited for immunohistochemistry, diagnostics or biomedical research arising as a valuable 
tool in science.  
Antibodies are composed by small globular protein domains belonging to immunoglobulin 
family. The antigen binding fragment (Fab) is composed by two identical polypeptide chains of 
∼500 amino acids (heavy chain, H) attached by disulfide bridges to two identical polypeptide 
light chains of ∼250 amino acids (light chain, L). At the same time, H and L chains are 
composed by a variable N-terminal region (V) respectively and one constant C-terminal region 
(C) for the L chain and three for the H chain (figure 24). The high variability of the variable 
domains, where antigen binding occurs, is the key feature to the immense number of different 
antibody sequences already described and their specificities. 
 
Figure 24. Schematic representation of an immunoglobulin. 
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The understanding of the antibody structural motifs has permitted the development of 
antibody engineering for the expression of tailored-made monoclonal antibodies useful for 
vaccines, immunoassays and therapeutics.  
Over a variety of antigens, antibodies recognize carbohydrate-based antigens from 
glycoproteins or glycolipids at the cell glycocalix with high specificity. For instance, the 
recognition by antibodies of the -Gal epitope of the xenoantigen, present in xenografts 
triggers, within minutes, the hyperacute rejection of the organ.117–119 The knowledge of binding 
epitopes of these glycan antigens is an essential input for the very active field in saccharide-
based vaccines development.120  
1.3.2.3. Other protein receptors: Tubulin 
Tubulin is the structural building block of microtubules (MT), the main component of cellular 
cytoskeleton. It is essential for cell processes such as cell division, vesicle transport or cell 
shape93,121,122 and consequently an attractive therapeutic target for anticancer drugs.93 In fact, 
numerous anticancer drugs have been developed targeting MT and interfering in microtubule 
dynamics inducing the cell arrest and apoptosis.123 In addition, MT targeted anticancer drugs 
have been approved for cancer treatment and are in current clinical use (Taxol, Vinblastine) 
while others are or have been in advanced clinical trials. The mechanism of tubulin binding 
agents (TBAs) is focused on the stabilization or destabilization of the MT. 
MTs are long tube shaped protein polymers composed by the polymerization of tubulin 
heterodimers formed, at the same time, by two subunits: -tubulin and -tubulin (figure 25). 
The MT dynamic behavior, polymerization and de-polymerization, is defined as dynamic 
instability and mediated by GTP/GDP exchange through tubulin subunits ( and ).124 Indeed, 
the -tubulin subunit is always bound to GTP, acquiring a conformation suitable for MT 
polymerization, whereas the -tubulin subunit can be bound either to GTP or GDP, favorable 
for MT polymerization or de- polymerization, respectively (figure 25).125,126 Consequently, two 
terminal motifs may be distinguished in a MT, the dubbed (+) end (terminated by -tubulin) 
that grows and shortens more rapidly than the (-) end, which is terminated by -subunit. In 
humans, a total of nine - and nine - tubulin isotypes have been identified, that differs on the 
C-terminal sequence.127 Different post-translational modifications may affect the dynamic 
properties of MT and its modulation.128 
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Figure 25. Panel A:Polymerization of MTs. Panel B: MTs dynamics. Adapted from Jordan et al. 93 
MT dynamics is carefully regulated in cells and permit that MT performs multiple functions 
during the cell life-time.93,122,129 During the interphase, MTs mediate in intracellular trafficking 
and are responsible of cell shape. During mitosis, MT dynamics dramatically increase for the 
attachment, separation and segregation of chromosomes.122 The alteration of MT dynamics is 
the key principle of action of MT targeted drugs123 such as taxol-like molecules, which block 
mitosis and kill tumor cells.93  
Of note, the microtubule contains two microtubule stabilizing agent binding sites in -tubulin 
subunit,130 the luminal and the pore site. While the luminal site is present in the tubuin 
heterodimer and in MT, the pore site appears at the interface of heterodimers and therefore is 
only present in MT.130 The case of the reference taxane anti-tumor drug paclitaxel is thought to 
gain access to its binding site by diffusion from one site to the other.125  Epothilones, a family 
of polyketide macrolactone natural compounds identified in soil bacteria,  are currently under 
study as alternative to taxanes as antitumor drugs targeting the luminal site.131 
1.3.3. Nucleic acids: DNA 
DNA encodes the genetic information needed for life processes. Thus, an aberration on the 
DNA sequence or on its translation may trigger lethal consequences. Hence, DNA has been 
considered the traditional target for medicinal chemistry to treat cancer for many years.  
The 3D structure elucidation of double-stranded DNA in 1953 by Watson and Crick132 was a 
revolutionary challenge in biology awarded with the Nobel Award. However, apart from the 
double stranded DNA, other supramolecular DNA arrangements such as triple helix DNA133,134 
and quadruplexes135 also naturally occurs. Many natural and synthetic products have been 
developed that associate with the double-stranded DNA helix with potential therapeutic 
applications.134,136–138 
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From the molecular recognition point of view, DNA transcription may be considered as a great 
example of selective recognition by proteins where numerous protein systems (transcription 
factors, TFs) selectively recognize consensus DNA sequences to start the biological processes 
of the central dogma of the biology.139 
Transcription factors (TFs) are specialized proteins that participate in the regulation of gene 
expression by binding to key DNA regulatory sequences, and thereby promoting or inhibiting 
the assembly of the transcriptional complex.140 TFs display a modular structure built by peptide 
domains with a variety of functions from DNA binding to stimulatory effect on transcription.140 
TFs are often classified on the basis of DNA binding structural elements. Of note, the basic DNA 
binding domains, for instance C/EBP family,141,142 are often found in association with leucine 
zipper motifs and only bind to DNA once TFs dimers are formed.143 
From the medicinal point of view, TFs may be considered as interesting therapeutic targets 
since many TFs have been implicated in human diseases (including cancer), inflammatory or 
heart diseases. Thus, TFs mimetics have been designed for gene medicine144–146 and hence 
control the DNA transcription. The key feature of TFs mimetics is the achievement of sequence 
selective mimetics with significant affinity; therefore, the development of sequence selective 
TFs mimetics is still challenging with an enormous potential in gene medicine. 
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From the formation side, the key objective of this Thesis is to acquire knowledge on the 
application of NMR methods to study molecular recognition events.  
In the scientific context, the general objective of the thesis is to apply ligand- and receptor-
based NMR methods to study the interaction of a variety of ligands of diverse chemical nature 
with receptors of biological and/or biomedical interest. Within the explored ligands, glycans 
have been specially employed. Thus, one specific objective is to advance in the understanding 
of the structural features that govern glycan interactions, including the derivation of epitopes. 
In particular, in the glycoscience field, the specific objectives have aimed to: 
-Define the molecular recognition features of a synthetic Tn-antigen mimetic. 
-Demonstrate the multivalency of a bifunctional ligand towards different targeted proteins. 
-Explore the binding of monoclonal antibodies towards carbohydrate-based antigens. 
-Provide insight into binding mode and specificity of different Hemagglutinin strains towards 
sialic acid epitopes.  
In the general scientific arena, the specific objectives have aimed to: 
-Employ protein-based NMR methods to characterize the intrinsic structural propensity of a 
DNA-binding protein motif. 
-Characterize the bound conformation of a novel epothilone derivative towards tubulin, both 
in its dimeric state and when forming microtubules.  
-Assess the possibilities of different ligand-based NMR methods to screen dynamic 
combinatorial libraries in the presence of a given receptor. 
-Understand the specificity and the interaction features of novel DNA minor groove binders 
towards a consensus DNA sequence. 
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3.1. Introduction 
In the era of the omics, glycomics has become important given the ubiquitous presence of 
glycans in biological processes. The chemical diversity of carbohydrates is rather high. 
Individual monosaccharides associate in a variety of manners to form polysaccharides 
displaying multiple connections or oligosaccharides that are decorated with multiple pendant 
groups, or glycosylated lipids, peptides or proteins. All these variations permit to encode 
biological information that is transmitted in a rather complex manner. This translation process 
is denominated sugar code, which remains largely unexplored. Very probably, the 3D 
structures of the glycoconjugates and their dynamic features are at the heart of triggering the 
corresponding biological event, though a cascade of recognition events.  
Carbohydrate recognition by receptors is mediated by weak interactions (see introduction) and 
often displays weak affinities. However, in nature, carbohydrates are usually found in 
branched and multivalent scaffolds (i.e. multi branched sialylated glycans in the human upper 
respiratory tracts) that permit to overcome the limitation of weak affinity by the cooperative 
binding of several carbohydrates to the receptors. Therefore, carbohydrate multivalency is a 
key principle in nature to achieve strong, yet reversible interactions (i.e. virus infection).1 In 
addition, carbohydrate multivalency has to take into account also in carbohydrate based drug 
design. The current therapeutic approach is to employ monovalent drugs and consequently, 
high doses are required to be effective. As a result, the achievement of multivalent scaffold 
architectures has huge potential in the therapeutic action of carbohydrate-based drugs.1–3  
The numerous roles of glycoconjugates in life processes are mediated by binding proteins that 
decode the information content in the glycome through their recognition of glycans. 
Therefore, the understanding of the basis of the molecular recognition between 
glycoconjugates and their different receptors is mandatory for the rational design of proper 
drugs. In this context, NMR arises as a valuable tool for gathering essential information and 
providing key knowledge on molecular recognition and a 3D view of the ligand-receptor 
complex. 
In the following sections of this chapter, I will describe different examples of the application of 
different NMR methods, in many occasions assisted by molecular modelling techniques, to 
analyse the interaction of glycans by different receptors, lectins and antibodies. 
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3.2. Structural insights in the recognition of the Tn antigen by lectins 
In the late 50s, an antigen similar to already known T antigen was first observed by Moureau et 
al. They dubbed it as “T antigen nouvelle” (Tn antigen, figure 1).4 The simple chemical 
structure of the Tn antigen consists of a GalNAc residue -linked to the hydroxyl group of a Ser 
or Thr amino acid residue. A decade later, the presence of this Tn antigen in tumor cells was 
described, opening its study as a “tumor associated carbohydrate antigen” (TACA). The Tn 
antigen is found in more than the 90% of the tumor cells,5 since it is overexpressed in 
glycoproteins such as O-glycosylated mucins in the cell membrane. In fact, it could be 
considered as a cancer biomarker due to this atypically high abundance in tumors. Despite its 
simplicity, the Tn antigen plays a key role in numerous human disorders starting from the Tn 
syndrome,4,6–8 cancer,5,9–12 HIV infection13 or IgA nephropathies.14 For instance, the aberrant 
glycosylation of membrane proteins produce an overexpression of the Tn antigen15 in more 
than 90% of breast tumors. Moreover, the presence of the Tn antigen is directly correlated 
with metastatic potential and poor prognosis.15–18 
It has been reported that the Tn antigen is bound by the C-type macrophage galactose binding 
lectin (MGL), deactivating the immune response and thus enabling the tumor to escape from 
inmunosurveillance triggering metastasis and tumor progression.18–20 Thus, the implication of 
the Tn antigen in cancer and other serious pathologies has been studied during the last years 
and consequently considered as a potential therapeutic target. Many efforts are currently 
underway worldwide to develop a carbohydrate-based vaccine against the Tn antigen. 
However, the appropriate epitope with similar binding properties has not yet been discovered. 
The synthesis of Tn mimetics and Tn antigen epitopes is one of the open ways towards the 
development of antitumor vaccines. Because of its carbohydrate nature and its relative small 
size as an antigen, the vaccination process has to overcome the key problems related to the 
presentation of the epitopes to the immune system and the presence of glycosidases.21–24 
Thus, new methods have to be developed to enhance the presentation of the epitope and 
then, the concomitant immune response. The success of the synthesis of Tn epitope mimetics 
resides in the recognition of these analogues by anti-Tn antibodies with the same efficiency as 
the “natural” Tn antigen. 
The work exposed in the following pages present the study of the structural and 
conformational properties of new Tn antigen mimetics (mimetic 1 and mimetic 2, scheme 1) 
developed by the group of Prof. Cristina Nativi at University of Florence25 as potential Tn 
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vaccination substitutes. The recognition properties have been compared to those of a Tn 
simplified model (-OMeGalNAc) and its related monosaccharide, galactose.  
The mimetic 1 consists of a tricyclic structure that can be seen as a conformationally 
constrained mimetic that maintains the key structural features of Tn antigen. In contrast, 
mimetic 2 is the glycopeptide extension of 1 mimicking the glycosylated N-terminus STTAV 
sequence of mucin CD43.26,27 The carboxylic moiety at the end of both structures provides 
these two molecules with the possibility of performing different chemical modifications at 
these positions to achieve the proper presentation into multivalent architecure (i.e. 
nanoparticle functionalization, glycodendrimers, virus-like particles…) for the development of 
an efficient and effective vaccine. 
 
Scheme 1. Scheme of the structures of Tn antigen and mimetics 1 and 2. 
From the NMR perspective, the study of the binding properties was addressed from the ligand 
point of view. The major aim of the study was to obtain its contact epitope information to 
different Gal/GalNAc-binding lectins. Thus, these mimetics were tested with three lectins from 
diverse sources; plants (from legume Erythrina Cristagalli Lectin, ECL),28 mammals (C-type 
lectin from human, Macrophage Galactose Lectin, MGL),15 and invertebrates (from snail, Helix 
Pomatia Agglutinin, HPA)29 origin.  
3.2.1. The plant lectin: Erythrina Cristagalli (ECL) 
The Erythrina cristagalli lectin (ECL) is a galactose (Gal) specific legume lectin isolated from the 
cockspur coral tree.28,30 The ECL has been studied since the early 80s, but it was in 2004 when 
ECL was thoroughly characterized and its affinity towards galactosides was evidenced. 
Remarkably, ECL displays better affinity towards GalNAc versus Gal.28 ECL is a glycoprotein of 
56.8 kDa consisting in two subunits of similar molecular weight and exhibits hemagglutinating 
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activity and mitogenic effect over T lymphocytes in in-vitro tests.31,32 However, its biological 
functions in the plant itself are still unknown.  
 
Scheme 2. Scheme of the Tn antigen simple model, -OMeGalNAc (analogue 3). 
First, the STD-NMR-based study of ECL in the presence of the Tn antigen simple model, -
OMeGalNAc (3) was successfully performed as a positive control of the binding activity (figure 
1). 
Then, the STD-NMR of mimetic 1 in the presence of ECL (figure 2) was carried out, clearly 
showing its recognition. Basically, all protons of mimetic 1 received saturation from the 
protein. The analysis of the STD spectra of both molecules (1 and 3) in the presence of ECL 
(table 1), indicated that H1 and H2 at the galactose pyranose ring always received the highest 
saturation from the protein. Some differences between 1 and 3 were observed for protons H3 
and H4.  
As mentioned in the introduction, a major efficiency in the saturation is translated into a closer 
distance between the observed nucleus and the protein protons at the binding site. In our 
particular case, the observed STD intensities indicate that H1 and H2 are much closer to the 
binding site than H5 and H6.  
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Figure 1. STD (below) and off-resonance (on top) NMR spectra (500 MHz) of a ECL:-OMeGalNAc mixture (1:100 
molar ratio) with 40 M ECL. The temperature was 298 K and a 2 seconds saturation time at the aromatic region 
( 7 ppm) was employed. A spin lock filter was used to minimize the background of the protein protons. 
 
Figure 2. STD (below) and off-resonance (on top) NMR spectra (500 MHz) of a ECL:1 mixture (1:100 molar ratio) 
with 40 M ECL. The temperature was 298 K and a 2 seconds saturation time at the aromatic region ( 7 ppm) 
was employed. A spin lock filter was used to minimize the background of the protein protons. 
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 Absolute STD intensity (%) Relative STD intensity (%)
 Mimetic 1 Mimetic 2 OMeGalNAc Mimetic 1 Mimetic 2 OMeGalNAc 
H1 7.2 4.2 1.7 90 45 98 
H2 8.0 7.9 1.7 100 85 100 
H3 5.3 5.1 1.3 66 55 78 
H4 5.3 3.6 1.4 66 39 83 
H5 4.7 4.3 0.9 59 46 51 
H6 3.8 3.2 0.8 48 35 49 
H7a/H7b 2.6 and 3.3 2.6 - 33 and 41 28 - 
H8 5.7 9.3 - 72 100 - 
NAc -  1.0 - - 60 
OMe -  1.1 - - 66 
Table 1. STD intensities from the STD spectra shown in figures 2, 3 and 6. 
 
Figure 3. Observed STD intensities for the different protons of the model compound and the two mimetics when 
interacting with ECL. The data mimetic 1 (in green), OMeGalNAc (in red) and mimetic 2 (in blue). 
 
Figure 4. Epitope mapping deduced by STD NMR for the binding of OMeGalNAc and mimetic 1 to ECL. 
Competition studies were also performed to further elucidate if both molecules share the 
same binding site. The observation of competition between the two molecules would indicate 
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that they bind at same binding site whereas the absence of competition will suggest that they 
bind in different places of the protein (unless allosteric behavior is suspected). To address 
competition by NMR, ligand displacement experiments were performed starting with a sample 
of OMeGalNAc as reference compound in presence of the lectin. The experiment was 
carried out by monitoring the evolution of the STD signal intensities of selected and isolated 
protons (in terms of chemical shift) of the reference compound upon increasing additions of 
the competitor. Figure 5 shows up the evolution of the signals at increasing amounts of 
competitor (mimetic 1). Due to the typical signal overlapping of carbohydrates, the selection of 
the signal to be monitored was not trivial. Fortunately, H4 from mimetic 1 and O-methyl group 
of -OMeGalNAc appeared clearly isolated and then were monitored to follow the 
competition process. 
 
Figure 5. Competition STD-NMR between OMeGalNAc and 1 with ECL (500 MHz, 298 K).  On the left handside, 
off-resonance upon increasing amounts of 1 up to molar ratio 1:4 -OMeGalNAc:1. On the right, the 
corresponding STD spectra of each ratio. The concentration of ECL was 10 M. 
The competition study revealed that mimetic 1 is able to displace -OMeGalNAc from the 
binding site, thus demonstrating that both molecules compete for the same binding pocket of 
the protein. When both compounds are in 1:0.5  -OMeGalNAc:1 ratio, H4 signal from mimetic 
1 in the STD is similar than the same H4 signal from -OMeGalNAc. When higher molar ratios 
of mimetic 1 were employed, the H4 and methyl signals of analogue 1 were significantly 
reduced, thus indicating that the analogue is removed from the binding site. 
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As next step, the behavior of glycopeptide Tn mimetic 2 was studied. In this case, the tricyclic 
compound is connected to a peptide fragment derived from the N-terminal of CD43 
glycoproteins, trying to mimic the Tn antigen presentation in mucins. Thus, the STD NMR 
spectrum of mimetic 2 in the presence of ECL (molar ratio 1:100) was obtained (figure 6). It can 
be observed that only the protons from the sugar part provide STD intensities, while the 
signals corresponding to the peptide fragment barely show up. The epitope mapping for 2 is 
plotted in figure 3 in comparison with that deduced for mimetic 1 and -OMeGalNAc. Even 
though some differences were observed, especially for H4, the epitope profile follows a similar 
pattern for both mimetics, 1 and 2, with H2 receiving the highest saturation from ECL. On the 
other hand, the peptide part of the mimetic 2 gives very weak STD effect, only observable for 
the Thr moiety close to the pyranose ring. Only ca. 20% of STD relative intensity was measured 
(100% for H2, table 1) for H and Hprotons, with 6% for the methyl groups. All these results 
indicate that the peptide has marginal contacts with the lectin, being the sugar part the key 
interacting epitope. 
 
Figure 6. The interaction of 2 with ECL. The STD-NMR spectrum (500 MHz, 298 K) obtained for a 100:1 mixture of 
2:ECL is shown at the bottom, while the off-resonance spectrum is shown at the top. The concentration of the 
lectin was 40 M. A spin lock filter was used to minimize the background of the protein signals, while the on-
resonance frequency for protein saturation was set at the aromatic region ( 7ppm). 
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3.2.2. The human lectin: Macrophage Galactose Lectin (MGL) 
The Macrophage Galactose Lectin (MGL, CD301) is a transmembrane receptor present in cells 
of the immune system,33 with a C-type lectin domain in its extracellular part. The C-type lectin 
family is defined by its calcium dependence for binding and accommodate a calcium ion in 
their structure which is essential to shape the binding site and directly interacts with the 
ligand.34 MGL specifically binds glycans with terminal GalNAc residues and has been associated 
with the immune response to the pathologies produce by the Tn antigen.15 Previous works 
have reported that MGL recognize the Tn antigen located at the surface of the glycosylated 
mucins present in numerous carcinomas such as breast or colon and it can be involved in the 
modulation of the immune response towards some tumor cells.18 
Applying the same methodology as described above, a positive control STD experiment (figure 
7) with -OMeGal (4, scheme 3), showed that H4 provided the strongest STD intensity, while 
the other protons present in the pyranose ring are weaker as previously reported.35,36  
 
Scheme 3. Structure of the -OMeGal (analogue 4). 
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Figure 7. The interaction of -OMeGal with MGL. The STD-NMR spectrum (500 MHz, 308 K) is given below, while 
the off-resonance spectrum is given on the top. A 100:1 -OMeGal:MGL molar ratio was employed. The 
measured relative STD intensities were: H1 21%, H2+H3 51%, H4 100%, H5 20%, H6 14%, OMe 13%. 
 
Figure 8. Epitope mapping results for the binding of -OMeGal and 1 to MGL. 
Next, the STD-NMR study of mimetic 1 in the presence of MGL was performed. Interestingly, 
the deduced STD-derived epitope of 1 to MGL was different to that found for -OMeGal 
epitope (figure 8). For 1, H1 showed the highest STD value, providing an epitope closer to that 
already described for -OMeGalNAc35 where protons H1 and H2 receiving the highest 
saturation. STD-NMR-based competition experiments were then carried out. Initial 
competition studies showed that mimetic 1 was not able to displace -OMeGalNAc from the 
binding site of MGL. Thus, STD-NMR competition experiments (figure 9) were carried out using 
α-OMeGal, although it is a weaker ligand than -OMeGalNAc for MGL.35  The STD intensities of 
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H4 of α-OMeGal and mimetic 1 were followed upon the step-wise addition of mimetic 1 to the 
mixture solution (figure 9). A sevenfold excess of mimetic 1 with respect to α-OMeGal was 
necessary to reach a significant competition (H4 signals form mimetic 1 and -OMeGal showed 
then similar intensities and the methyl signal experienced a clear reduction, figure 9). These 
results indicate that mimetic 1 binds to MGL even more weakly than α-OMeGal does, probably 
over the millimolar range. 
 
Figure 9. Competition STD-NMR between OMeGal and 1 with MGL (500 MHz, 308 K). On the left-hand side, the 
off-resonance spectra upon increasing amounts of 1 up to 1:7 molar ratio -OMeGalNAc:1. On the right-hand 
side, the corresponding STD spectra of each ratio -OMeGalNAc:1. The concentration of MGL was 10M. 
3.2.3. The invertebrate lectin: Helix Pomatia Agglutinin (HPA) 
Lectins extracted from snails are known to recognize blood group antigens. In the present 
context, the recognition of the Tn antigen by the Helix Pomatia Agglutinin (HPA), a lectin form 
the edible snail, was characterized in 1969 by Prokop et al37 being a milestone in TACAs 
research, due to its relevance in  breast tumors and  carcinomas.38 HPA specifically binds to 
terminal -GalNAc residues,29 and therefore it was  included as an additional model lectin to 
test the binding properties of the Tn antigen mimetics. 
The STD spectrum of HPA in the presence of mimetic 1 (figure 10) showed clear saturation 
transfer signals. The highest saturation was shown by H1 and H2, whereas H7 displayed no 
intensity. The STD intensities were then compared to those obtained for the positive control, 
-OMeGalNAc (figure 11).  
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Figure 10. The interaction of 1 with HPA. The STD spectrum (500 MHz, 308 K) obtained for a 100:1 mixture of 
1:HPA is shown at the bottom, while the off-resonance spectrum is shown at the top. The concentration of the 
lectin was 40 M. A spin lock filter was used to minimize the background of the protein signals, while the on-
resonance frequency for protein saturation was set at the aromatic region ( 7ppm). 
 
Figure 11. The interaction of the model compound, -OMeGalNAc, with HPA. The STD spectrum (500 MHz, 308 K) 
obtained for a 100:1 mixture of -OMeGalNAc:HPA is shown at the bottom, while the off-reference spectrum is 
shown at the top.  The concentration of the lectin was 40 M. A spin lock filter was used to minimize the 
background of the protein signals, while the on-resonance frequency for protein saturation was set at the 
aromatic region ( 7ppm). 
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 Absolute STD intensity (%) Relative STD intensity (%) 
 Mimetic 1 OMeGalNAc Mimetic 1 OMeGalNAc 
H1 5.1 8.5 100 76 
H2 5.1 11.1 100 100 
H3 2.5 7.6 49 68 
H4 1.3 6.9 26 62 
H5 n.d. 6.8 n.d. 61 
H6 2.3 5.6 45 50 
H7 n.d. - n.d. - 
H8 n.d. - n.d. - 
Ac - 5.6 - 50 
OMe - 4.1 - 37 
Table 2. STD intensities measured for the interaction of mimetic 1 and -OMeGalNAc with HPA. 
The epitope mapping analysis of the STD spectra obtained permitted deducing that H1 and H2 
of mimetic 1 received the highest saturation, while H3, H4 and H6 showed weaker intensities. 
This fact suggests that the recognition of mimetic 1 mainly involves the carbohydrate 
structure, while the bicyclic extension is not involved in the molecular recognition event. 
However, for -OMeGalNAc, although the major saturation transfer was observed at H2 signal, 
the whole pyranose ring is recognized by HPA. From a global perspective, the profile of the STD 
intensities for both molecules (figure 12) is fairly similar, suggesting that both molecules 
display a similar binding mode to HPA. 
 
Figure 12. The profile of the STD intensities for each proton of mimetic 1 (in black) and -OMeGalNAc (in grey) for 
the interaction with HPA. 
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Figure 13. STD-based epitope mapping for the binding of ligands -OMeGalNAc and mimetic 1 to HPA. 
3.2.4. Conclusions 
Therefore, the overall picture of the obtained results for the interaction of 1 with the three 
lectins can be concluded that this mimetic behaves as a reasonable mimetic of the Tn antigen. 
This molecule presents a similar binding mode to that observed for the Tn model (-
OMeGalNAc), while the rigid scaffold mimetic 1 does not impede the binding. Nevertheless, 
the relative affinities vary among the three tested lectins. The STD-NMR-based competition 
experiments revealed that mimetic 1 is able to remove -OMeGalNAc from the binding site of 
ECL, indicating a similar or even higher affinity.  Interestingly, the data obtained for 
glycopeptide mimetic 2 have also indicated that ECL recognizes its sugar moiety with a similar 
epitope to that deduced for the recognition of mimetic 1 and -OMeGalNAc. Additionally, the 
analysis of the NMR data has also shown that 1 is also a fair mimic of the Tn model in the 
interaction with HPA lectin. However, for MGL, much higher concentrations of 1 were needed 
to partially remove -OMeGal from the lectin binding site. Therefore, the binding affinity is 
now rather weak. This fact indicates that the bicyclic moiety strongly interferes with the 
binding site amino acids. Previous molecular modelling data have shown that the acetamide 
moiety of Tn directly participates in the interaction with MGL.35 Therefore, it is highly likely 
that the chemical modification present in 1 at this moiety strongly affects MGL binding. 
All these data permit to consider the tricyclic mimetic 1 as a rigid but selective mimic of the Tn 
antigen, always depending on the chemical architecture of the receptor binding site.  
3.2.5. Experimental 
MGL lectin was provided (Prof. H.J. Gabius, LMU, Munich, Germany) as its extracellular 
fragment (amino acids 68-316), containing the carbohydrate recognition domain (CRD, amino 
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acids 187-316). The lectins Erythrina Cristagalli (ECL) and Helix Pomatia (HPA) were purchased 
from Sigma-Aldrich. 
The -OMeGalNAc as well as the -OMeGal were commercially available from Sigma-Aldrich, 
while mimetics 1 and 2 were chemically synthesized by Prof. Nativi’s group at the University of  
Florence.39 
Samples with ECL and HPA were prepared in deuterated PBS buffer (137 mM NaCl, 2.7 mM 
KCl, 10 mM Na2HPO4; 1.7 mM KH2PO4, pH 7.3), while perdeuterated TRIS buffer (10 mM Tris, 1 
mM CaCl2, 75 mM NaCl, pH 7.5) in D2O was used for MGL. 
All NMR experiments were acquired on a Bruker Avance instrument operating at 500 MHz (1H 
frequency). For the STD-NMR experiments, the saturation frequency was set either at 7 ppm 
(aromatic region) or at 0 ppm (aliphatic region). All the STD-NMR spectra displayed were 
collected with a short spin lock filter to minimize the background of the protein signals. 
For ECL, the STD-NMR spectra were acquired using a sample containing 40 M ECL and 4 mM 
mimetic 1 (molar ratio 1:100) at 298 K. For HPA, the STD spectra were acquired on a sample 
containing 40 M lectin and 4 mM mimetic 1 (molar ratio 1:100) at 298 K and 308 K. Finally, 
for MGL, the STD-NMR spectra were acquired on a sample containing 10 M of MGL and 1mM 
of mimetic 1 (molar ratio 1:100) at 308 K. 
STD-NMR-based competition experiments 
To a solution of 30 M of ECL and 3 mM of -OMeGalNAc, increasing amounts of mimetic 1 
were added, until a final concentration of 12 mM of 1 was reached (4-fold excess with respect 
to -OMeGalNAc) (table 3). The STD-NMR spectra were recorded in a 500 MHz spectrometer 
at 298 K. 
 ECL (M) -OMeGalNAc (mM) Mimetic 1 (mM) 
Exp. 1 30 3 0 
Exp. 2 30 3 1.5 
Exp. 3 30 3 3 
Exp. 4 30 3 6 
Exp. 5 30 3 7.5 
Exp. 6 30 3 9 
Exp. 7 30 3 12 
Table 3. Description and summary of the experiments and concentrations employed for the STD-NMR-bsaed 
competition assays with ECL. 
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In the case of MGL, to a solution of 10 M MGL and 1 mM -OMeGal, increasing amounts of 1 
were added until a final concentration of 8.1 mM of 1 was reached (8-fold excess with respect 
to OMeGal) (table 4). The STD-NMR spectra were recorded in a 500 MHz spectrometer at 
308 K. 
 MGL (M) -OMeGal (mM) Mimetic 1 (mM) 
Exp. 1 10 1 0 
Exp. 2 10 1 0.3 
Exp. 3 10 1 1.7 
Exp. 4 10 1 8.1 
Table 4. Description and summary of the experiments and concentrations employed for the STD-NMR-based 
competition assays with MGL. 
3.3. Bifunctional ligands with one glycan epitope: Towards the simultaneous 
target of two different proteins 
As mentioned above, carbohydrates participate in the early stages of diverse inter and extra 
cellular recognition events that facilitate the interaction between partners (from small 
molecules to large entities: cells, bacteria, viruses, etc.) to start or to maintain a chain of 
subsequent biological processes. As paradigmatic examples, the rolling of leukocytes in blood 
vessels40 or recognition of pathogens to initiate defense response can be mentioned.41  
In this context, the family of the galectins presents diverse functions at the extracellular matrix 
(ECM) or inside the cell. Galectins are a type of carbohydrate-binding proteins (lectins) that 
have the ability to recognize -galactosides.42 All the galectins contain a well conserved 
carbohydrate binding domain (CRD) responsible for carbohydrate binding. Many families of 
galectins have already been described and classified. Some of them show one CRD, while other 
show two CRDs, usually functioning in a non-cooperative manner. Galectin 3 (hgal-3) is the 
only galectin that contains a tail of repetitive amino acids attached to its single CRD.43,44 It has 
been described that the cytoplasmic upregulation of this chimera-type lectin has anti-
apoptotic effects,45–47 whereas nuclear and extracellular hgal-3 produces completely opposite 
pro-apoptotic or even anti-apoptotic activity, depending on the type of cells or its intracellular 
localization.48–52 Interestingly, human  gal-3 (hgal-3) has been described to form oligomeric 
structures (pentamers) in the extracellular environment.53 
The presence of hgal-3 in the extracellular matrix (ECM) has been correlated with the activity 
of some matrix metalloproteinases (MMPs) being itself a substrate of MMPs. These enzymes, 
remove the tail from hgal-3, impairing the ability of oligomerization.53–59 MMPs are a large 
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class of at least 23 different zinc-dependent enzymes present in the extracellular matrix that 
are involved in many physiological cellular processes and its dysregulation produces 
pathologies, tumor growth or metastasis. Of note, galectins can enhance MMPs production 
and malignancy, related to tumor growth and progression. Thus, the association of hgal-3 in 
ECM to many tumors makes hgal-3 a therapeutic target. Moreover, since there are MMPs in 
the ECM involved in tumor progression, the design of multiple valency ligands to 
simultaneously target both receptors might be valuable to fight against the pathology. 
However, MMP inhibitors have failed in clinical trials because of limited solubilities in 
physiological conditions and low selectivities due to the MMP remarkable property to adapt 
their binding pocket to inhibitor´s shape. Thus, dual-target-related molecules may be a new 
approach to overcome the limitation of scarce selectivity of the MMP inhibitors.60 
As mentioned above, multivalent processes are a common situation in carbohydrate-protein 
interactions. In many occasions, the ligand (sugar) presentation is multivalent. In fact, in many 
glycoconjugates present multibranched structures that contains several copies of the same 
carbohydrate epitope in the same molecule. Therefore, it can simultaneously bind several 
carbohydrate receptors. On the other hand, the glycan receptors, e.g. lectins can have more 
than one carbohydrate recognition domain in the same molecule or exist in a multimeric. In all 
cases, the receptors simultaneously present several carbohydrate binding sites. 
The work present here represents the continuation of our previous studies performed in 
collaboration with the group of Prof. Cristina Nativi at the University of Florence. We have 
reported on the design of bifunctional linear compounds containing the lactose moiety on one 
end and a metalloproteinase inhibitor of sulfamide-hydroxamate type61–63 on the other end. 
Our results showed the feasibility of this approach, since the synthetic compound was able to 
simultaneously bind human gal-3 carbohydrate recognition domain (hgal-3 CRD) at one end 
(the glycan epitope) and the catalytic domain of MMP-12 (catMMP-12) at the alternative end 
(the hydroxamate epitope).64  
In this work, and as logical extension of our initial findings, we have explored a multivalent 
strategy. Thus, a water soluble MMP inhibitor that incorporates two glycan branches (figure 
14) for an increased valency to enhance the avidity for hgal-3 CRD has been employed and its 
molecular recognition properties by both catMMP-12 and hgal-3 CRD has been evaluated. The 
molecular recognition events have been followed by using different NMR strategies, including 
those based on ligand observation, as STD-NMR experiments, and also others based on the 
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observation of the protein signals by means of HSQC-based experiments, using isotopically 15N 
labeled proteins. 
 
 
Figure 14. Scheme of compound 3. 
 
Figure 15. The 
1
H NMR spectrum of compound 3 at 600 MHz (298 K) with the assignment of different signals. 
After assigning the different NMR signals of 3 using standard 2D NMR methods, the interaction 
with the two proteins was studied independently. The interaction of 3 with catMMP-12 was 
followed from the protein´s point of view using a chemical shift perturbation analysis of the 
1H-15N amide cross peaks measured in 1H-15N HSQC spectra obtained for the catMMP-12 in the 
absence and presence of the ligand. Additionally, the interaction of 3 with hgal-3 CRD was 
studied both from the ligand´s point of view through STD-NMR and from protein´s point of 
view using analogous approach to that described above for catMMP-12. Finally, the possible 
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formation of a ternary complex was studied by monitoring the changes in the shapes of the 
cross peaks in the 1H-15N HSQC spectra of 15N labeled catMMP-12 bound to 3, in the absence 
and in the presence of hgal-3 CRD. 
3.3.1. The interaction of 3 with hgal-3 CRD 
The existence of interaction of ligand 3 with hgal-3 CRD was first evidenced by the mere 
observation of its standard 1D 1H NMR spectrum in the presence of the lectin. The existence of 
significant line broadening effects in the resonance signals of the ligand when the lectin was 
added to the solution indicated the presence of a binding event.  Indeed, since the linewidth of 
the NMR signals is directly related to transverse relaxation rate (1/T2), the binding of a 
medium-small molecule (such as 3) to a large receptor strongly modifies its relaxation 
properties, a phenomenon that can be monitored at the line width level. In fact, high 
molecular weight proteins show broad signals whilst low molecular weight ligands show 
narrow NMR signals. Thus, the observation of broadening effects for the NMR signals of a 
putative ligand in the presence of the receptor indicates a reduction in the transversal 
relaxation T2 that can be directly associated with the formation of a molecular complex. 
The line broadening of the ligand´s signals in the NMR spectra acquired for two samples with 
different ligand/protein ratios (10:1 and 50:1) were compared to that observed in the absence 
of the receptor (bottom panel of figure 16). As shown in figure 16, at a of 10:1 molar ratio 
(3:hgal-3 CRD) significant broadening of the NMR signals of the ligand was observed, especially 
for protons H1 and H4 of the terminal Gal residue, and to a minor extent for the anomeric H1 
of Glc, while other protons, such as H8, A or B, were less affected. At a higher 3:hgal-3 CRD 
molar ratio (50:1), the signal broadening was partially reverted towards that of the free ligand 
in solution. 
Chapter 3. NMR applications to carbohydrate recognition 
66 
 
 
Figure 16. The interaction of 3 with hgal-3 CRD. Bottom panel: 
1
H NMR spectrum for the free ligand in solution. 
Middle panel: 
1
H NMR spectrum for a 50:1 molar ratio (2.5 mM:50 M) mixture of 3:hgal-3 CRD. Top panel: 
1
H 
NMR spectrum for a 10:1 molar ratio (0.5 mM:50 M) mixture of 3:hgal-3 CRD. The asterisks indicate the ligand 
protons that show major line broadening. They especially correspond to the Gal moiety. All NMR spectra were 
processed with the same line broadening functions. 
The intermolecular interaction was further confirmed by STD-NMR experiments. The STD 
(figure 17) spectrum of compound 3 in the presence of hgal-3 CRD (1:50 protein:ligand molar 
ratio) revealed that the terminal lactose moiety displayed the strongest STD effect. The 
aliphatic protons of the linkers resonating al higher field (H26, H26, H10, H11) also showed 
STD, while other, some protons far from the sugar moiety (C, H16, H17, H18 and H15) also 
showed some saturation effects. A control STD-NMR experiment performed or the ligand in 
absence of the lectin performed under the same irradiation conditions (on resonance 
frequency at -0.22 ppm) also showed some signals (at  3.25, 2.20, and 1.52 ppm), indicating 
the existence of ligand-ligand interactions. However, the H15-H18 signals did not appear in this 
spectrum, suggesting the existence of transient non-specific interactions between this ligand 
region and the lectin. 
The STD results reflect that lactose is the major epitope, especially involving H4, H5 and H6 of 
the terminal Gal moiety, as frequently observed for the interaction of Gal units with 
galectins.35 
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Figure 17. The interaction of 3 with hgal-3 CRD. STD-NMR spectra (500 MHz, 298 K) obtained for a sample 
containing of hgal-3 CRD and 3 in a 1:50 molar ratio (50 M:2.5 mM). A: The spectrum at the bottom show the 
blank STD spectrum obtained for the free ligand in solution. The middle panel shows the off-resonance spectrum. 
The top panel shows the STD spectrum. The dashed lines indicate the ligand protons that show STD in the blank 
experiment. B: Expansion of the spectral region from  3.1-4.5 ppm, where the key sugar protons are annotated. 
B 
A 
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Figure 18. The ligand epitope of compound 3 interacting with hgal-3 CRD according to the STD-NMR data. 
In order to further asses the carbohydrate-dependent specificity of the interaction between 3 
and hgal-3 CRD, STD-NMR based competition experiments were pursued. Since the simplest 
competitor ligand, lactose, could not be used due to the unavoidable signal overlapping with 
the resonances of the two lactose moieties present in compound 3, a 19F NMR-based 
competition study was employed using a fluorinated lactose derivative, namely N-
trifluoroacetyl lactosamine, provided by Dr. Stefan Oscarson, at the University of Dublin. This 
molecule avoids the 1H NMR signal overlapping by taking advantage of the single 19F signal of 
the competitor. In particular, 19F transverse relaxation rates (1/T2) are very sensitive to 
changes between the free and bound forms,65,66 and may be employed to study the 
competition process. First, the T2 of the 
19F NMR signal of free N-trifluoroacetyl lactosamine 
was measured (0.5 seconds, figure 19) through the Carr-Purcell-Meiboom-Gill (CPMG) 
sequence experiment.67 In the presence of hgal-3 CRD (at a ligand:lectin molar ratio of 20:1), 
the T2 for the 
19F NMR signal was significantly shorter (figures 19 and 20), the linewidth of the 
19F signal was significantly larger, and the signal intensity was concomitantly reduced, as a 
result of the interaction of the disaccharide with the protein. Then, to this solution (N-
trifluoroacetyl lactosamine:hgal-3 CRD 20:1), compound 3 was added in a stepwise manner 
and the recovery of the intensity of the 19F NMR signal was recorded each step. It is evident 
that, the intensity of the 19F NMR signal (figure 20) was systematically recovered approaching 
the intensity observed for the free disaccharide, indicating that compound 3 is indeed able to 
remove N-trifluoroacetyl lactosamine from the lectin´s binding site. 
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Figure 19. The interaction of N-trifluoroacetyl lactosamine with hgal-3 CRD as deduced from CPMG spin echo-
based NMR measurements. In red (squares): Intensity decay with the echo time of the 
19
F NMR signal for the  
anomer. In blue (diamond): Intensity decay with the echo time of the 
19
F NMR signal for the  anomer. In purple 
(circles): Intensity decay with the echo time of the 
19
F NMR signal for the  anomer in the presence of hgal-3 CRD. 
In green (triangles): Intensity decay with the echo time of the 
19
F NMR signal for the  anomer in the presence of 
hgal-3 CRD. 
 
Figure 20 Compound 3 competes with N-trifluoroacetyl lactosamine for the binding site of hgal-3 CRD. 
Representation of the recovery of the 
19
F NMR signal intensity of N-trifluoroacetyl lactosamine in the CPMG NMR 
spectra recorded for a solution of N-trifluoroacetyl lactosamine (1 mM) in the presence of 50 M of hgal-3 CRD. 
The variations of the 
19
F NMR intensities for the signals of both anomers upon increasing additions of compound 
3 are evident (0.5 mM TFA was added as the 
19
F NMR reference signal). 
As further step, the stoichiometry of the binding process was assessed since the dilactosyl 
branching of the ligand could support the simultaneous binding of two hgal-3 CRD. Thus, 
diffusion ordered spectroscopy (DOSY) was the employed NMR experimental approach to 
estimate the possible changes in the average hydrodynamic translational diffusion coefficients 
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in the free and bound states.68 The diffusion coefficient of hgal-3 CRD was monitored by DOSY 
measurements in the presence of increasing amounts of compound 3.  At sub-stoichiometry 
amounts of the ligand, where the stoichiometry 2:1 protein:ligand could be favored, no 
significant changes in the diffusion coefficient of the protein were observed (figure 21). Thus, 
no evidences of simultaneous binding of two galectin moieties to the same ligand molecule 
could be obtained, strongly suggesting that under the experimental conditions used, no 
positive cooperativity (if any occurs) for binding of a second protein was appreciated.  
 
Figure 21. DOSY experiments for hgal-3 CRD in the absence and presence of 3. In green, the free hgal-3 CRD (200 
M); in red, the mixture of hgal-3 CRD (200 M) and 3 (60 M); in blue, the mixture of hgal-3 CRD (200 M) and 3 
(100 M). No significant variations in the diffusion coefficient may be appreciated. 
Next, a chemical shift perturbation analysis (CSP) based on 1H-15N HSQC experiments was 
carried out in order to assess that the ligand binds at the canonical lactose-binding pocket of 
hgal-3 CRD. Thus, 1H-15N HSQC spectra (figure 22) were recorded for the 15N labelled hgal-3 
CRD in the absence and presence of compound 3 (protein:ligand molar ratio 1:10; 0.1 mM:1 
mM). 
The assignment of the chemical shifts of the backbone NH cross peaks followed the previously 
described assignment for the free protein (BMRB69 entry 19491). Chemical shift perturbations 
after the addition of the bifunctional compound 3 were observed and monitored, showing that 
major CSP took place around the lactose binding site as defined in the X-ray structures (figure 
22) deposited in the Protein Data Bank (PDB70 ID: 3ZSJ). 
1H (ppm) 
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Figure 22. The interaction of 3 with hgal-3 CRD. Superimposition of the 
1
H-
15
N HSQC spectra recorded for hgal-3 
CRD in the absence (red) and presence of 1 mM of compound 3 (black). 
 
Figure 23. Weighted average CSP of the NH backbone resonances (see experimental section) of hgal-3 CRD in the 
presence of 3. The X-ray structure (PDB ID: 3ZSJ) of hgal-3 CRD is shown at the right-hand side. The amino acids 
with significant CSP of their NH backbone signals are highlighted in surface representation (dark green for those 
with  above 0.03 ppm and light green for those above 0.02. They correspond to the canonical lactose binding 
site. 
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3.3.2. The interaction with the Matrix Metalloproteinase (MMP-12)  
Once the interaction towards the hgal-3 CRD was assessed, the binding process towards 
catMMP-12 moiety was also explored. The same methodological NMR protein-based approach 
was followed, using  1H-15N HSQC-based CSP analysis with a 15N isotopically labelled catMMP-
1271 (BMRB69 6391) to investigate the formation of the ligand/protein complex. 
The 1H-15N HSQC spectrum of 15N labelled catMMP-12 (159 amino acids) was assigned and 
compared to that recorded after addition of an excess of compound 3 (figure 24). It should be 
mentioned that the initial sample of catMMP-12 contained acetohydroxamic acid (AHA) in 
order to inhibit the intrinsic proteolytic activity and to ensure that the protein life time is 
enough to record good quality 1H-15N HSQC spectra.71 
Figure 25 shows the weighted average CSP of the catMMP-12 NH backbone resonances upon 
addition of 3. Three different regions of catMMP-12 that are clearly perturbed when the 
inhibitor AHA is displaced by 3, a stronger binder. These regions can be defined as the initial 
part of beta strand IV (G178-H183), T215 in the alpha 2 helix closed to the catalytic site, and 
the so called S1´pocket (S229-Y242), where the aromatic moiety is supposed to fit.   
 
Figure 24. The interaction of 3 with catMMP-12. Superimposition of the 
1
H-
15
N HSQC spectra recorded for 
15
N-
catMMP-12 in the presence of AHA (black) and after the addition of compound 3 (purple). The key perturbed 
cross peaks are highlighted 
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Figure 25. Weighted average CSP of the catMMP-12 NH backbone resonances upon interaction with 3 (with 
respect to the chemical shifts in the presence of AHA).  In the right-hand side, the X-ray structure (PDB ID:1Z3J) of 
the catMMP-12 is shown. The amino acids with the strongest chemical shift perturbations in their backbone NH 
are highlighted in the surface representation in red for those with above 0.3 ppm and in pink for those over 
0.17 ppm). 
These observations are in full accordance with the binding mode previously described64 for 
MMP inhibitors based on N-isobutyl-N-(4-methoxyphenylsulfonyl) glycyl hydroxamic acid 
(NNGH). Therefore, the presence of the lactose moiety does not interfere with the binding of 
the hydroxamic moiety to catMMP-12. 
3.3.3. The hgal-3 CRD:3:catMMP-12 ternary complex 
After these individual studies of the binding of compound 3 to each single protein, the 
formation of the hgal-3 CRD:3:catMMP-12 ternary complex was evaluated. In this case, 1H-15N 
HSQC experiments focused on the observation of the catMMP-12 signals were performed. 
First, the 1H-15N HSQC spectrum of catMMP-12 in the presence of an excess of compound 3 
was recorded as a control. Under these conditions, the catMMP-12 binding site is saturated 
with the ligand. Second, an equimolecular amount of hgal-3 CRD with respect to catMMP-12 
was added to the solution and the corresponding HSQC spectrum was recorded under the 
same experimental conditions. The comparison of the 1H-15N HSQC spectra recorded before 
and after the addition of hgal-3 CRD showed a clear decrease in intensities of many NH cross 
peaks (figure 26). This observation is likely due to the change in apparent molecular weight of 


 (
p
p
m
) 
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the observed catMMP-12 due to the formation of supramolecular complex, with the 
concomitant increase of the transverse relaxation rate and reduction of the intensity of the 1H-
15N HSQC cross-peaks. We can therefore assume that a ternary complex is formed, in which 3 
is able to simultaneously bind to catMMP-12 through the hydroxamic acid functionality and to 
hgal-3 CRD through the lactose epitope. 
 
Figure 26. The formation of the ternary complex through the measurement of 
1
H-
15
N HSQC spectra for catMMP-
12. On the right-hand side, 
1
H-
15
N HSQC spectrum recorded for the mixture of catMMP-12 and 3 (in molar 
excess), without the lectin.  On the left-hand side, 
1
H-
15
N HSQC spectrum recorded for the same mixture after the 
addition of an equimolar amount of hgal-3 CRD (with respect to catMMP-12). 
3.3.4. Conclusions 
A novel bifunctional ligand to simultaneously interaction with two different protein targets has 
been synthesized. The ligand shows a divalent display of lactose epitopes to bind galectins and 
a hydroxamic moiety to target matrix metalloproteinases. The NMR investigation has 
permitted to assess, in a non-ambiguous manner, the existence of interaction between the 
designed epitopes with their corresponding proteins in a similar manner to that taking place 
for the individual portions, while evidences for the formation of a ternary complex between 
the ligand and the two proteins has also been derived from the NMR analysis. 
3.3.5. Experimental 
The bifunctional compound 3 was synthesized by the group of Prof. Cristina Nativi at the 
University of Florence. The synthesis will be published elsewhere. The N-trifluoroacetyl 
lactosamine was provided by Prof. Stefan Oscarson at the University of Dublin. 
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The hgal-3 CRD samples (15N isotopically labelled and unlabeled carbohydrate recognition 
domain from amino acids Met113 to Met249) were provided by Dr. Filipa Marcelo from the 
University Nova of Lisbon. The assignment was taken from BMRB entry 14941.  
The catMMP-12 15N isotopically labeled (V108 to G263) was provided by Marco Fragai from 
University of Florence.71 The assignment was taken from BMRB 6391.  
Ligand resonances were assigned by the acquisition of a set of standard NMR experiments: 1D 
1H-NMR, 2D homonuclear spectra TOCSY at different mixing times and ROESY and 2D 
heteronuclear 1H-13C HSQC in D2O in a 600 MHz Bruker Avance spectrometer equipped with a 
cryoprobe. 
 
 
 
Figure 27. 
1
H-
13
C HSQC of compound 3. 
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The chemical shift data of 3 are listed in the following table. 
Proton 
1
H-Chemical Shift ( ppm) 
13
C-Chemical Shift ( ppm)
 
H1 Gal 4.29 102.9 
H2 Gal 3.39 70.8 
H3 Gal 3.50 72.4 
H4 Gal 3.77 68.4 
H5 Gal 3.57 75.3 
H6a Gal 3.60 60.9 
H6b Gal 3.60 60.9 
H1 Glc 4.33 102.1 
H2 Glc 3.17 72.7 
H3 Glc 3.48 74.2 
H4 Glc 3.49 78.2 
H5 Glc 3.43 74.7 
H6a Glc 3.64 59.9 
H6b Glc 3. 81 59.9 
H7a 3.60 68.4 
H7b 3.80 68.4 
H8a 3.25 39.1 
H8b 3.30 39.1 
H9 2.09 35.3 
H10 1.42 24.7 
H11 1.42 24.7 
H12 2.09 35.3 
H13 3.15 38.4 
H14 3.15 38.4 
H15 2.28 - 
H16 2.68 - 
H17 2.49 - 
H18 2.28 - 
H19 2.11 35.3 
H20 1.42 24.7 
H21 1.42 24.7 
H22 2.09 35.3 
H23 2.95 38.9 
H24 1.25 26.3 
H25 1.05 25.3 
H26 1.00 25.2 
H27 1.24 27.9 
H28 3.04 48.4 
A 7.66 129.3 
B 6.98 114.5 
Table 5. Chemical shift of the 
1
H resonances of 3 at 298 K (600 MHz). 
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For the line broadening analysis, 1H-NMR spectra were acquired in a 500 MHz Bruker Avance 
spectrometer equipped with a cryoprobe on a sample containing 50 M of hgal-3 CRD in PBS 
deuterated buffer pH 7.3. A 0.5 mM ligand concentration was used for the sample at a 1:10 
hgal-3 CRD:3 molar ratio with 50 M of hgal-3 CRD, while a 2.5 mM ligand concentration for 
the sample at the 1:50 hgal-3 CRD:3 ratio. All spectra were processed with the same line 
broadening function. 
STD-NMR experiments. The sample with the highest ratio protein:ligand molar ratio (1:50) was 
used for the STD-NMR experiments. The on-resonance frequency was set at -0.22 ppm with a 
total saturation time of 2 seconds and a spin lock filter to minimize the background of the 
protein resonances. No water suppression was applied. 
19F competition study. A 500 MHz (1H frequency) Bruker Avance spectrometer was employed 
to record a set of 19F-NMR spectra on a sample containing N-trifluoroacetyl lactosamine (1 
mM) in the presence of hgal-3 CRD (50 M) in PBS deuterated buffer (pH 7.2) and TFA (0.5 
mM, used as internal standard). Increasing amounts of 3 were added to the sample in stepwise 
manner and 19F-NMR spectra were recorded after each addition. The final point was recorded 
for a sample displaying an equimolecular concentration of N-trifluoroacetyl lactosamine and 3 
(table 6). 
 hgal-3 CRD (M) N-trifluoroacetyl lactosamine (mM) Compound 3 (mM) 
Exp. 1 50 1 0.15 
Exp. 2 50 1 0.30 
Exp. 3 50 1 0.45 
Exp. 4 50 1 0.60 
Exp. 5 50 1 1 
Table 6. Experimental conditions of the 
19
F-NMR competition study between 3 and N-trifluoroacetyl lactosamine. 
Diffusion NMR experiments. DOSY experiments were performed using a 500 MHz Bruker 
Avance spectrometer. The DOSY experiments were acquired with 16 gradient increments to a 
final intensity decay of 90%. The measured samples contained 200 M hgal-3 CRD in PBS 
deuterated buffer pH 7.3 in the absence and presence of different amounts of 3 (60 M and 
100 M). 
1H-15N heteronuclear correlation spectra. 1H-15N HSQC spectra were recorded using a 600 MHz 
Bruker Avance spectrometer equipped with a cryoprobe. For the catMMP-12, spectral widths 
of  14 ppm (centered at  4.70 ppm) in the 1H dimension and  40 ppm (centered at  118 
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ppm) in the 15N dimension were used. The same parameters were employed for the 
multimeric complex analysis.  
For hgal-3 CRD, the spectral width was  14 ppm (centered in  4.70 ppm) in the 1H dimension 
and  34 ppm (centered in  119 ppm at the 15N dimension). For 15N-labeled hgal-3 CRD (0.1 
mM) two spectra were acquired, either in the absence or in the presence of compound 3 (1 
mM), in PBS buffer at pH 7.3. For 15N-labeled catMMP-12 (0.2 mM), two spectra were 
acquired, either in the absence or in the presence of compound 3 (2 mM) in perdeuterated-
TRIS buffer pH 7.9. 
The chemical shift perturbations were analyzed by calculating the corresponding weighted 
average data according to the following equation: 
For analyzing the formation of the ternary complex, a sample of 15N-labeled catMMP-12 (0.08 
mM) in the presence of a slight excess of compound 3 (0.1 mM, corresponding to a 1:1.25 
molar ratio) was employed.  1H-15N HSQC of the complex was acquired in the absence and 
presence of non-labeled hgal-3 CRD (0.18 mM) in perdeuterated TRIS buffer at pH 7.9. 
3.4. Glycan-antibody interactions: One example 
3.4.1. Anti-Gal antibodies 
The -galactose (-gal) epitope is a unique carbohydrate structure that is absent in humans 
but is present in numerous animal species.72 Moreover, all humans produce anti-gal 
antibodies, as the IgG displayed in all humans or the anti-gal IgM and IgA isotypes.73 Since the 
-gal epitope is an antigen for humans, it triggers the antibody-antigen reaction, thus 
activating the immune response and the complement system.74,75 However, the shortage of 
human organs for transplantation has opened the door to new alternatives involving the use of 
animal organs for humans; xenotransplantation. In this context, porcine organs have been 
considered as suitable xenografts although different obstacles have to be avoided. Rejection of 
xenografts is related to the fast anti-gal antibody/-gal epitope immune response.76 The 
rejection is produced by hyperacute response (HAR), a mechanism that is activated within a 
few minutes.74,75,77,78 Moreover, acute humoral xenograft rejection (AXHR) may also appear 
within hours once HAR is avoided.78,79 The existence of these two challenging events, HAR and 
∆𝛿(𝑝𝑝𝑚) = √(∆𝛿( 𝐻1 ))
2
+ (
∆𝛿( 𝑁15 )
5
)
2
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AXHR, have led to the development of different strategies to bypass the rejection, such as the 
immunosuppression of the human immunological system or the use of -gal epitope knock out 
pig xenografts.74,77,80  Unfortunately, the clinical efficacy of these strategies, even combined, 
has not been successful. Indeed, the high sensitivity and avidity of the anti-gal human antibody 
towards the xenoantigen finally triggers the rejection of the xenograft.77 Nevertheless, the 
possibilities of exploiting the anti-gal antibody/-gal epitope immune response has recently 
gained increased attention for the development of autologous vaccines75,81,82 following cancer 
therapies and then kill the residual cancer cells and avoid metastasis. In the present work, the 
recognition features of different monoclonal anti-gal antibody fragments have been studied. 
 
Figure 28. The -gal epitope disaccharide (Gal1-3Gal)
 
In particular, three monoclonal antibodies, anti-gal A4, A11 and G12, have been employed. The 
antibody constructs consist in fragments of their hyper-variable light chains, including the 
binding sites. 
A NMR approach using the ligand point of view was applied to address the recognition of the 
antibodies and evaluate the ligand epitope and the interaction mode. The commercially 
available disaccharide Gal-1-3GalOMe was employed as -gal epitope probe. After the full 
assignment of the NMR spectra of the disaccharide using a standard set of 1D and 2D NMR 
experiments, STD-NMR experiments were carried out, as described in the experimental 
section. 
Figure 29 shows the STD spectrum of the -gal epitope in the presence of the anti-gal A4 
antibody. The analysis showed the interaction of the disaccharide preferentially at the non-
reducing end. The protons H3´, H2´, H1´and H5´ received the highest saturation from the 
antibody. Additionally, the reducing end of the disaccharide also showed STD responses 
although with lower intensities than those displayed by the non-reducing galactose. 
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Figure 29. STD (below) and off-resonance (on top) NMR spectra (600 MHz) of the interaction of the disaccharide 
with the anti-gal A4 antibody. The temperature was 298 K and a 2 seconds saturation time at the aliphatic region 
( 0.8 ppm) was employed. Glycerol impurities present in the sample are marked with stars. 
 Absolute STD intensity (%) Relative STD intensity (%) 
H1 3.9 59 
H4 3.8 57 
H6 3.9 59 
H1’ 6.7 100 
H2' 6.6 99 
H3’ 5.0 75 
H4' 3.8 57 
H5' 6.1 92 
H6' 2.3 35 
OMe 2.5 38 
Table 7. The STD intensities of the disaccharide in the presence of the anti-gal A4 antibody. 
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Figure 30. Epitope mapping of the ligand when interacting with the anti-gal A4 antibody. 
In contrast, in the presence of the anti-gal A11 antibody, the STD spectrum (figure 31) of the 
disaccharide showed very low STD intensities, which precluded the accurate quantification of 
the intensities. H2´ and H3´ received the highest saturation but H1 of the reducing end showed 
high STD as well. According to these data, the binding epitope includes both saccharide units 
from the -gal epitope. Nevertheless, the observed low absolute STD intensities below 1% 
(table 8) strongly suggest that anti-gal A11 antibody recognizes the -Gal epitope with 
significantly lower affinity than the anti-gal A4 analogue. 
 
Figure 31. STD (below) and off-resonance (on top) NMR spectra (600 MHz) of the interaction of the disaccharide 
with the anti-gal A11 antibody. The temperature was 298 K and a 2 seconds saturation time at the aliphatic 
region ( 0.8 ppm) was employed. Glycerol impurities present in the sample are marked with stars. 
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 Absolute STD intensity (%) Relative STD intensity (%) 
H1 0.36 50 
H2 0.42 58 
H3 0.46 64 
H4 0.32 44 
H2' 0.72 100 
H3' 0.72 100 
H4' 0.28 39 
H5' 0.37 51 
OMe 0.12 17 
Table 8. The STD intensities estimated for the disaccharide in the presence of the anti-gal A11 antibody. 
 
Figure 32. Epitope mapping analysis of the ligand in the presence if the anti-gal A11 antibody. 
Finally, similar STD results to those described above for the A11 antibody were obtained for 
the disaccharide in the presence of the anti-gal G12 analogue (figure 33). In this case, the 
measured STDs are rather low, precluding the accurate measurement of the STD intensities.  
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Figure 33. STD (below) and off-resonance (on top) NMR spectra (600 MHz) of the interaction of the disaccharide 
with the anti-gal G12 antibody. The temperature was 298 K and a 2 seconds saturation time at the aliphatic 
region ( 0.8 ppm) was employed. 
 Absolute STD intensity (%) Relative STD intensity (%) 
H1 0.7 56 
H2 1.1 91 
H4 0.6 50 
H2' 1.2 100 
H3' 0.8 69 
H5' 0.5 42 
H6' 0.2 18 
OMe 0.5 43 
Table 9. The STD intensities estimated for the disaccharide in the presence of the anti-gal G12 antibody. 
The epitope mapping of the -gal epitope shows that H2´and H3´received the highest 
saturation as well as H2 from the reducing end.  
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Figure 34. Epitope mapping analysis of the ligand in the presence of the anti-gal G12 antibody. 
3.4.2. Conclusions 
The analysis of the STD data for the -gal epitope disaccharide (Gal1-3Gal) in the presence of 
the three monoclonal antibodies permitted to demonstrate that all of them indeed bind the 
xenoantigen (-gal ) by recognizing the non-reducing end, especially at the Gal H2-H3 region. 
However, the STD intensities differ among the three antibodies and suggest that the anti-gal 
A4 displays the strongest binding for Gal1-3Gal while anti-gal A11 and G12 recognize the -
gal epitope disaccharide with similar affinity, although significantly lower than the anti-gal A4 
antibody. 
3.4.3. Anti-sialic acid antibodies 
It is noteworthy to mention that artificial monoclonal antibodies are not only useful for clinical 
applications but they may also be employed for epitope analysis using histopathology. In fact, 
immunohistochemistry takes advantage of antibody-antigen interactions to detect key 
epitopes present at the cell membrane or at the surface of the tissues.83–85 As already 
mentioned, a high diversity of glycoproteins and glycolipids cover the cell membrane forming 
the glycocalix. Using the glycocalix, the high diversity of glycosylations plays an important role 
in extracellular cell events such as cell-cell communication,86 virus infection85  or immune 
response.9,75,87 In humans, N-glycans, O-glycans, and glycosphingolipids are often terminated 
with a sialic acid, a nine carbon atoms monosaccharide with a carboxylic moiety. Sialic acid 
also display structural diversity including the N-acetylneuraminic (Neu5Ac) and N-
glycolylneuraminic (Neu5Gc) acids among those with biological significance.88–91 In humans, 
Neu5Ac is the sialic acid derivative most abundant in the respiratory pathways and is involved 
in influenza infection.92–94 In contrast, humans are not able to produce Neu5Gc, but this 
derivative may originate from the dietary incomes or can be metabolically incorporated.95,96 
Chapter 3. NMR applications to carbohydrate recognition 
85 
 
Despite the importance of sialic acids, their exact roles still remain uncertain. However, it is 
today evident that their dysregulations are associated to medical disorders.90  
In this context, we have also investigated the interaction of anti-sialic antibodies, anti-sialic 1 
and anti-sialic 2, with the corresponding epitopes. These antibodies have been proposed as 
probes for immunohistochemical studies to try to detect sialic acid-based disorders. Two 
different fragments of the hyper-variable light chain of the antibody have been expressed that 
specifically target sialic acid derivatives. Again, NMR methodology based on the ligand 
perspective has been adopted to monitor the corresponding interactions.  
 
Figure 35. Chemical structures of sialic acid derivatives Neu5Ac (left) and Neu5Gc (right). 
The STD-NMR analysis of Neu5Gc in the presence of anti-sialic 1 (figure 37) showed the 
preferred recognition of the minor anomer present in solution, the  anomer. Indeed, H9, H5 
and H7 from the -anomer displayed the highest STD intensities while the predominant -
anomer showed much smaller saturation (table 10).  
 
Figure 36. The mutarrotation equilibrium between the Neu5Gc anomers. The intermediate open form is not 
shown. 
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Figure 37. STD (below) and off-resonance (on top) NMR spectra of the interaction of Neu5Gc with the anti-sialic 1 
antibody. The temperature was 298 K and a 2 seconds saturation time at the aromatic region ( 7 ppm) was 
employed. 
 Absolute STD intensity (%) Relative STD intensity (%) 
-H3a 4.16 60 
-H3b 4.20 60 
-H5 6.64 95 
-H7 6.90 99 
-H9a 6.32 91 
-H9b 6.97 100 
- CH2OH 3.29 47 
-H5 0.35 5 
-H9a 0.49 7 
-H9b 0.38 5 
-CH2OH 0.10 1 
Table 10. The STD intensities estimated for Neu5Gc in the presence of the anti-sialic 1 antibody. 
The STD results show the highly-preferred binding towards the -anomer. The importance of 
the anomer configuration for the binding event towards the anti-sialic 1 antibody may have 
biological relevance. In humans, sialic acid is often found attached to the glycan using  
configuration, although the  anomer accommodates the bulky carboxylate group in an 
equatorial orientation. Thus, the specificity of the anti-sialic 1 antibody could be exploited to 
detect  linked Neu5Gc moieties in human tissues. 
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Figure 38. Epitope mapping analysis of Neu5Gc in the presence of the anti-sialic 1 antibody. 
Fittingly, no STD was observed for the Neu5Ac analogue in the presence of the anti-sialic 1 
antibody under the same experimental conditions employed for the Neu5Gc analogue (figure 
39).  
 
Figure 39. No STD intensities (bottom) are observed for Neu5Ac in the presence of the anti-sialic 1 antibody. The 
off-resonance spectrum is shown on the top panel. 
Next, the interaction of the anti-sialic 2 antibody against Neu5Gc and Neu5Ac was studied. 
Again, a high specificity towards the  anomer of Neu5Gc was observed (figure 40) with the 
region defined by H9, H7 and H5 composing the key interacting epitope. 
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Figure 40. STD (below) and off-resonance (on top) NMR spectra of the interaction of Neu5Gc with the anti-sialic 2 
antibody. The temperature was 298 K and a 2 seconds saturation time at the aromatic region ( 7 ppm) was 
employed.. 
 Absolute STD intensity (%) Relative STD intensity (%) 
-H3a 4.0 63 
-H3b 4.3 68 
-H5 6.2 98 
-H7 5.6 89 
H9a 2.9 46 
H9b 6.3 100 
- CH2OH 2.4 38 
-H5 0.3 4 
H6 0.3 4 
- CH2OH 0.2 3 
Table 11. The STD intensities estimated for Neu5Gc in the presence anti-sialic 2 antibody. 
The epitope mapping analysis (figure 41) revealed similar results to those obtained for anti-
sialic 1. According to the obtained STD intensities, Neu5Gc shows a similar binding epitope 
versus both anti-sialic antibodies with a similar affinity range. 
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Figure 41. Epitope mapping analysis of Neu5Gc in the presence of the anti-sialic 2 antibody. 
Again, no STD was observed for the Neu5Ac analogue in the presence of the anti-sialic 2 
antibody under the same experimental conditions employed for the Neu5Gc analogue (figure 
42). Both antibodies behave in a similar manner versus the two sialic acid moieties (figures 43 
and 44). 
 
Figure 42. No STD intensities (bottom) are observed for Neu5Ac in the presence of the anti-sialic 2 antibody. The 
off-resonance spectrum is shown in the top panel. 
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Figure 43. The comparison of the STD-NMR experiments for Neu5Gc in the presence of anti-sialic 1 (central 
spectrum) and anti-sialic 2 (bottom). The off-resonance spectrum in the presence of anti-sialic 1 is shown at the 
top. 
 
Figure 44. The relative STD intensities of -Neu5Gc acid in the presence of anti-sialic 1 (grey) and 2 (black) 
antibodies. 
α-H3a α-H3b α-H5 α-H7 α-H9 α-CH2OH 
anti-sialic 2 63 68 98 89 100 38
anti-sialic 1 60 60 95 99 100 47
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In summary, both monoclonal antibodies display similar affinities and selectivities towards -
Neu5Gc while the Neu5Ac is not recognized either in the  or  anomers. 
These simple sialic acid monosaccharides are not directly attached to the cell surfaces but they 
form part of glycans. Thus, a N-acetyl lactosamine moiety was glycosylated with -Neu5Gc 
moiety to yield the naturally occurring Neu5Gc(2-3)N-acetyl lactosamine and Neu5Gc(2-
6)N-acetyl lactosamine trisaccharide models (figure 45) that were employed to test the 
monoclonal antibody anti-sialic 1 and 2, following the same NMR-based methodology. 
 
Figure 45. The Neu5Gc(2-3)N-acetyl lactosamine (1) and Neu5Gc(2-6)N-acetyl lactosamine (2) trisaccharides. 
The 1H NMR spectrum of 1 showed a large overlapping of the resonance signals between  3.6 
ppm and 3.7 ppm, precluding the non-ambiguous identification of the signals in the STD 
spectrum.  
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Figure 46. The 
1
H NMR spectrum (600 MHz) of trisaccharide 1. 
Nevertheless, the STD spectrum (figure 47) obtained for trisaccharide 1 in the presence of the 
anti-sialic 1 antibody showed STD signals for CH2OH, H6´´, H5´´, and H7´´, indicating that the 
interaction takes place through the terminal Neu5Gc (figure 48). 
 
Figure 47. STD (below) and off-resonance (on top) NMR spectra of the interaction of trisaccharide 1 with the anti-
sialic 1 antibody. The temperature was 298 K and a 2 seconds saturation time at the aromatic region ( 7 ppm) 
was employed. 
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Absolute STD intensity (%) Relative STD intensity (%) 
H5´´ 2.4 100 
H6´´ 2.0 81 
H7´´ 1.5 61 
CH2OH 1.6 68 
Table 12. The STD intensities estimated for trisaccharide 1 in the presence of the anti-sialic 1 antibody. 
 
Figure 48. Epitope mapping analysis of trisaccharide 1 in the presence of the anti-sialic 1 antibody. 
Then, the binding of trisaccharide 2 towards the anti-sialic 1 antibody was examined under 
similar experimental conditions. A better signal dispersion was observed in the 1H NMR 
spectrum of 2, which largely facilitated the accurate identification and quantification of the 
STD signals (figure 49).  Different sialic acid signals received the highest saturation, but also 
STD signals from the Gal moiety and even the acetyl group from the GlcNAc residue were 
evident. Thus, the recognition of 2 by the anti-sialic 1 antibody involves an extended epitope 
(figure 50). 
The chemical natural of the two disaccharides provides major differences in their 3D shapes. 
Trisaccharide 1, adopts a rather linear conformation while its analogue 2 displays a “hook-like” 
geometry. This difference may explain the observed differences in the interaction epitopes: in 
2, once the terminal Neu5Gc is recognized at the binding site of the antibody, the different 
orientation of the N-acetyl lactosamine moiety provides additional contacts between the Gal 
and NAc moieties and the antibody. 
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Figure 49. STD (below) and off-resonance (on top) NMR spectra of the interaction of trisaccharide 2 with the anti-
sialic 1 antibody. The temperature was 298 K and a 2 seconds saturation time at the aromatic region ( 7 ppm) 
was employed. 
 Absolute STD intensity (%) Relative STD intensity (%) 
H4' 1.3 100 
H5' 1.0 73 
H6' 0.9 69 
H4´´ 0.7 56 
H5´´ 1.0 77 
H6´´ 1.2 90 
H9a´´ 0.9 65 
CH2OH 1.0 72 
NAc 0.6 43 
Table 13. The STD intensities estimated for trisaccharide 2 in the presence of the anti-sialic 1 antibody. 
 
Figure 50. Epitope mapping analysis of trisaccharide 2 in the presence of the anti-sialic 1 antibody. 
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The same procedure was followed to address the study of the interaction of trisaccharides 1 
and 2 with the anti-sialic 2 antibody. 
Again, the obtained STD spectrum (figure 51) for trisccharide 1 in the presence of anti-sialic 2 
showed clear STD intensities that permitted identifying the CH2OH group of the sialic acid 
moiety as a major epitope. Other protons from the Neu5Gc residue were also identified, 
permitting the description of a similar epitope (figure 52) to that described above for the anti-
sialic 1 recognition.  
 
Figure 51. STD (below) and off-resonance (on top) NMR spectra of the interaction of trisaccharide 1 with the anti-
sialic 2 antibody. The temperature was 298 K and a 2 seconds saturation time at the aromatic region (7 ppm) 
was employed. 
 Absolute STD intensity (%) Relative STD intensity (%) 
H5´´ 14.5 79 
H6´´ 9.2 51 
H7´´ 10.0 55 
CH2OH 18.3 100 
Table 14. The STD intensities estimated for trisaccharide 1 in the presence of the anti-sialic 2 antibody. 
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Figure 52. Epitope mapping analysis of trisaccharide 1 in the presence of the anti-sialic 2 antibody. 
The analysis of the STD data for trisaccharide 2 in the presence of anti-sialic 2, (figure 53) 
showed that the terminal Neu5Gc received the highest saturation and that also the GlcNAc 
acetyl group was part of the epitope (table 15). The overlapping problem precluded a more 
defined epitope mapping (figure 54). Thus, the existence of an extended epitope comprising 
the three saccharide units could not be discarded. 
 
Figure 53. STD (below) and off-resonance (on top) NMR spectra of the interaction of trisaccharide 2 with the anti-
sialic 2 antibody. The temperature was 298 K and a 2 seconds saturation time at the aromatic region ( 7 ppm) 
was employed. 
 Absolute STD intensity (%) Relative STD intensity (%) 
H5´´ 1.2 78 
H6´´ 1.0 68 
H7´´ 0.8 52 
H9a´´ 1.2 80 
CH2OH 1.5 100 
NHAc 0.5 35 
Table 15. The STD intensities estimated for trisaccharide 2 in the presence of the anti-sialic 2 antibody. 
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Figure 54. Epitope mapping analysis of trisaccharide 2 in the presence of the anti-sialic 2 antibody 
3.4.4. Conclusions 
Therefore, both monoclonal anti-sialic antibodies interact with the two -Neu5Gc-containing 
trisaccharides. In both cases, the major epitope involves the -Neu5Gc moiety. For the -
Neu5Gc(2-3) analogue, the antibodies only bind the sialic acid moiety. However, an extended 
epitope of the Neu5Gc(2-6) analogue, involving the different monosaccharide residues, is 
recognized by the antibodies. The different 3D geometries of the two molecules are at the 
heart of the observed molecular recognition behavior. 
3.4.5. Experimental 
A set of standard 1D and 2D NMR experiments (1H, TOCSY, 1H-13CHSQC, NOESY, ROESY) were 
performed in a 500 MHz Bruker Avance spectrometer at 298 K to assign the 1H and 13C NMR 
resonances of the -gal epitope disaccharide. For the assignment of trisaccharides 1 and 2, 
Neu5Ac and Neu5Gc, the experiments were carried out in D2O and PBS pH 7.3 at 298 K using a 
600 MHz Bruker Avance spectrometer equipped with a triple-channel cryoprobe. 
STD-NMR experiments were acquired in the 600 MHz Bruker Avance Spectrometer at 298 K. 
The saturation frequency was set up at  0.8 ppm (aliphatic region) for the anti-gal A4, A11 and 
G12 antibodies and at  7 ppm (aromatic region) for the anti-sialic antibodies. The saturation 
time was 2 seconds. All the STD-NMR experiments were collected without spin lock. The STD 
background of the target antibody was deduced by acquiring a blank STD experiment for the 
pure antibody without ligand and subtracted from the genuine STD in the presence of the 
corresponding ligand. 
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For the case of anti-gal A4, A11 and G12 samples, the concentration of the antibody was 10 
M and 900 M ligand (molar ratio 1:90). The samples contained deuterated PBS buffer (137 
mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4; 1.7 mM KH2PO4, pH 7.3). 
Similar conditions were employed for the preparation of the samples containing anti-sialic 
samples. For the anti-sialic 1, the sample concentration of the antibody was 20 M (molar 
ratio 1:45) in deuterated PBS buffer at pH 7.3. For the anti-sialic 2 in the presence of 
trisaccharide 1 spectra, the concentration of the antibody was 20 M (molar ratio 1:90) in 
deuterated PBS buffer at pH 7.3.For the anti-sialic 2 in the presence of trisaccharide 2, the 
concentration of the antibody was 10 M (molar ratio 1:90) in deuterated PBS buffer at pH 
7.3. 
a. -gal epitope assignment 
Standard NMR experiments were acquired on a 5 mM sample of the -Gal epitope in D2O. 
Table 16 shows the assignment of the NMR resonance signals. 
 
 
1
H-Chemical Shift (ppm) Multiplicity (J value) 
13
C- Chemical Shift (ppm) 
H1 4.31 d, J=7.9 Hz 103.5 
H2 3.56 dd, J=9.9, 7.9 Hz 69.1 
H3 3.70 m 77.3 
H4 4.11 m 70.7 
H5 3.62 dd, J=7.9, 4.34Hz 74.9 
H6 3.74 m 61.1 
H1’ 5.08 d, J=3.8 Hz 95.2 
H2’ 3.79 dd, J=10.3, 3.9 Hz 68.2 
H3’ 3.88 dd, J=10.3, 3.3 Hz 69.2 
H4’ 3.94 d, J=3.2 Hz 69.1 
H5’ 4.11 m 64.7 
H6’ 3.66 m 60.8 
OMe 3.51 s 56.9 
Table 16. NMR chemical shifts (, ppm) and coupling constants (Hz) for for the -gal disaccharide epitope. 
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b. Neu5Ac assignment 
NMR experiments were acquired on 3mM samples of the ligands in D2O. Tables 17, 18 and 19 
show the assignment of the corresponding NMR signals of Neu5Nac and Neu5Gc. Two 
different set of signals  and  were observed. Their assignments are given in different tables. 
 
 
1
H-Chemical Shift (ppm) Multiplicity (J value) 
13
C- Chemical Shift (ppm) 
H3a 1.72 t, J = 13.1 Hz 38.8 
H3b 2.14 dd, J = 13.8, 5.2 Hz 38.8 
H4 3.90 m 66.7 
H5 3.78 t,J=10.1 Hz 51.9 
H6 3.89 m 70.3 
H7 3.39 d, J = 9.7 Hz 68.2 
H8 3.60 m 70.0 
H9a 3.46 dd, J = 12.2, 6.6 Hz 63.1 
H9b 3.69 dd, J = 12.2, 2.3 Hz 63.1 
Ac 1.90 s 22.1 
Table 17. NMR chemical shifts (, ppm) and coupling constants (Hz) for N-Acetyl Neuraminic acid (Neu5Ac). 
c. Neu5Gc assignment 
 
 
1
H-Chemical Shift (ppm) Multiplicity (J value) 
13
C- Chemical Shift (ppm) 
H3 1.73 t, J = 13.0 Hz 39.0 
H3’ 2.14 dd, J = 13.8, 5.2 Hz 39.0 
H4 4.00 m 66.5 
H5 3.86 t, J=10.3 Hz 51.7 
H6 3.99 m 69.9 
H7 3.38 d, J = 9.7 Hz 68.1 
H8 3.60 m 70.1 
H9 3.46 dd, J = 12.1, 6.5 Hz 63.0 
H9’ 3.69 dd, J = 12.5, 2.1 Hz 63.0 
CH2OH 3.99 s 60.8 
Table 18. NMR chemical shifts (, ppm) and coupling constants (Hz) for for N-Glycolyl Neuraminic acid (Neu5Gc). 
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1
H-Chemical Shift (ppm) Multiplicity (J value) 
13
C- Chemical Shift (ppm) 
H3 2.62 t, J = 12.4 Hz 40.6 
H3’ 1.51 dd, J = 12.5, 4.4 Hz 40.6 
H4 3.51 m 72.2 
H5 3.76 m 68.2 
H6 3.87 m 70.0 
H7 3.37 m 67.9 
H8 3.73 m 71.4 
H9a 3.49 m 62.5 
H9b 3.72 m 62.5 
CH2OH 3.99 s 60.8 
H3a 1.69 m 39.3 
H3b 2.09 m 39.3 
H4 3.99 m 66.8 
H5 3.87 m 51.8 
H6 3.96 m 69.8 
H7 3.37 m 68.4 
H8 3.63 m 70.2 
H9a 3.48 m 63.2 
H9b 3.71 m 63.2 
CH2OH 4.00 m 60.8 
Table 19. NMR chemical shifts (, ppm) and coupling constants (Hz) for Neu5Gc acid. 
d. Trisaccharides assignment 
NMR experiments were acquired for 3 mM samples of the ligands in D2O. Tables 20 and 21 
show the NMR parameters for each ligand. 
 
 
1
H-Chemical Shift (ppm) Multiplicity (J value) 
13
C- Chemical Shift (ppm) 
H1 4.43 d, J = 8.2 Hz 101.2 
H2 3.68 m 55.1 
H3 3.68 m 72.6 
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H4 3.64 m 78.3 
H5 3.51 m 74.7 
H6a 3.57 dd, J=11.9,6.3 Hz 62.5 
H6b 3.79 m 62.5 
H1' 4.48 d, J = 7.9 Hz 102.5 
H2' 3.50 m 69.3 
H3' 4.04 m 75.5 
H4' 3.64 m 72.1 
H5' 3.63 m 75.2 
H6a' 3.78 m 59.9 
H6b´ 3.93 m 59.9 
H3a´´ 2.70 dd, J = 12.6, 4.6 Hz 40.0 
H3b´´ 1.74 t, J=12.1 Hz 40.0 
H4´´ 3.71 m 68.0 
H5´´ 3.86 m 51.3 
H6´´ 3.88 m 67.4 
H7´´ 3.51 m 68.0 
H8´´ 3.82 m 71.8 
H9a´´ 3.65 m 61.0 
H9b´´ 4.03 m 61.0 
CH2OH 4.04 m 61.0 
A 3.64 m 68.0 
A´ 3.94 m 67.9 
B 1.87 m 27.0 
C 3.01 t, J=6.9 Hz 37.9 
Ac 1.96 s 102.2 
Table 20. NMR chemical shifts (, ppm) and coupling constants (Hz) for trisaccharide 1. 
 
 
1
H-Chemical Shift (ppm) Multiplicity (J value) 
13
C- Chemical Shift (ppm) 
H1 4.47 dd, J= 5.8, 2.5 Hz 101.0 
H2 3.69 m 54.8 
H3 3.56 m 74.4 
H4 3.56 m 80.6 
H5 3.55 m 84.4 
H6 3.76 m 60.2 
H6b 3.92 m 60.2 
H1’ 4.38 d, J= 7.9 Hz 103.4 
H2’ 3.46 m 70.7 
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H3’ 3.59 m 72.4 
H4’ 3.85 m 68.3 
H5’ 3.75 m 73.7 
H6’ 3.47 m 63.4 
H6b´ 3.93 m 63.4 
H3a´´ 2.61 dd, J= 12.4, 4.7 Hz 40.2 
H3b´’ 1.65 t, J=12.2 Hz 40.2 
H4´´ 3.69 m 68.0 
H5´´ 3.82 m 51.5 
H6´´ 3.82 m 71.8 
H7´´ 3.47 m 68.3 
H8´´ 3.85 m 78.4 
H9a´´ 3.57 m 62.6 
H9b´´ 3.80 m 62.6 
CH2OH 4.04 s 61.0 
A 3.65 m 67.9 
A´ 3.96 m 67.9 
B 1.88 dd, J=9.2, 4.1 Hz 27.0 
C 3.03 t, J= 6.9 Hz 37.6 
NHAc 1.99 s 102.2 
Table 21. NMR chemical shifts (, ppm) and coupling constants (Hz) for trisaccharide 2. 
3.5. Sialylated glycans and influenza 
As mentioned above, sialic acid moieties at the glycocalyx plays a key role human upper 
respiratory tracts.94,97,98 Thus, it is exposed to pathogens through the air, becoming involved in 
common pathologies such as influenza. 
Influenza viruses are a family of RNA viruses responsible for flu and are associated with several 
major human pandemics in the 20th century. One major concern resides in its ability to mutate 
and then to infect other species. Its genome codifies for 10 proteins. Two of them are located 
at the surface of the virus particles. The first one, Hemagglutinin (HA) is important for cell 
adhesion and infection. The second one, Neuraminidase (NA) is the key player for virions 
release.99,100 Both proteins are characterized by its ability to bind sialic acid residues. Indeed, 
the transmission between species of the influenza virus relies on the mutation of only a few 
amino acids of these proteins, which are strongly involved in the binding to sialic acid. At 
present, 16 hemagglutinins and 9 neuraminidases subtypes of influenza A have already been 
described.101–104 Due to the large variety of combinations and origin diversity of the proteins 
(avian, human, other mammals), the different influenza viruses have been named by the 
presence of hemagglutinins from H1 to H16 and of the corresponding neuraminidases, from 
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N1 to N9. For instance, the H1N1 considers the presence of the hemagglutinin subtype 1 (H1) 
and the neuraminidase subtype 1 (N1) at the surface of the influenza virus. Moreover, the 
influenza viruses that infect humans have also been classified, based on their virulence and 
pathogenicity, in three types A, B and C affecting humans. While human influenza A and B 
viruses cause seasonal epidemics, influenza C causes only mild illness.105 
Sialylated glycan receptors at the host cells have been shown to display a key role for influenza 
viral infection since they serve as anchorage for the influenza virus, via HA recognition, 
allowing the virus invasion and infection. The easy mutation ability of the HA has triggered the 
transfection from animal species to humans. The avian and porcine influenza viruses showed 
specificity towards 2-3 sialic acid linked to galactose (Gal), while many studies have shown 
that human influenza strains binds 2-6 sialic acid linkages97,106–115 The single mutation of one 
or two amino acids at the binding site of the avian influenza strains is enough to switch the 
specificity from 2-3 sialylated glycans to the 2-6 analogues, thus triggering human infection. 
Therefore, the full understanding of the HA specificity and binding mode would help to the 
design of better drugs targeting the pandemic influenza. 
3.5.1. Results and discussion 
In this work, a small library of five sialylated linear and branched glycans (figure 55, scheme 4) 
has been synthesized by sequential enzymatic synthesis using a battery of glycosyl transferase 
enzymes taking advantage of the enzymatic substrate selectivity and specificity, as well as the 
absence of side products. These factors make the enzymatic approach highly reliable for the 
synthesis of glycans, avoiding the protecting and deprotecting steps typical of the chemical 
synthesis of carbohydrates. Next, the recognition of the linear glycans (glycans 1 to 3 figure 55, 
scheme 4) by different HA strains have been elucidated by using NMR methods from the ligand 
point of view.  
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Figure 55. Schematic structures of ligands 1-5. 
 
 
 
Scheme 4. Formulae of the linear glycans 1-3 and numbering code of the constituent monosaccharide units. 
The synthetic route followed for the synthesis of the linear ligands 1 to 3 is shown in figure 56 
From the starting building blocks, successive Gal and GlcNAc extensions were followed, in an 
alternative manner, to finally extend the oligosaccharide to intermediates 3b and 1c. Finally, 
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the Neu5Ac was added to the terminal Gal with the different 2-3 (avian) or 2-6 (human) 
linkages. 
 
Figure 56. Synthetic routes of glycans 1 to 3. 
As reactants, glycosyl donor in their UDP- or CMP- activated carbohydrates are required for 
the enzymes, which are transferred to the main scaffold by the activity of different 
transferases. In the case of the Gal extension, the reactant UDP-Glc is first epimerized to Gal 
and then transferred, by the action of a recombinant enzyme with epimerase and transferase 
activity (4GalT-GalE), to form a specific 1-4 linkage with the terminal GlcNAc ethyl azide as 
starting building block.  The next GlcNAc addition is directly added to the growing 
oligosaccharide chain from its activated UDP- form by the activity of the GlcNAc-transferase, 
3GlcNAcT, to form a 1-3 linkage to the Gal unit. These two steps are sequentially repeated 
once (glycans 1 and 2) or twice (glycan 3). In the last steps of the synthesis, for the addition of 
the Neu5Ac residue, two different sialyl transferase enzymes with the same sialyl donor 
substrate, CMP-Neu5Ac previously obtained by enzymatic sytnhesis, have been used to 
address the different linkages, 2-3 (glycan 1) or 2-6 (glycans 2 and 3): the ST3 fusion sialyl 
transferase yields the 2-3 linkage, while the hST6Gal sialyl transferase incorporates the 
corresponding 2-6 linkage to the terminal Gal. The experimental section contains the detailed 
description of the conditions of the different reactions. 
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The synthesis of the biantennae ligands (glycans 4 and 5) was accomplished using a similar 
strategy (figure 57), but employing a key branched nonasaccharide starting building block (4b) 
obtained by enzymatic degradation of a complex undecasaccharide (4a) isolated from natural 
sources. This preliminary step was required to remove the terminal neuraminic acid of the 
starting material (4a) with a comercial sialidase (AUS neuraminidase, Sigma Adrich). From 4b, 
sequential growing steps were run similarly as for the linear oligosaccharides.  
 
Figure 57. Synthetic routes to the branched ligands 4 and 5. 
After the synthesis, a set of standard NMR experiments (TOCSY, NOESY, 1H-13C HSQC, 1H-13C 
HSQC-TOCSY) were collected for chemical shift assignments (see experimental section). To 
differentiate the signals corresponding to each N-Acetyl group present in the Neu5Ac and 
GlcNAc residues a combined set of TOCSY and NOESY experiments acquired in water (10% 
deuterated) were needed (figure 58). In all cases, the acetyl group of Neu5Ac residue appeared 
at higher field.  
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Figure 58. NOESY spectrum of glycan 3 in water (10% deuterated) at 600 MHz equipped with a cryoprobe (298 K). 
The NH-NAc cross-peaks are annotated. 
The glycans were then tested against the influenza A human variants of H1N1, H7N9 and H6N1 
strains and to the original avian strains of H7N9 and H6N1. The human strains display affinity 
towards the Neu5Ac 2-6Gal linkage as evidenced by Nycholat et al by using glycoarrays116 and 
by Macchi et al by using NMR.117 Due to the large protein size of HA variants (a trimer of 60 
KDa per monomer), the use of 1H-15N HSQC titrations to analyze the binding event form the 
protein’s perspective is not suitable for this case. Therefore, we again employed NMR 
methodology from the ligand´s point of view with STD NMR experiments.  
The analysis of the STD spectrum of 2 in the presence of the HA of the human H1N1 strain 
(figure 59) identified the acetyl group of the Neu5Ac as the most saturated signal, followed by 
H3a and H3b of Neu5Ac and the acetyl group of GlcNAc 2. Although it was not possible to 
completely analyze the crowded region from  3.5 to 4 ppm due to extensive signal 
overlapping, interestingly, H4 of Gal 1 and Gal 2 residues showed saturation transfer from the 
protein, indicating the presence of an extended epitope along the complete oligosaccharide 
chain. 
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Figure 59. The interaction of glycan 2 with H1N1 strain of HA. The STD spectrum (600 MHz, 298 K) obtained for a 
86:1 mixture of glycan 2:H1N1 is shown at the bottom, while the off-reference spectrum is shown at the top.  The 
concentration of the HA was 3.5 M. The on-resonance frequency for protein saturation was set at the aromatic 
region ( 7 ppm) during 2 seconds. 
Similar results were obtained from the STD experiments performed for the complex of the HA 
of the H1N1 variant and compound 3 (figure 60). Similarly, the main contact is located at the 
Neu5Ac end of the molecule. In fact, the acetyl group of the Neu5Ac receives the highest 
saturation followed by the H3a and H3b of the Neu5Ac and the acetyl group of GlcNAc 3. The 
discrimination among the different acetyl groups is remarkable, suggesting that only the acetyl 
groups from the Neu5Ac and GlcNAc 3 residues are in close contact with the protein. Again, 
the signals of H4 from Gal 3 and overlapping signal from Gal 1 and Gal 2 residues showed 
saturation, as expected for the extended epitope observed with 2, which would involve at least 
the galactose units 2 and 3. 
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Figure 60. The interaction of glycan 3 with H1N1 strain of HA. The STD spectrum (600 MHz, 298 K) obtained for a 
86:1 mixture of glycan 3:H1N1 is shown at the bottom, while the off-reference spectrum is shown at the top.  The 
concentration of the HA was 3.5 M. The on-resonance frequency for protein saturation was set at the aromatic 
region (7 ppm) during 2 seconds. 
For a better understanding of the binding event, a computational model was generated from 
the available H1N1 human variant PDB structure (PDB ID 4JTV).118 Thus, glycan 3 was modeled 
using the GLYCAM force field.119 The built model suggests that the binding site of the HA 
involves loop 130, loop 220, and the alpha helix 190 (left panel of figure 61).  Indeed, the 
experimental STD intensities are in accordance with the built binding mode and suggest the 
existence of a fully folded umbrella-type topology at the glycosidic bond Neu5Ac(2-6)Gal, 
similar to that already described for other strains.117,120–122 The analysis of the obtained 
geometry permitted to deduce that the HA efficiently binds the glycan by favoring the gauche-
trans (gt) conformation for the  dihedral angle of the terminal Gal 3 moiety (O6Gal3-C´6Gal3-
C´5Gal3-O´5Gal3 (gauche) and O6Gal3-C´6Gal3-C´5Gal3-C´4Gal3 (trans)) and selecting the typical extended 
geometry for the subsequent 1-3 and 1-4 glycosidic linkages (right panel of figure 61). 
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Figure 61. Proposed 3D model for the complex formed by the interaction of glycan 3 with the HA of the H1N1 
variant. The binding site is represented, showing the topology of the glycan and the interaction pattern. 
As mentioned in the introduction to this section, the importance of single mutations between 
different strains may drive the change in the specificity of the HA from viruses with different 
targeted species and, therefore, the study of the binding specificity of mutants display special 
relevance. Hence, glycan 3 was tested against two different HA influenza A avian strains (H6N1 
and H7N9), specific for 2-3) Neu5Ac-Gal linkages, and against their mutated relatives 
targeting humans, specific for the 2-6 analogues.  
The STD-NMR spectra of the avian wild type (WT) and mutant human variant H6N1 strains in 
the presence of glycan 3 are shown in figure 62. From the higher efficiency in the saturation 
transfer, it is evident that the mutant (2-6 specific) strain shows an enhanced binding for 3 in 
comparison to that of the WT strain, which is specific for the 2-3 linkage.   
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Figure 62. The interaction of glycan 3 with the two HA of the H6N1 strains. STD-NMR spectrum acquired at 600 
MHz (298 K). The top panel shows the off-resonance spectrum. The middle panel contains the STD spectrum of 3 
in the presence of the HA of the H6N1 mutant strain. The bottom panel displays the STD of glycan 3 in the 
presence of the H6N1 wild type. The saturation frequency was set up at  7 ppm (aromatic region) and the 
saturation time was 2 seconds. In both cases the same protein:ligand molar ratio (1:60) were used. 
In particular, the STD-NMR spectrum of the H6N1 mutant strain showed a preferential binding 
towards the Neu5Ac end as described above for the H1N1 variant. The spectrum permits to 
discriminate the acetyl groups of the GlcNAc units (GlcNAc 1 and GlcNAc 2) from that the 
Neu5Ac. However, no signals for Neu5Ac H3a and H3b or for Gal 1 and Gal 2 H4 were 
observed.  Only, H4 from Gal 3 was observed in the STD. Therefore, no evidence of the 
existence of an extended contact epitope along the full oligosaccharide chain was found in this 
case. For H6N1 WT, the STD signals were much less intense to those observed for the mutant 
human variant although a similar STD profile was observed for the acetyl region when 
compared to that of the mutant strain. Therefore, glycan 3 presents a much better affinity 
towards the HA of the mutant H6N1 strain.  
Following similar methodology to that described above, glycan 3 was modeled in the binding 
site of the H6N1 HA mutant strain, using as starting point the available X-ray structure of H6N1 
(PDB coordinates provided by personal communication with Prof. De Vries) (figure 63). The gt 
( dihedral angle) conformer of glycan 3 was docked to the crystal structure and the obtained 
complex was further minimized. The obtained 3D model fits with the obtained STD data, 
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where H4 from Gal 3 is fairly close to the surface of the protein, while H3a and H3b from 
Neu5Ac and H4 from Gal 2 are far away, at more than 4 Å of distance. In this case, the folded 
umbrella topology displayed by glycan 3 is slightly opened and places the reducing end of the 
oligosaccharide chain out of the protein binding pocket. 
 
Figure 63. Proposed 3D model for the complex formed by the interaction of glycan 3 with the HA of the H6N1 
mutant strain and comparison with the model for H1N1. The folded umbrella topology adopted by the glycan is 
shown, together with the interaction pattern. 
Only three amino acids have changed in the H6N1 mutant with respect to the H6N1 WT strain: 
Leu153Ile, Leu142Ile and Gly225Asp (figure 64). Glycine 225 (WT) confers flexibility to the loop 
220 and allows the 2-3 linkage oligosaccharide to be bound. However, its mutation into an 
Asp residue defines the presentation of loop 220, now hindering the binding of NeuNAc2-
3Gal moieties, but enabling the binding of the conformer of the Neu5Ac2-6Gal fragment, 
which forms the interacting epitope together with GlcNAc 3. 
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 153 142 225 
H6N1 wt LEU LEU GLY 
H6N1 mutant ILE ILE ASP 
Figure 64. The mutated amino acids at the binding site of the HA of the H6N1 strain. In green, the wild type H6N1. 
In magenta, the H6N1 mutant strain. 
An analogous study was performed for the H7N9 HA strains. The STD-NMR spectrum (figure 
65) acquired for the complex of 3 with the mutant H7N9 strain presents a similar acetyl 
pattern to those observed for H6N1 and H1N1. However, the STD intensity of the GlcNAc 3 
OAc group is marginal, significantly weaker than those observed before. For the wild type 
strain, the highest STD was much weaker than that measured for the mutant. Thus, the STD 
data also confirm that the wild type displays very weak affinity towards the 2-6 linkage, while 
the mutant strain is now able to recognize the Neu5Ac end of the glycan. However, there is not 
any extended epitope in this case and the experimental data strongly suggest that the 
reducing end of the glycan is pointing out of the protein. 
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Figure 65. The interaction of glycan 3 with the two HA of the H7N9 strains. STD-NMR spectrum acquired at 600 
MHz (298 K). The top panel shows the off-resonance spectrum. The middle panel contains the STD spectrum of 3 
in the presence of the HA of the H7N9 mutant strain. The bottom panel displays the STD of glycan 3 in the 
presence of the H7N9 wild type. The saturation frequency was set up at  7 ppm (aromatic region) and the 
saturation time was 2 seconds. 
A 3D model was built following the same methodology described above (figure 66), using the 
available crystal structure (PDB provided by Prof. De Vries) as a template for the gt conformer 
of the glycan. 
 
Figure 66. 3D model for the complex formed by the interaction of glycan 3 with the HA of the H7N9 mutant strain 
and comparison with the equivalent models with H6N1 and H1N1. A folded umbrella topology is adopted, 
although the glycan points out of the binding pocket. No extended epitope is present in this case. 
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Indeed, the generated 3D model showed that the glycan is only bound through the Neu5Ac 
non-reducing end, with the oligosaccharide chain pointing out of the pocket.  
The mutations of only three amino acids (Val186Lys, Lys193Thr and Gly228Ser) at the binding 
site of HA dramatically switch the binding properties of the proteins (figure 67). Again, glycine 
228 in the wild-type H7N9 provides the proper flexibility to the loop 220 to be able to 
accommodate the Neu5Ac2-3Gal-containing glycan. However, the Gly228Ser mutation is able 
to bind the 2-6 linked glycan. In fact, according to the 3D model, the new Ser228 and Lys186 
amino acids establish intermolecular hydrogen bonds with the sialic acid moiety. 
 
 186 193 228 
H7N9 wt VAL LYS GLY 
H7N9 mutant LYS THR SER 
Figure 67. The mutated amino acids at the binding site of the H7N9 HA strain. In green, the wild type H7N9. In 
magenta, the H7N9 mutant strain. 
3.5.2. Conclusions 
In summary, the recognition features of glycans 2 and 3 when interacting with the HA of the 
H1N1 strain has been elucidated. Both molecules are recognized via the Neu5Ac moiety and 
present an extended epitope along the oligosaccharide chain, adopting a folded umbrella-like 
topology at the hemagglutinin binding site. Moreover, the mutation of three residues in the 
HAs of the H6N1 and H7N9 strains produce the switch of their binding properties from the 
selective selection of the Neu5Ac2-3Gal moiety to the recognition of the Neu5Ac2-6Gal 
analogue. However, the binding epitopes of the glycans rather different to those observed in 
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the H1N1 case and do not extend through the entire oligosaccharide chain, but only to the 
sialic acid residue and partially to its vicinal monosaccharides. 
3.5.3. Experimental 
Materials 
All the HAs were provided by Dr. Robert De Vries form Utrecht University in the Netherlands. 
The H1N1 was the strain A/Kentucky/2007; H6N1 wild type and mutant, the A/Taiwan/1/2013 
and the H7N9 wild type and mutant, the A/Shanghai2/2/2013. 
Synthesis of the compounds 
 General Methods 
 Gal extension 
The procedure described by Blixt et al.123 was followed with minor modifications. Briefly, the 
initial mixtures contained the acceptor substrate (1 eq, 20-35 mM) and UDP-glucose (1.5 eq, 
35-50 mM) in TRIS buffer (0.5-1 mL, 100 mM TRIS, 20 mM MgCl2 pH 9). The reactions were 
initiated by addition of the fusion protein 4galT-galE123 (15 mU based on the 
galactosyltransferase activity). The mixtures were slowly mixed at 37 °C in an incubator 
overnight. The pH was monitored and kept at a value of 9 by dropwise addition of NaOH. Once 
the reaction was observed to be completed by thin-layer chromatography (TLC) (see below), 
the reaction mixture was then ultrafiltered through a 10 kDa MWCO membrane to remove the 
proteins and passed through a Dowex cation resin to remove the excess of UDP-Glc and the 
released UDP and further purified by size exclusion chromatography (Sephadex P-2, 5×115 cm, 
H2O). At all steps, the product was monitored by TLC performed on glass plates coated with 
Silica gel 60 (E. Merck) using the eluent system ethyl acetate:methanol:acetic acid:water 
(6:3:3:2 by volume) and visualized by treatment with 10% sulfuric acid in ethanol, followed by 
heating. The final products were checked by mass spectrometry data acquired with a MALDI-
TOF (Applied Biosystems, DE) using 2,5-dihydroxy benzoic acid as matrix. 
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 GlcNAc extension 
The initial mixtures contained the acceptor substrate (1 eq, 20-35 mM) and UDP-N-
acetylglucosamine (1.5-2 eq, 30-60 mM) in sodium cacodylate buffer (0.5-1 mL, 100 mM Na 
cacodylate, 25 mM KCl, 1 mM DTT, 2 mM MgCl2, pH 7.5). The reactions were initiated by 
addition of the enzyme 3GlcNAcT124 (30 L ≈ 1.5 mU) from Helicobacter pylori. The reaction 
mixtures were slowly mixed at 37 °C in an incubator for 96 h, and the pH was monitored and 
kept at a value of 7.5 by dropwise addition of NaOH. Once the reaction was completed, the 
reaction mixture was then ultrafiltered through a 10 kDa MWCO membrane to remove the 
proteins and passed through a Dowex cation resin to remove the excess of UDP-Glc and the 
released UDP and further purified by size exclusion chromatography (Sephadex G25, 5×115cm, 
H2O). At all steps, the product was monitored by TLC, with two sequential elutions using the 
eluent system iso-propanol:water:ammonium hydroxide (6:3:2 by volume) on glass plates 
coated with Silica gel 60 (E. Merck) and visualized by treatment with 10% sulfuric acid in 
ethanol followed by heating. The final products were checked by mass spectrometry data 
acquired with a MALDI-TOF (Applied Biosystems, DE) using 2,5-dihydroxy benzoic acid as 
matrix 
 CMP-Neu5Ac production 
To a reaction mixture containing Neu5Ac (1 eq, 150 mol, 50 M) and CTP (1.2 eq, 180 mol, 
60 M) in Tris buffer (100 mM TRIS, 20 mM MgCl2, pH 9), CMP-Neu5Ac synthase
125 (50 L) and 
commercial available inorganic pyrophosphatase (2.5 L) were added. The mixtures were 
slowly mixed at 37 °C (310 K) in an incubator overnight, and the pH was monitored and kept at 
a value of 9 by dropwise addition of NaOH. The reaction was monitored by TLC performed on 
glass plates coated with Silica gel 60 (E. Merck) using the eluent system iso-
propanol:water:ammonium hydroxide (6:3:2 by volume) and ethyl acetate:methanol:acetic 
acid:water (6:3:3:2) (the plate was ran once by each eluent system) and visualized by 
treatment with 10% sulfuric acid in ethanol followed by heating. No purification steps were 
necessary for further use of the product. 
Enzyme expression 
The expression of the 2,3-sialyltransferase PmST1 was adapted from the previously described 
protocol by Yu et al.126 Briefly, the enzyme was expressed using Escherichia Coli BL21 (DE3), 
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purified in Ni2+-NTA resin and directly used for the synthesis. The activity of the enzyme was 
determined by an enzymatic assay using radioactively tagged CMP-Neu5Ac. 
Synthesis of compound 1 
The synthesis of the precursor of compound 1 (compound 1c) was performed as described in 
the general methods section. Precursor 1c (1 eq, 6.1 mol, 30.5 mM) and CMP-Neu5Ac (1.5 eq, 
9.15 mol, 46 mM) were dissolved in 200 L TRIS buffer (100 mM TRIS, 20 mM MgCl2, pH 9). 
The sialyltransferase PmST1 previously expressed was then added (10 L, 35 mU) to the 
reaction mixture. The reaction was mixed at 37 °C in an incubator for 4 days, and the pH was 
monitored and kept at 9 by dropwise addition of NaOH. The product was monitored by TLC 
performed on glass plates coated with Silica gel 60 (E. Merck) using the eluent system ethyl 
acetate:methanol:acetic acid:water (3:3:3:2 by volume) and visualized by treatment with 10% 
sulfuric acid in ethanol followed by heating. The reaction mixture was ultrafiltered through a 
10 kDa MWCO membrane to remove the sialyltransferase and passed through a Dowex cation 
resin to remove the excess of CMP-Neu5Ac and the released CMP and further purified by size 
exclusion chromatography (Sephadex G25, 5×130 cm, H2O). The final product in 62 % yield in 
the last reaction step was checked by NMR (see assignment section) and MS (MALDI-TOF) m/z 
[M + H]+ = 1131 and [M + Na]+ = 1153 (figure 68). 
 
Figure 68. MALDI-TOF spectrum of compound 1. 
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Synthesis of compound 2 
Precursor 1c (1 eq, 6.1 mol, 50 mM) and CMP-Neu5Ac (2 eq, 12 mol, 100 mM) were 
dissolved in 120 L of sodium cacodylate buffer (100 mM sodium cacodylate, 20 mM MgCl2, 
pH 8.5). The sialyltransferase hST6Gal127 was then added (10 L, 11.2 mU) to the reaction 
mixture. The reaction was mixed at 37 °C (310 K) in an incubator 7 days, and the pH was 
monitored and kept at 8.5 by dropwise addition of NaOH. The product was monitored by TLC 
performed on glass plates coated with Silica gel 60 (E. Merck) using the eluent system ethyl 
acetate:methanol:acetic acid:water (3:3:3:2 by volume) and visualized by treatment with 10% 
sulfuric acid in ethanol followed by heating. The reaction mixture was ultrafiltered through a 
10 kDa MWCO membrane to remove the sialyltransferase and passed through a Dowex cation 
resin to remove excess of CMP-Neu5Ac and the released CMP and further purified by size 
exclusion chromatography (Biogel P-2, 5×115 cm, H2O). The final product was checked by NMR 
(see assignment section) and MS (MALDI-TOF) m/z [M + H]+ = 1132 and [M + Na]+ = 1154 
(figure 69). 
 
Figure 69. MALDI-TOF spectrum of compound 2. 
Synthesis of compound 3 
Precursor 3b (1 eq, 5.9 mol, 50 mM) and CMP-Neu5Ac (2 eq, 12 mol, 100 mM) were 
dissolved in 120 L of sodium cacodylate buffer (100 mM sodium cacodylate, 20 mM MgCl2, 
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pH 8.5). The sialyltransferase was then added (10 L, 11.2 mU) to the reaction mixture. The 
reaction was mixed at 37 °C (310 K) in an incubator 5 days, and the pH was monitored and kept 
at 8.5 by dropwise addition of NaOH. The product was monitored by TLC performed on glass 
plates coated with Silica gel 60 (E. Merck) and visualized by treatment with 10% sulfuric acid in 
ethanol followed by heating  using the eluent system ethyl acetate:methanol:acetic acid:water 
(3:3:3:2 by volume). The reaction mixture was ultrafiltered through a 10 kDa MWCO 
membrane to remove the sialyltransferase and passed through a Dowex cation resin to 
remove the excess of CMP-Neu5Ac and the released CMP and further purified by size exclusion 
chromatography (Sephadex G25, 5×115 cm, H2O). The final product was checked by NMR (see 
assignment section) and MS (MALDI-TOF) m/z [M + H]+ = 1497 and [M + Na]+ = 1519 (figure 
70). 
 
Figure 70. MALDI-TOF spectrum of compound 3. 
Synthesis of compound 4 
Compound 4a (1 eq, 8.3 mol, 20 mM) was dissolved in 410 L of a 62.5 mM stock solution of 
sodium ethylacetate. The comercially available AUS Neuraminidase (from Sigma Aldrich) (10 
L) was added to the reaction mixture and then mixed in an incubator at 37ºC (310 K) for 2 
days. The reaction was worked it up by ultrafiltration through a 10 kDa MWCO membrane to 
remove the sialyltransferase and passed through a Dowex cation resin to remove excess of 
CMP-Neu5Ac and the released CMP and further purified by size exclusion chromatography 
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(Sephadex G25, 5×115cm, H2O). The product (compound 4b) was monitored by TLC performed 
on glass plates coated with Silica gel 60 (E. Merck) and visualized by treatment with 10% 
sulfuric acid in ethanol followed by heating using the eluent system isopropanol: water: 
ammonium hydroxide (6:3:2 by volume). The extension of the LacNAc units was performed as 
described in the general methods sections to finally obtain compound 4d. The precursor 4d (1 
eq, 2 mol, 40 mM) and CMP-Neu5Ac (4 eq, 8 mol, 160 mM) were dissolved in 50 L of 
sodium cacodylate buffer (100 mM sodium cacodylate, 20 mM MgCl2, pH 8.5). The 
sialyltransferase was then added (7 L) to the reaction mixture. The reaction was mixed at 37 
°C (310 K) in an incubator 7 days, and the pH was monitored and kept at 8.5 by dropwise 
addition of NaOH. The product was monitored by TLC performed on glass plates coated with 
Silica gel 60 (E. Merck) and visualized by treatment with 10% sulfuric acid in ethanol followed 
by heating using the eluent system isopropanol: water: ammonium hydroxide (6:3:2 by 
volume).  The reaction mixture was ultrafiltered through a 10 kDa MWCO membrane to 
remove sialyltransferase and passed through a Dowex cation resin to remove the excess of 
CMP-Neu5Ac and the released CMP and further purified by size exclusion chromatography 
(Sephadex G25, 5×115 cm, H2O). The final product was checked by MS (MALDI-TOF) m/z [M + 
H]+ = 3136 and [M + Na]+ = 3158 (figure 71). 
 
Figure 71. MALDI-TOF spectrum of compound 4a. 
Synthesis of compound 5 
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From compound 4b, described above, the extension of the LacNAc units to finally obtain 
compound 5b was performed as described in the general methods section and checked by MS 
(MALDI-TOF) m/z [M + H]+ = 3240 and [M + Na]+ = 3262 (figure 72). Then precursor 5b (1 eq, 
1.7 mol, 34 mM) and CMP-Neu5Ac (4 eq, 6.8 mol, 136 mM) were dissolved in 50 L of 
sodium cacodylate buffer (100 mM sodium cacodylate, 20 mM MgCl2, pH 8.5). The 
sialyltransferase was then added (7 L) to the reaction mixture. The reaction was mixed at 37 
°C (310 K) in an incubator 7 days, and the pH was monitored and kept at 8.5 by dropwise 
addition of NaOH. The product was monitored by TLC performed on glass plates coated with 
Silica gel 60 (E. Merck) and visualized by treatment with 10% sulfuric acid in ethanol followed 
by heating using the eluent system isopropanol: water: ammonium hydroxide (6:3:2 by 
volume).  The reaction mixture was ultrafiltered through a 10 kDa MWCO membrane to 
remove sialyltransferase and passed through a Dowex cation resin to remove excess of CMP-
Neu5Ac and the CMP released and further purified by size exclusion chromatography 
(Sephadex G25, 5×115 cm, H2O). The purification of compound 5 could not be finished during 
the internship and therefore, the MS spectrum could not be obtained. 
 
Figure 72. MALDI-TOF spectrum of compound 5b. 
NMR experiments 
The 1H NMR resonances of glycans 1, 2 and 3 were assigned by the acquisition of a set of 
standard homo- and hetero-nuclear NMR experiments: 1D 1H-NMR, 2D TOCSY at different 
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mixing times and 2D heteronuclear 1H-13C HSQC and 1H-13C HSQC–TOCSY in D2O in a 600 MHz 
Bruker Avance spectrometer, equipped with a cryoprobe at 298 K. The assignments are given 
below. 
 
1
H/
13
C (, ppm) Neu5Ac Gal 3 GlcNAc 3 Gal 2 
1  4.37/103.4 4.38/102.5 4.38/102.8 
2  3.46/70.9 3.72/55.2 3.51/70.0 
3 1.64, 2.59/40.1 3.62/72.6 3.65/72.4 3.64/72.3 
4 3.58/68.4 3.85/68.6 3.64/78.1 4.08/68.5 
5 3.72/52.1 3.74/73.7 3.52/74.5 3.64/74.9 
6 3.62/72.6 3.47, 3.91/63.3 3.76, 3.88/60.0 3.65, 3.69/61.1 
7 3.48/68.5    
8 3.81/72.0    
9 3.57, 3.80/62.7    
NH 7.84  8.08  
NAc 1.94/22.1  1.97/22.40  
 
1
H/
13
C ( , ppm) GlcNAc 2 Gal 1 GlcNAc 1 A 
1 4.35/102.5 4.38/102.8 4.52/100.9 3.97, 3.69/68.7 
2 3.72/55.2 3.51/70.0 3.71/55.1  
3 3.65/72.4 3.64/72.3 3.72/72.3 B 
4 3.63/78.4 4.08/68.5 3.59/80.4 3.36, 3.40/50.3 
5 3.50/74.6 3.64/74.9 3.52/74.8  
6 3.76, 3.88/60.0 3.65, 3.69/61.1 3.76, 3.88/60.0  
NH 8.10  8.12  
NAc 1.95/22.3  1.96/22.3  
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1
H/
13
C ( , ppm) Neu5Ac Gal 2 GlcNAc 2 
1  4.47 4.37 
2  3.46/71.0 3.72/54.9 
3 2.60, 1.65/40.3 3.61/72.5 3.71/72.4 
4 3.66/69.5 3.86/69.4 3.61/78.6 
5 3.73/52.1 3.74/73.6 3.52/74.6 
6 3.65/72.4 3.47, 3.91/63.4 3.76, 3.89/60.3 
7 3.52/69.7   
8 3.81/71.8   
9 3.57, 3.80/62.9   
NAc 1.96/22.5  1.98/22.5 
 
1H/13C ( , ppm) Gal 1 GlcNAc 1 A 
1 4.51 4.61 3.63;3.81/68.2 
2 3.51/70.2 3.67/54.9  
3 3.66/82.0 3.70/72.4 B 
4 4.08/69.5 3.61/78.6 3.50, 3.44/47.5 
5 3.64/74.9 3.52/74.6  
6 3.66, 3.69/61.0 3.76, 3.86/60.3  
NAc  1.98/22.5  
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1
H/
13
C ( , ppm) Neu5Ac Gal 2 GlcNAc 2 
1  4.48/102.4 - 
2  3.53/68.2 3.70/54.9 
3 1.73, 2.69/39.4 4.03/75.5 3.69/72.0 
4 3.62/68.6 3.86/67.6 3.64/78.4 
5 3.77/51.6 3.64/75.2 3.51/74.5 
6 3.56/72.9 3.70, 3.65/61.0 3.79, 3.89/59.9 
7 3.53/68.2   
8 3.82/71.9   
9 3.79, 3.57/62.6   
NH 7.98  8.2 
NAc 1.96/22.4  1.96/22.4 
 
1
H/
13
C ( , ppm) Gal 1 GlcNAc 1 A 
1 4.39/103.0 4.53/101.1 3.70, 3.97/68.7 
2 3.52/69.7 3.73/55.3  
3 3.65/82.1 3.66/72.2 B 
4 4.08/68.4 3.67/77.9 3.41, 3.36/50.4 
5 3.67/75.2 3.53/74.7  
6 - 3.92, 3.75/60.2  
NH  8.18  
NAc  1.97/22.4  
 
STD-NMR experiments were performed on the complexes of the different HAs and the 
different glycans using PBS (pH 7.3) deuterated buffered solutions. For the case of H1N1 HA, a 
sample of 3.5 M of HA and 300 M of glycan 2 (molar ratio 1:86) was prepared. The same 
molar ratio HA:ligand (1:86) was used for the case of H1N1 HA (3.5 M) and glycan 3 (300 M). 
For the H6N1 (wild type and mutant strains) and H7N9 strains (wild type and mutant), a 
solution of 5 M of HA and 300 M of glycan 3 was employed (molar ratio 1:60). The STD 
experiments were acquired at 298 K on a Bruker Avance 600 MHz spectrometer equipped with 
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a cryoprobe; the saturation frequency was set up at  7 ppm (aromatic region) during 2 
seconds.  
Computational model 
The initial conformation of glycan 3 was obtained using the GLYCAM online carbohydrate 
builder.119,128 Of all possible structures, the most stable gauche-trans (gt) conformation around 
the  angle of the terminal Gal residue, to which the sialic acid moiety is linked, was taken as 
starting geometry. The available X-ray crystal structures of H1N1 and the wild types of H6N1 
and H7N9 were taken from the Protein Data Bank70 (H1N1 ID: 4JTV; H6N1 wt ID: 4YYA; H7N9 
wt ID: 4N63). The coordinates of the H6N1 and H7N9 mutants were provided by Dr. De Vries 
from Utrecht University in the Netherlands. Then, the corresponding glycan-HA complexes 
were built and minimized (5000 iterations) using the Maestro program (Schrodinger 
Computational Suite) and employing the AMBER* force field in implicit water solvent. The 
macromolecule was considered to be fixed during the minimization process, while the ligand 
was left flexible. 
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4.1. Introduction 
Proteins are inherently dynamic and sample a vast ensemble of conformations. Thus, protein 
conformations, different than the native one, may play an important role in molecular 
recognition.1 In this context, NMR has permitted the study of the dynamics of globular and 
structural well defined proteins as well as the structural characterization of disordered ones, 
thus overcoming the limitations of X-ray crystallography. 
Not only protein dynamics play a key role in the molecular recognition event. The conformation 
and dynamics of the ligands are also rather important to explain the binding events. Therefore, 
the conformational analysis of the bound ligand is also essential to understand the binding 
process. 
In summary, molecular recognition processes involve dynamic players that adapt their 3D 
arrangement to favor the binding. Only under certain conformational conditions, the 
interaction between partners occurs. In this context, NMR experimental data are essential to 
get insights into the conformational behavior of ligands and receptors in their free and bound 
states. 
NMR can also be employed for the real-time monitoring of the evolution of chemical reactions. 
The gained information can be employed to mechanistically understand the transformation of 
reactants into final products. Moreover, NMR has also provided key insights in the 
deconvolution of the interaction of dynamic combinatorial libraries with receptors, a process 
where multiple reversible reactions takes place. 
Since the conceptual NMR-based approaches to study sugar interactions are general within the 
molecular recognition field, I have also employed analogous methodologies to study other 
ligand-receptor interaction processes related to interesting biological and biomedical events, in 
collaboration with other research groups. In particular, in the following sections of this chapter, 
I will describe different examples of the application of NMR methods to the study of the 
structural, conformational and dynamics features of different systems with diverse chemical 
nature: from the analysis of the degree of ordering of flexible protein domains, to the 
characterization of the interaction of epothilone derivatives with tubulin, including the 
evaluation of the recognition of a family of molecules by the DNA minor groove. Finally, the 
possible applications of NMR in dynamic combinatorial chemistry have also been scrutinized. 
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4.2. NMR structural analysis of the N-terminal region of the C/EBP homologous 
protein (N-CHOP) 
It is highly recognized that protein secondary and tertiary structures are essential for protein 
functions. However, it is now clear that disordered and unfolded protein domains can also be 
biologically active following an external stimulus.2,3 The concept “intrinsically disordered 
protein” (IDP) refers to proteins without a defined tertiary structure at physiological conditions. 
The genomic analysis of IDPs indicates that their proportion increase with the organism 
complexity.4–7 However, IDPs often display evidences of local order, which may be crucial for 
their interactions with other partners.8–12 In fact, the recognition of an external stimulus by the 
IDP generally triggers the adoption of a well-defined tertiary structure. The response to a 
specific stimulus is usually related with the cellular location in which the interaction takes place. 
Thus, IDPs act as occasional workers at punctual locations in the cell. 
Right now, most of the characterized IDPs are associated to cell cycle control and DNA 
regulation6,11,13–16 However, IDPs can also be found as independent proteins or as domains of 
partially structured proteins.2,5  
Even though X-ray crystallography methods cannot be employed to characterize the structure 
of IDPs due to its high conformational heterogeneity, fortunately a variety of NMR methods are 
suitable for the structural and dynamic elucidation of IDPs. In this manner, the folding 
propensities of different IDPs have been unraveled by analyzing their heteronuclear 1H-15N NMR 
spectra, those that permit measuring the longitudinal (R1) and transversal (R2) relaxation rates 
as well as the steady-state heteronuclear 1H-15N NOE (hetNOE). These parameters display high 
sensitivity to the adoption of ordered regions on IDPs within the ps-ns time scale.17,18  
Protein dynamics may be defined by measuring the motional freedom of the NH vector of each 
amino acid residue and defining the associated rotational motion correlation time (c). The 
amino acids belonging to a structured protein domain have a restricted motion due to the 
adoption of a stable 3D structure. In this case, they display a large c. In contrast, amino acids 
that lack a stable secondary and/or tertiary structure display short c. The hetNOE may also be 
employed to discriminate well-structured from flexible regions, due to its change in sign (figure 
1).  
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Figure 1. Representation of the T1, T2 and hetNOE against the total rotational motion correlation time c). 
Herein we discuss the conformational features as IDP of the N-terminal domain of C/EBP 
homologous protein (CHOP) protein, a partially unstructured protein of the family of 
CCAAT/enhancer-binding protein (C/EBP). The C/EBP family protein consists on a group of 
proteins present in the cytosol of the cells that regulates DNA transcription19 and has shown an 
apoptotic response to DNA damage or stress of the endoplasmic reticulum.20 The C/EBP family 
has a highly conserved bzip (“basic leucine zipper”) domain that binds to a consensus sequence 
of nucleotides while the N-terminus is diverse among the family and regulates the transcription 
activity of CHOP.19 The bzip leucine zipper is expected to adopt a -helix structure when bound 
to DNA, whereas the N-terminus domain behaves as an IDP (figure 2).21 Because the structural 
studies of the CHOP are scarce and CHOP is of interest due to its implications in diabetes or 
neurodegenerative pathologies,22,23 the elucidation of the dynamic features of CHOP may shed 
light on the regulation of the activity of CHOP, a potential therapeutic target. 
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Figure 2. On the left: scheme of CHOP protein. On the right: Model of interaction of CHOP with DNA. 
4.2.1. Results and discussion 
The backbone dynamics of CHOP were analyzed by NMR measuring its relaxation parameters 
on a 15N labeled domain provided by Dr. Carlos Fernández Tornero at CIB-CSIC.  
 
Figure 3. N-terminal domain fragment studied by NMR. 
Prior to this analysis, CHOP N-terminus domain fragment (N-CHOP, 53 amino acids from Glu 48 
to Arg 93) (figure 3) assignment was achieved employing direct 13C-NMR detection experiments 
(CBCANCO, CON) (figure 4). This approach was employed since IDPs display a lack of 1H signal 
dispersion (figure 5 and 6) and fast HN-water exchange precludes the assignment by traditional 
Chapter 4. NMR applications to dynamic and other systems 
139 
 
15N-based methods. A previous chemical-shift index analysis24 of the chemical shifts of C and 
C had predicted the existence of a -helix structure propensity comprising amino acids 60-68. 
To confirm the structural results, the dynamics of N-CHOP, containing this region, was 
evaluated by measuring hetNOEs, R1 and R2 rates. 
 
Figure 4. The CON NMR spectrum of full N-terminal domain of CHOP (700 MHz, 298 K). 
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Figure 5. The 
1
H-
15
N HSQC spectrum 
15
N labelled full N-terminal domain of CHOP (1 mM, 700 MHz, 298 K). The 
signals of the NH of the backbone appear in a very narrow region ( 7.5-8.5 ppm) typically observed for 
unstructured proteins. 
 
Figure 6. The 
1
H-
15
N HSQC of N-terminal domain fragment of CHOP (N-CHOP, 53 amino acids: Glu48 to Asp101) 
(700 MHz, 298 K). 
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For anisotropic systems as IDPs, R1 (1/T1) and R2 (1/T2) analysis is restricted by the model-free 
approach25 analysis, whilst hetNOEs (figure 7) are sensitive reporters of the presence of fast 
motions and provides information on the regions with different mobility.17 
 
Figure 7. The 
1
H-
15
N hetNOE spectra of N-CHOP (700 MHz, 298 K). Left panel: 
1
H-
15
N HSQC of N-CHOP at 
equilibrium, without proton saturation. Right panel: 
1
H-
15
N HSQC of N-CHOP with proton saturation. Peaks 
corresponding to amino acids with positive hetNOE are annotated. 
The analysis of the hetNOE NMR spectra (figures 7 and 8) revealed the existence of a region 
with positive hetNOE values that comprises the amino acids from serine 59 to glutamine 65. 
They display a large c, characteristic of structured amino acids, strongly suggesting that this 
region (Ser59 to Glu65) has a propensity to adopt secondary structure. In contrast, the rest of 
the backbone NHs displayed negative hetNOE value, associated with short c and thus, to the 
presence of fast and mobile amino acids, as frequently occurs at the N-terminal and C-terminal 
ends, in many occasions behaving as disordered regions. 
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Figure 8. Histogram of the 
1
H-
15
N hetNOE analysis of N-CHOP. The change in sign in the Ser59 to Glu65 region is 
evident. 
As mentioned above (figure 1), the evaluation of the relaxation rates R1 and R2 for anisotropic 
models (i.e. IDPs) helps to detect structured regions. Typically, structured macromolecules 
display a large c with short R1 (large T1) and large R2 (short T2). On the other hand, small 
molecules and unstructured domains display short c with short R1 and R2.  
 
Figure 9. Histogram of the ratio R2/R1 of N-CHOP.  
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The R2/R1 ratio for N-CHOP (figure 9) displays larger values for Ser59 to Glu65 region, while the 
rest of the amino acids, in particular those close to the N- and C-terminus, are more mobile. 
NMR methods also provide information on the chemical exchange process between the water 
from the solvent and the exchangeable backbone NHs whose exchange rate will depend of their 
solvent accessibility and hence of the structure. The 1H chemical exchange with the solvent is 
usually significantly restricted in the case of the non-accessible NHs of the backbone in 
structured domains. In contrast, flexible and unstructured domains are exposed to the solvent, 
thus facilitating the chemical exchange. Thus, chemical exchange-phase modulated experiments 
(CLEANEX-PM) were acquired to observe the chemical exchange of the NHs with water from the 
solvent based in the magnetization transfer from the selectively excited solvent protons to the 
exchangeable protons of the protein backbone. The advantage of CLEANEX-PM experiments 
resides in their ability to suppress the NOE contributions from C Hs but also the exchange-
relayed NOE peaks, only displaying those peaks affected by the chemical exchange process.26,27 
CLEANEX-PM filtered experiments were recorded at different mixing times (figure 10). At 
increasing mixing times, peak intensities gradually increase as function of the proton exchange 
rate with solvent. The analysis of these experiments revealed that the amino acids of the key 
region (Ser59 to Glu68) have a reduced exchange rate or even do not appear in the spectrum, 
thus confirming that they are less exposed to the solvent.  
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Figure 10. CLEANEX-PM spectra of N-CHOP (700 MHz, 298 K). Panel A: 
1
H-
15
N HSQC spectrum. Panel B: CLEANEX-
PM spectrum with 24 ms of mixing time. Panel C: CLEANEX-PM spectrum with 6 ms of mixing time. 
4.2.2. Conclusions 
The NMR-based dynamic analysis of the N-terminus domain of CHOP has revealed evidences of 
a propensity to adopt a defined secondary structure in the Ser59 to Glu65 region. The 
measured dynamic parameters, positive hetNOE and large R2/R1 ratios, are associated to large 
c  values characteristic of structured proteins. Furthermore, 
1H chemical exchange experiments 
have also shown that the amino acids of this region have a significantly reduced chemical 
exchange with water solvent. This fact suggests that they are protected from the solvent. Based 
on a previous chemical shift index analysis, this region may adopt a -helix secondary structure. 
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4.2.3. Experimental 
R1, R2, and 
1H-15N hetNOE experiments were acquired on a 1 mM sample of 15N labelled of N-
CHOP derived from proteolysis of the full protein. The fragment of 53 amino acids was provided 
by Dr. Carlos Fernández Tornero (CIB-CSIC). A SE buffer containing 90 % H2O and 10 % D2O was 
employed.  
R1, R2, and 
1H-15N hetNOE experiments targeting the 15N spins of the backbone and tryptophan 
side chain were performed at 700 MHz Bruker Avance spectrometer at CERM (Florence) by Dr. 
Isabella Felli. Experimentally, for relaxation measurements, 10 data points were acquired 
interleaved with relaxation delays in the range 20 ms - 1.5 s (20, 100, 200, 350, 500, 600, 800, 
1000, 1200 and 1500 ms) for R1 and 31.36 ms - 0.47 s (31.36, 62.72, 94.08, 125.44, 156.80, 
219.52, 283, 344.96, 407.68 and 470.40 ms) for R2, using a delay between experiments of 3 s. R2 
was measured using a 0.9 ms delay between refocusing pulses in the CPMG train. 
Heteronuclear 1H-15N NOE was measured in an interleaved manner using a 1H saturation time of 
3 s and a relaxation delay of 3 s. For the saturation, 120° pulses were used. CLEANEX-PM 
filtered experiments were acquired at different mixing times for CLEANEX spin lock module26 (6, 
12, 18 and 24 ms). All experiments were acquired at 298 K. 
 Data analysis 
The hetNOE, R1 and R2 data were deduced from the NMR spectra with Bruker software using 
the peak intensity values for the calculations. R1 and R2 values were obtained by fitting the 
decay of each peak intensity to an exponential function as implemented in the software 
Dynamic Center.  
The 1H-15N assignment was translated from the previous assignment provided by Dr. Ángeles 
Canales (Complutense University of Madrid). 
4.3. Microtubule stabilizing agents: The binding of Epothilone analogues to 
tubulin 
Epothilones (figure 11) are a group of molecules with a common 16-membered ring that are 
potent molecules to stabilize microtubules (microtubule-stabilizing agents, MSA) by interacting 
with tubulin. In this manner, they arrest the cell cycle resulting in apoptosis.28–30 Indeed, 
epothilones have been used as potent anti-tumor drugs in chemotherapy.31  
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Figure 11. Scheme of the structure of epothilone A and B. 
Two binding sites coexist in tubulin that may be involved in epothilone binding, dubbed the 
luminal site32,33 and pore site.34,35 The luminal site is an internal site of the -subunit, while the 
pore site is external, only present in microtubules, and involves the  and  subunits of 
different heterodimers. 
Given the favorable biopharmaceutical properties of epothilones, pharmacodynamics and 
pharmacokinetics, different derivatives have been synthesized to further improve their (already 
good) properties. In fact, several epothilone derivatives have gone into advance stages of 
clinical trials36–39 and some of them have already been approved by the FDA.40 Some of the 
synthetic derivatives have replaced the epoxide moiety by a cyclopropane.41–43 In fact, the 
epothilone derivative studied in this section (figure 12) consists in a trans-configured 
cyclopropane derivative of the epothilone A (EPO-tc) that has been shown to display a strong 
activity in in-vitro tests using a wide sample of cell lines. 
 
Figure 12. Scheme of the trans-cyclopropane epothilone (EPO-tc) derivative studied in this section. 
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4.3.1. Results and discussion 
After assignment of the 1H NMR resonances of EPO-tc using standard NMR methods, its 
interaction with tubulin was addressed from the ligand point of view. Thus, STD-NMR 
experiments were performed for EPO-tc in the presence of dimeric tubulin and microtubules. 
Dimeric tubulin only displays the luminal binding site while the pore site only appears in 
microtubules.  
The STD spectrum of EPO-tc in presence of microtubules (figure 13) showed that every EPO-tc 
proton receives saturation from the protein in a high extent (table 1). Unfortunately, the 
presence of the GMPCPP6 nucleotide analogue to stabilize the sample precludes the accurate 
quantification of several EPO-tc signals. 
When the STD-NMR experiment was performed in the presence of dimeric tubulin (figure 14), 
information on the binding at the luminal site of the -subunit was extracted.44,45 In both cases, 
the derived epitope of EPO-tc (figure 15) indicates that the epothilone ring as well as the 
aromatic region participates in the binding event. The derived epitopes in both cases (figure 16) 
followed a similar pattern supporting the binding towards the luminal site. However, since in 
the presence of dimeric tubulin fewer NMR signals could be identified in a non-ambiguous 
manner, this conclusion should be considered with caution. 
A conformational analysis protocol was then performed to interpret the STD data and to fully 
describe the binding event. Thus, tr-NOESY experiments were performed to get information on 
the interproton distances in the bound state and thus, on the 3D arrangement of the ligand. 
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Figure 13. The STD (below) and off-resonance (on top) NMR spectra (600 MHz, cryoprobe) of a microtubule:EPO-tc 
mixture (1:45 molar ratio, 10 M microtubule, 0.1 mM GMPCPP6, 450 M EPO-tc). The temperature was 310 K and 
a 2 seconds saturation at  -1.5 ppm was employed. A spin lock filter was used to minimize the background of the 
protein. Signals with X correspond to stabilizer nucleotide and buffer impurities. 
 
Figure 14. STD (below) and off-resonance (on top) NMR spectra (600 MHz, cryoprobe) of a dimeric tubulin:EPO-tc 
mixture (1:45 molar ratio, 10 M dimeric tubulin). The temperature was 298 K and a 2 seconds saturation at  -1.5 
ppm was employed. A spin lock filter was used to minimize the background of the protein protons. Signals with X 
correspond to stabilizer nucleotide and buffer impurities. 
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 Microtubules Dimeric tubulin 
 Absolute STD (%) Relative STD (%) Absolute STD (%) Relative STD (%) 
H2a 22.3 70 - - 
H2b 22.3 70 13.8 46 
H3a 22.3 70 - - 
H3b 30.4 95 26.6 89 
H6 13.0 41 n.d. n.d. 
H7 n.d. n.d. n.d. n.d. 
H8 n.d. n.d. - - 
H9a 28.7 90 - - 
H9b 23.8 75 15.0 50 
H10a n.d. n.d. - - 
H10b n.d. n.d. 17.8 59 
H11a n.d. n.d. - - 
H11b n.d. n.d. - - 
H12 27.1 85 23.0 76 
H13 31.9 100 23.0 76 
H14a 28.7 90 - - 
H14b n.d. n.d. n.d. n.d. 
H15 30.7 96 29.1 97 
H16a 27.6 86 - - 
H16b 24.3 76 20.4 68 
H17 25.8 81 - - 
H18 31.3 98 - - 
H19 31.9 100 - - 
A 31.9 100 29.1 97 
B 31.9 100 29.1 97 
C 31.0 97 30.0 100 
D 25.6 80 26.6 89 
E 21.6 68 21.9 73 
F - - 18.4 61 
Table 1. STD intensities of the proton signals of EPO-tc. n.d.: not determined (signals were observed but 
quantification is not accurate due to overlapping) 
 
Figure 15. Epitope mapping as deduced by STD-NMR for EPO-tc. Panel a: the binding epitope to microtubules. 
Panel B: the binding epitope to dimeric tubulin. 
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Figure 16. Observed STD intensities for the different protons of EPO-tc with the different tubulins. The data are 
given for microtubules (in blue) and for dimeric tubulin (in red). 
Interproton NOE Intensity 
H2-CH3 18 Weak 
H2-H12 Medium 
H3-H12 Strong 
H6- H12 Weak 
H6- CH3 17 Strong 
H6- CH3 16 Strong 
H7-CH3 18 Strong 
H7-CH3 17 Strong 
H14-H12 Strong 
C-H15 Medium 
C-H3 Weak 
C-H12 Weak 
E-F Strong 
E-D Strong 
CH3 17- CH3 18 Weak 
Table 2. The observed NOEs in the tr-NOESY experiment perfomed for EPO-tc in the presence of microtubules. 
The combined analysis of NOE data (table 2) together with a conformational search protocol 
allowed to deduce the bound conformation. The torsion angles that defined the EPO-tc ring are 
shown in table 3 in comparison with the reference structure of EPO-A reported by Canales et 
al.46 
Interestingly, the only significant differences are located in the bonds close to the trans-
cyclopropane ring of EPO-tc in accordance with a necessary adaptation to the binding site area 
where the cis-epoxy ring of EPO-A is located. 
 
0
5
10
15
20
25
30
35
H2a H3b H9b H12 H13 H15 H16b A B C D E
A
b
so
lu
te
 S
TD
 (
%
) 
Chapter 4. NMR applications to dynamic and other systems 
151 
 
Dihedral angle (°) EPO-A* EPO-tc 
C1C2C3C4 -171.7 -169.5 
C2C3C4C5 -58.6 -59.3 
C3C4C5C6 -74.6 -72.5 
C4C5C6C7 147.1 145.5 
C5C6C7C8 -61.4 -60.1 
C6C7C8C9 -68.2 -65.1 
C7C8C9C10 168.1 171.4 
C8C9C10C11 177.1 165.8 
C9C10C11C12 170.9 70.4 
C10C11C12C13 -105.7 101.7 
C11C12C13C14 -2.8 -145.6 
C12C13C14C15 98.0 93.4 
C13C14C15O1 -75.4 -70.9 
C14C15O1C1 149.7 134.0 
Table 3. The torsion angles of the bound conformation of EPO-A and EPO-tc. *Reported values by Canales et al.
46
 
Thus, as a further step, the obtained NMR data, including the derived epitope and the bound 
conformation, were employed to build a 3D model of bound EPO-tc. The obtained lowest 
energy conformer of EPO-tc is in agreement with the NMR experimental data was then docked 
into the described luminal binding site previously obtained for the EPO-A complex to generate 
the EPO-tc-tubulin complex (figure 17). 
 
Figure 17. The 3D model for the EPO-tc:tubulin complex at the luminal binding site. Left panel: EPO-tc:tubulin 
complex. Right panel: superimposition of EPO-A (blue) and EPO-tc (yellow) at the luminal binding site. 
The docking calculations were performed with AutoDock47 and provided a similar binding mode 
to that described for EPO-A.31,48 The binding pocket is described by the helix H7;  strand S7 and 
the M loop of -tubulin subunit. EPO-tc establishes hydrogen bonds with His229, Asp226 and 
Thr276 while the rest of the binding pocket is predominantly hydrophobic. Therefore, the 
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presence of the trans-cyclopropane moiety in the epothilone derivative does not induce 
significant differences in the binding mode except local conformational adjustments around the 
trans-cyclopropane ring. 
4.3.2. Conclusions 
The combined NMR and molecular-modelling approach has permitted deducing that the EPO-tc 
derivative binds tubulin both in its dimeric and microtubule state of aggregation. The STD-
derived epitopes were similar. The obtained bound conformations in both states were similar to 
those described for EPO-A with no significant changes in the binding modes. 
4.3.3. Experimental 
EPO-tc was provided by Prof. K-H Altmann from the Swiss Federal Institute of Technology (ETH) 
in Zürich, Switzerland. 
The 1H NMR resonances of EPO-tc (table 4) were assigned using standard NMR experiments (1D 
1H NMR, 2D TOCSY at different mixing times, 2D NOESY) in D2O in a 600 MHz Bruker Avance 
spectrometer, equipped with a cryoprobe at 298 K and 310 K. 
 
c 
1
Hppm) 
H2a 1.89 
H2b 2.38 
H3a 1.96 
H3b 2.08 
H6 3.39 
H7 3.67 
H8 1.11 
H9a 1.51 
H9b 1.61 
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H10a 1.04 
H10b 1.19 
H11a 0.94 
H11b 1.37 
H12 0.77 
H13 0.56 
H14a 1.45 
H14b 2.19 
H15 5.98 
H16a 0.93 
H16b 1.34 
H17 1.11 
H18 0.90 
H19 0.14 
A 7.46 
B 7.54 
C 7.27 
D 2.55 
E 3.87 
F 4.30 
Table 4. The 
1
H NMR resonances (, ppm) for EPO-tc at 298 K. 
STD-NMR experiments were performed using a PBS (pH 7.3) deuterated buffered solution. A 
sample containing 10 M of dimeric tubulin and 450 M of EPO-tc (molar ratio 1:45) was 
prepared. The same molar ratio tubulin:EPO-tc (molar ratio 1:45) was used for the microtubules 
(10 M) preparation. The microtubule sample was complemented with 0.1 mM GMPCPP6 as 
stabilizer. The STD experiments were acquired at 298 K for dimeric tubulin, and 310 K for 
microtubules, on a Bruker Avance 600 MHz spectrometer equipped with a cryoprobe. The 
saturation frequency was set at  -1.5 ppm (aliphatic region) and the saturation time was 2 
seconds.  
Docking calculations were performed with AutoDock 4.247 with a 64 points box centered in the 
luminal binding site of -subunit spacing 0.35 Å using a genetic algorithm. The coordinates of 
the crystal structure of the -subunit (PDB49 ID 4I50) were employed for the calculation while 
the ligand was built using Maestro from Schrodinger suite software. 
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4.4. The combined use of Dynamic Combinatorial Chemistry and NMR for 
searching new ligands 
The search of novel ligands towards proteins has traditionally involved the chemical synthesis of 
compounds through reactions that result in the irreversible formation of new covalent bonds. 
However, recent interest has emerged on the employment of reversible reactions, under 
equilibrium control. Indeed, the application of dynamic combinatorial chemistry (DCC), which is 
based on a pool of reversible reactions, has become an interesting key tool in the drug 
discovery process.50,51 
DCC is based on the knowledge of the behavior of a set of well-defined reversible reactions 
(dynamic combinatorial library, DCL). As a result of the reversibility, the reactants interconvert 
under thermodynamic control and are sensitive to the presence of external stimuli. In this 
context, the existence of interactions of the species present in a DCL-based mixture with a 
protein target should lead to the amplification of the formation of the interacting species 
(figure 18) according to Le Chatelier’s principle. Following this concept, the drug discovery 
process may take the advantage of the template effect of therapeutic targets (i.e. proteins) on 
the particular DCL mixture giving rise to the synthesis of specific binders.52–56 
 
Figure 18. Scheme of the basis of DCC. DCL species reversibly react to form the products. In the presence of a 
target receptor, the formation of the particular molecule that selectively binds to the receptor is highly favored. 
The equilibrium is shifted and the synthesis of the bound molecule is preferred. 
Thus, the choice of a suitable DCL is critical for the success of the DCC approach. Therefore, 
several reactions suitable for DCC have already been described.52,57,58 Of course, there are a 
number of requisites that should be considered, given the presence of a protein template: pH, 
aqueous media, temperature, etc. Conversely, the reversible reactions of the DCL components 
should equilibrate fast enough under these conditions. The formation of acylhydrazones under 
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these conditions has already been described.59–65 These molecules are suitable DCL components 
for protein templated DCC although the reaction process may be rather slow and require a 
nucleophilic catalyst for fostering the appropriate equilibration.65 
There are relatively few contributions that have described the application of NMR techniques 
for in-situ monitoring of the success and outcomes of DCC methodology. As described 
throughout this Thesis, STD-NMR may provide the direct identification of the bound ligands to a 
given receptor, even employing a relatively complex mixture of molecules.66 Moreover, being a 
ligand-based NMR method, STD-NMR requires a relatively small amount of protein (in the low 
micromolar range), while a large excess of ligand (in the high micromolar range, even milimolar) 
is usually required. Furthermore, additional ligand-based NMR experiments, such as tr-NOESY 
or DOSY, may also be employed in this context. Tr-NOESY experiments provide a direct proof of 
binding with the simple observation of the change in the sign of the NOESY cross-peaks of the 
ligand, passing from the free to the bound states. The analysis of these cross-peaks can be used 
to deduce the bound ligand conformation. Alternatively, DOSY monitors the changes in the 
translational diffusion coefficient upon complex formation. 
In this section, as a proof-of-concept and to complement the different methodologies employed 
through this Thesis with a different perspective, ligand-based NMR experiments have been 
employed for the analysis of a DCL in the presence of a target protein. The DCL contained five 
different acylhydrazides and one aldehyde and could obviously produce the formation of 5 
different acylhydrazones (figure 19). The chosen target protein was Frequenin-2 (Frq2), which is 
involved in synaptic connections and it is a therapeutic target for neurodegenerative diseases. 
This work has been performed in collaboration with Dr. Ruth Pérez at CIB-CSIC. 
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Figure 19. Scheme of the DCL mixture of acylhydrazides and the aldehyde together with the putative mixture of 
acylhydrazones. 
4.4.1. Results and discussion 
An initial set of experiments demonstrated that the reaction for the formation of the 
acylhydrazones does not equilibrate fast enough to accomplish the proper DCC conditions. 
Therefore, a nucleophilic catalyst (anisidine) was also added to the reaction mixture. A previous 
validation of the conditions was assessed by the acquisition of STD-NMR spectra of each 
product in the presence of the protein Frq2 (figures 20-24). In these samples, no catalyst was 
added to avoid the interconversion into the building blocks, aldehyde and corresponding 
acylhydrazide. The STD-NMR spectra revealed that all possible products except 5 were binders 
of the Frq2. 
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Figure 20. STD (below) and off-resonance (on top) NMR spectra of a 1mM sample of 1 in the presence of 10 M 
Frq2 (281 K, 600 MHz). 
 
Figure 21.STD (below) and off-resonance (on top) NMR spectra of a 1mM sample of 2 in the presence of 10 M 
Frq2 (281 K, 600 MHz). 
 
Figure 22. STD (below) and off-resonance (on top) NMR spectra of a 1mM sample of 3 in the presence of 10 M 
Frq2 (281 K, 600 MHz). 
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Figure 23. STD (below) and off-resonance (on top) NMR spectra of a 1mM sample of 4 in the presence of 10 M 
Frq2 (281 K, 600 MHz). 
 
Figure 24. STD (below) and off-resonance (on top) NMR spectra of a 1 mM sample of 5 in the presence of 10 M 
Frq2 (281 K, 600 MHz). 
The analysis of the STD-NMR spectra revealed that 3 displays the largest absolute STD 
intensities (best binder) while 5 is not recognized by Frq2 under the employed conditions. In 
principle, it should be expected that the formation of 3 would be favored under DCC conditions 
in the presence of Frq2. Therefore, the DCL mixture was equilibrated in the presence of Frq2 
and analyzed by NMR methods. 
The observation of the simple 1H NMR (figure 25) spectrum of the DCL mixture after 
equilibration showed the formation of the different products. Indeed, the analysis of the DOSY 
spectra revealed that the formed products displayed large diffusion coefficient (figure 25) in the 
presence of Frq2, demonstrating the formation of ligand:protein complexes. An additional 
verification of the existence of a molecular recognition process was achieved by performing tr-
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NOESY experiments. In this case, negative NOE cross-peaks were observed for the products of 
the mixture, while the reactants and catalyst displayed positive and quantum zero NOE cross 
peaks (figure 27).  
 
Figure 25. 1D 
1
H NMR spectrum of the mixture in the presence of Frq2 (281 K, 600 MHz). Weak signals arising from 
several formed products were observed. 
 
Figure 26. DOSY experiment of the DCL in the presence of Frq2 (black) and 
1
H NMR spectrum (red) (281 K, 600 
MHz). The signals from the products display significantly larger diffusion coefficient than those of the reactants 
due to formation of protein:ligand complex 
Chapter 4. NMR applications to dynamic and other systems 
160 
 
 
Figure 27. tr-NOESY spectrum of DCL mixture in the presence of Frq2 with a mixing time of 200 ms (281 K, 600 
MHz). At the bottom: Amplification of the region  7.2-8 ppm. The negative NOE cross-peaks corresponding to 
intermolecular NOEs of the products are highlighted with red solid arrows. 
Nevertheless, the observed signals corresponded to several products. No clear evidence was 
found for the formation of a unique product from this initial mixture. Thus, a simplified DCL was 
studied in the presence of Frq2.  
The chosen simplified DCL consisted on a mixture of product 5 and the starting building block of 
the best binder, 3. In this case, the existence of the equilibrium process of 5 would release 
aldehyde, which could concurrently be used for the formation of product 3. In the presence of 
Chapter 4. NMR applications to dynamic and other systems 
161 
 
Frq2, only the equilibrium of the formation of 3 would be affected, driving the DCL towards the 
formation of 3. 
 
Figure 28. Scheme of the simplified DCL. 
Indeed, the analysis of the 1H NMR spectra at t=0 and after 15 days revealed the presence of 
new weak signals at the aromatic region assigned to 3 and a new triplet at  2.2 ppm that 
belongs to H6 of the acylhydrazide precursor of 5. These new signals evidenced the progression 
of the mixture towards the formation of a unique product, 3, due to the amplification produced 
by Frq2.  
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Figure 29. 
1
H NMR spectrum of the sample 3+5+Frq2 at different reaction times (up to 15 days) (281 K, 600 
MHz).The new signals that reveal the formation of 3 (aromatic region) and 5 (aliphatic region) are marked with 
stars. 
In fact, the analysis of the NMR spectra after 15 days showed that only the weak signals 
corresponding to 3 display STD effects, validating this DCL system. 
 
Figure 30. STD (below) and off-resonance (on top) NMR spectra of the mixture 3+5+Frq2 (281 K, 600 MHz) after 15 
days. 
Finally, the binding site of 3 was assessed by using STD-NMR-based competition studies versus 
chlorpromazine (CPZ), a well-known Frq2 binder (PDB49 ID 5G08) (figure 31). When increasing 
amounts of CPZ were added, the STD intensities signals of 3 significantly decreased, strongly 
suggesting that 3 and CPZ compete for the same protein binding pocket. 
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4.4.2. Conclusions 
The employed DCL in the presence of Frq2 provided STD signals, except for 5, strongly 
suggesting that the presence of aromatic rings has a key role for Frq2 binding. The analysis of 
the DOSY experiments permitted to assess that the formed products interact with the target 
protein, since they display much larger diffusion coefficient than the initial reactants. This fact 
can be explained by the formation of protein:ligand complexes. Furthermore, tr-NOESY 
experiments also validated the existence of binding. 
The existence of amplification of one particular product from the DCL system was elusive when 
using the complete library. Thus, a simplified DCL was employed to reveal that product 3 is 
bound and amplified by Frq2 in the presence of 5. This fact validates the role of Frq2 as a 
selective template. Finally, STD-NMR-based competition studies demonstrated that the 
amplified product 3 competes for the same binding site than a well-known Frq2-binder, CPZ. 
4.4.3. Experimental 
STD-NMR experiments were performed using a perdeuterated TRIS (pH 7.9) buffered solution 
with an aliquot of d6-DMSO. A sample containing 10 M of Frq2 and 1 mM of DCL species 
(molar ratio 1:100) was prepared. The STD experiments were acquired at 281 K on a Bruker 
Avance 600 MHz spectrometer equipped with a cryoprobe. The saturation frequency was set 
at  -0.5 ppm (aliphatic region) and the saturation time was 2 seconds. A spin lock filter was 
applied to minimize signals from Frq2. The same conditions were used for the acquisition of 
the STD-NMR spectra of the individual products with Frq2. 
tr-NOESY experiment and DOSY experiments were performed on the same samples at 281 K on 
the same spectrometer. The tr-NOESY mixing time was fixed at 200 ms.  The DOSY experiments 
were acquired with 16 gradient increments to a final intensity decay of 90%.  
 STD-based competition studies 
To a solution of 10 M of Frq2 and 300 M of 3, increasing amounts of CPZ were added, until a 
final concentration of 450 M of CPZ was reached (table 1). The STD-NMR spectra were 
recorded in a 600 MHz spectrometer equipped with a cryoprobe at 281 K. The saturation 
frequency was set at  -0.5 ppm (aliphatic region) and the saturation time was 2 seconds. 
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 Frq2 (M) 3 (M) CPZ (M) 
Exp. 1 10 300 0 
Exp. 2 10 300 60 
Exp. 3 10 300 150 
Exp. 4 10 300 300 
Exp. 5 10 300 450 
Table 5. Description and summary of the experiments and concentrations employed for the STD-NMR-based 
competition assays with Frq2. 
4.5. NMR & ligand-DNA interactions 
Transcription factors (TFs) translate the information encoded in the DNA. Indeed, they play a 
key role in the regulation of gene expression67 and its alteration may triggers severe genetic 
pathologies such as cancer.68–71  Therefore, the development of sequence-selective synthetic 
molecules is of interest for advances in genetic medicine.72 In this context, the rational design 
of TF-mimics synthetic peptides that are selective towards specific DNA sequences has to 
overcome two major challenges: DNA affinity and selectivity. TFs display extremely selective 
binding to a consensus DNA sequence out of the vast of alternative sites that also display high 
affinity.73 At this point, one of the most useful approach for synthetic DNA binding peptides 
involve the use of small molecules, selective DNA binders, which may be conjugated with a 
given peptide domain. In fact, different small molecules have been described to target 
different DNA sites: intercalators bind DNA between base pairs,73,74 major groove binders bind 
at the major groove of the duplex helix,75,76 while minor groove binders have also been 
developed.77,78 The essence of the interaction of these small molecules with DNA resides in a 
complementary network of intermolecular hydrogen bonds, hydrophobic interactions and 
electrostatic forces together with the appropriate geometry of the ligand, suitable for 
accommodation at the DNA site.79,80  
The DNA minor groove displays different electrostatic potentials, depending on the nucleotide 
sequence. The minor groove wall of A/T-rich sequences shows negative potentials while, G/C-
rich sequences display positive potentials. In addition, A/T base pairs offer different number of 
possible hydrogen bonds than G/C. These topologic considerations have led the design of A/T- 
or G/C-selective molecules. In fact, the A/T-selective molecules at the minor groove share 
common features such as positive charges, number of hydrogen donors and acceptors and a 
concave shape.80 
In this section, we have investigated some features of DNA minor groove binders, designed 
and synthesized by the group of Prof. J.L. Mascareñas and E. Vázquez-Sentís at CIQUS 
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(University of Santiago de Compostela), by using NMR methods in combination with 
computational tools. The DNA sequence used for this study is a well-known model that 
consists in a double stranded (ds) dodecamer of base pairs with a particular palindromic 
sequence, d(CGCGAATTCGCG), the Dickerson’s dodecamer.81 
The two employed molecules (1 and 2, scheme 1) are inspired in the antimicrobial 
pentamidine, a well-known minor groove binder, and are characterized by possessing a 
suitable concave shape for minor groove binding, while the two amidinium moieties are 
positively charged providing stabilizing electrostatic interactions with A/T-rich sequences.82 
They differ in the chemical nature of the central aromatic moiety (phenyl or pyridine).  
 
 
 
Scheme 1. Scheme of the chemical structures of the synthetic compounds 1, 2 and the pentamidine. 
In this case, due to the size of the DNA-ligand complexes, it was possible to apply NMR 
experiments based in the observation of both, the ligand and the DNA receptor, by tr-NOESY 
and their intermolecular interactions in order to obtain structural information.  
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4.5.1. Results and discussion 
As a first step the 1H NMR resonances of the Dickerson’s dodecamer were assigned under our 
experimental conditions (see experimental section) and were in accordance with previous 
reported chemical shifts.83,84 Next, a chemical shift perturbation (CSP) strategy was applied. For 
any ligand or receptor molecule, the presence of its interacting partner provides perturbations 
of the chemical environment of the NMR-active nuclei, triggering changes in the 1H NMR 
chemical shifts. Fittingly, the largest changes in the chemical shifts of the receptor´s nuclei 
reveal the most affected ones due to the presence of the ligand. Thus, the interaction between 
the two compounds and the Dickerson dodecamer was analyzed by monitoring the CSP of the 
1H NMR signals of the DNA sequence upon addition of 1-2. A series of NOESY experiments 
were employed to monitor the CSPs of the DNA signals and at the same time to monitor the 
possible intermolecular contacts (figures 32-35).  
 
Figure 32. tr-NOESY of the DNA:1 complex (300 K, 500 MHz). Some ligand intramolecular NOE crosspeaks are 
annotated with green solid arrows. Some intermolecular NOE crosspeaks are annotated with red circles. 
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Figure 33. The interaction of 1 with DNA. Superimposition of the NOESY spectra recorded for DNA in the absence 
(red) and presence of 1 mM of compound 1 (black). 
 
Figure 34. tr-NOESY of the DNA:2 complex (300 K, 500 MHz). Some intramolecular NOE crosspeaks are annotated 
with green solid arrows. Some intermolecular NOE crosspeaks are annotated with red circles. 
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Figure 35. The interaction of 2 with DNA. Superimposition of the NOESY spectra recorded for DNA in the absence 
(red) and presence of 1 mM of compound 2 (black). 
The CSP analysis of the DNA:ligand (1:1 molar ratio) complex revealed that the most affected 
protons in complexes with 1 (figure 36) and 2 (figure 37) belong to the central part of the 
dodecamer d(-A6T7T8C9-), rich in adenines and thymines. Indeed, protons displaying largest CSP 
were H4’ of T7, T8, A6 and C9, oriented towards the DNA minor groove, while those exposed to 
the major groove did not display any significant perturbation, H3’ of A6, H7 of T7, H5 of C9 or 
H3’ of T8. 
 
Figure 36. Chemical shift perturbation of 
1
H NMR signals of the Dickerson´s dodecamer in the presence of 1. 
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Figure 37. Chemical shift perturbation of 
1
H NMR signals of the Dickerson´s dodecamer in the presence of 2. 
Furthermore, a 3D model of both ligand-DNA complexes were then generated by docking 
calculations using AutoDock47 (figures 38 and 39).  The obtained structures were qualitatively 
validated with the information provided by the assigned intermolecular NOEs (tables 6 and 7).  
 
Figure 38. 3D model of the interaction of 1 with Dickerson´s dodecamer. 
Compound 1 DNA proton 
distance in model (Å) 
(chain A 3´-5´) (chain B 5´-3´) 
H5 
H1´ A6 3.5 - 
H1´ T7 3.5 3.3 
H5´ T7 3.5 - 
H4´ C9 3.3 - 
H4´ T8 - 3.6 
H6 
H5´ T6 3.2 3.0 
H4´C9 - 3.0 
H1´ C9 3.7 2.8 
H1´ A6 2.2 3.4 
H4 
H4´ T8 - 3.3 
H4´ T7 2.4 3.4 
H1 H4´ C9 4.0 - 
Table 6. List of observed intermolecular NOEs in the complex 1:DNA and corresponding distances in the model. 
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Figure 39. 3D model of the interaction of 2 with Dickerson´s dodecamer. 
Compound 2 DNA proton 
distance in model (Å) 
(chain A 3´-5´) (chain B 5´-3´) 
H5 
H2 A6 2.2 2.3 
H1´ T7 3.3 3.2 
H5´ T7 3.7 3.6 
H4´ C9 3.2 3.1 
H5’C9 3.8 3.4 
H6 
H5´ T7 3.3 3.2 
H4´C9 3.0 2.8 
H1´ C9 3.0 3.1 
H2 A6 2.2 2.3 
H4 
H4´ T8 - 3.3 
H4´ T7 2.4 3.4 
H1 H4´ C9 4.0 - 
Table 7. List of observed intermolecular NOE in the complex 2:DNA and corresponding distances in the model. 
The analysis of the models revealed that, for both cases, the terminal amidinium moieties 
establish hydrogen bonds with the DNA and CH-pi hydrophobic interactions can also take place 
between ribose H4 and the aromatic rings. For 2, the possibility of an additional hydrogen 
bond between the nitrogen of the pyridine and the nucleotides could not be further validated. 
No significant differences could be observed between both models. In fact, the affinity results 
obtained by collaborators at Santiago de Compostela revealed that 2 only displays a slightly 
higher affinity (KD= 1.0 M) than 1 (KD= 1.8 M).
85 This comparable affinity also supports a 
fairly similar binding mode for both compounds. 
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4.5.2. Conclusions 
Ligands 1 and 2 display certain specificity towards A/T-rich regions of DNA establishing mainly 
hydrogen bond interactions with the base pairs at the minor groove of a dsDNA helix. The 
presence of cyclic nitrogen (2) does not provide significant changes in the binding mode. 
4.5.3. Experimental 
Compounds 1 and 2 were synthesized by Prof. Mascareñas and Vázquez-Sentís group from 
CIQUS, Santiago de Compostela.  
The Dickerson dodecamer ds(CGCGAATTCGCG) was purchased from Thermo-Scientific. 
The 1H NMR resonances of DNA dodecamer and ligand 1 and 2 were assigned by the 
acquisition of a set of standard NMR experiments (1D 1H-NMR, 2D TOCSY at different mixing 
times, 2D NOESY) in D2O in a Bruker Avance 500 MHz spectrometer at 300 K. For the 
assignments of DNA NHs resonances experiments were performed in H2O as well. 
tr-NOESY experiments of the mixtures of 1.1 mM of 1 or 2 with DNA (1:1 molar ratio) were 
performed in H2O and D2O at 300 K and a mixing time of 100, 200 and 400 ms in a Bruker 
Avance 500 MHz spectrometer.  
 
 
Scheme 2. Chemical representation of the structures of compound 1 to 2. 
1
H chemical shift values are annotated. 
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 1H (, ppm) H1’ H2’ H2’’ H3’ H4’ H5 H6 H7 H8 
Fr
e
e 
D
N
A
 
Cyt1 5.69 1.89 2.32 4.62 4.02 5.84 7.56   
Gua2 5.78 2.56 2.63 4.89 4.26    7.87 
Cyt3 5.53 1.78 2.19 - 4.05 5.29 7.18   
Gua4 5.36 2.57 2.66 4.91 4.23    7.76 
Ade5 5.91 2.60 2.85 4.97 4.37    8.02 
Ade6 6.07 2.48 2.84 4.91 4.38    8.02 
Thy7 5.81 1.90 2.47 - 4.10  7.02 1.19  
Thy8 6.01 2.08 2.46 4.78 4.09  7.29 1.45  
Cyt9 5.57 1.97 2.32 - 4.06 5.55 7.38   
Gua10 5.76 2.51 2.61 4.91 4.07    7.83 
Cyt11 5.67 1.81 2.24 - 4.05 5.36 7.24   
Gua12 6.08 2.29 2.53 4.60 4.08    7.86 
D
N
A
:1
 c
o
m
p
le
x 
Cyt1 5.66 1.84 2.89 4.60 3.96 5.79 7.52   
Gua2 5.78 2.54 2.60 4.88 4.23    7.84 
Cyt3 5.48 1.73 2.15 - 4.01 5.29 7.16   
Gua4 5.37 2.56 2.66 4.89 4.19    7.74 
Ade5 5.92 2.59 2.78 4.95 4.31    8.00 
Ade6 5.93 2.31 2.64 4.80 3.85    7.90 
Thy7 5.46 1.63 2.19 - 2.94  6.80 1.10  
Thy8 5.43 1.77 2.19 4.55 3.20  7.04 1.34  
Cyt9 5.33 1.77 2.15 - 3.58 5.41 7.18   
Gua10 5.73 2.53 2.56 4.87 4.17    7.78 
Cyt11 5.69 1.80 2.22 - 4.3 5.36 7.25   
Gua12 6.04 2.26 2.53 4.58 4.06    7.85 
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D
N
A
:2
 c
o
m
p
le
x 
Cyt1 5.66 1.80 2.24 4.57 3.97 5.79 7.53   
Gua2 5.77 2.52 2.26 4.84 4.23    7.84 
Cyt3 5.49 1.68 2.12 4.72 4.00 5.26 7.14   
Gua4 5.30 2.54 2.70 4.89 4.22    7.74 
Ade5 5.88 2.60 2.78 4.93 4.33    8.02 
Ade6 6.00 2.39 2.66 4.85 4.13    7.99 
Thy7 5.43 1.63 2.22 4.48 2.84  6.80 1.10  
Thy8 5.44 1.75 2.16 4.51 3.39  7.02 1.33  
Cyt9 5.45 1.78 2.15 4.70 3.57 5.44 7.17   
Gua10 5.72 2.54 2.56 4.89 4.23    7.79 
Cyt11 5.69 1.78 2.22 - 4.06 5.35 7.24   
Gua12 6.03 2.50 2.24 4.55 4.05    7.83 
Table 8. 
1
H NMR resonances of DNA signals given in ppm. 
Docking calculations for complexes of 1 and 2 with DNA were performed with AutoDock 4.247  
with a 64 points box centered in the A/T DNA region (spacing 0.35 Å) and using a genetic 
algorithm. The coordinates of the crystal structure of Dickerson dodecamer (PDB49 ID 1PRP) 
were employed for the calculation after refinement with Sybyl computational program. The 
ligands were built and minimized using Macromodel from Schrodinger suite software. 
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Different molecular recognition processes of biochemical interest have been characterized by 
the application of NMR. 
-The molecular recognition features of Tn-antigen mimetics have been revealed towards 
different lectins from different sources. The overall picture of tricyclic compound 1 reveals can 
mimic the Tn-antigen with a similar binding mode as Tn reference model (-OMeGalNAc) 
displaying higher affinity than Tn-reference for the case of ECL whilst MGL affinity is lower than 
the reference. On the other hand, glycopeptide mimetic 2 was also recognized by lectins with a 
similar binding mode to that observed for mimetic 1. All these data permit to consider the 
tricyclic mimetic 1 as a rigid but selective mimic of the Tn antigen suitable for further 
biomedical applications, always depending on the chemical architecture of the receptor 
binding site. 
-The multivalency of a bifunctional ligand targeting different proteins, hgal-3 and MMP12, was 
proved. The binding mode with each of the proteins was assessed by STD-NMR as well as the 
amino acids from the binding site of each protein were elucidated by 1H-15N HSQC (receptor 
point of view methodology). Evidences of simultaneous binding to both proteins were 
achieved by NMR. The spectroscopic data suggest that bifunctional ligand is able to target both 
proteins simultaneously, terminal lactose epitope is recognized by hgal-3 and hydroxamic acid 
by MMP12. 
-Three different monoclonal anti-glycan antibodies targeting the xenoantigen -Gal were 
tested with a xenoantigen disaccharide model applying ligand point of view NMR experiments, 
STD-NMR, proving that they are suitable receptors for the xeno-epitope. However, different 
affinities, qualitatively estimated by STD intensities, suggest that anti-gal A4 antibody displays 
the strongest affinity and may be considered as possible candidate for further biomedical 
applications. 
-The binding of two anti-sialic antibodies was examined by STD-NMR displaying a complete 
selectivity towards compared to Neu5Ac. Moreover, these monoclonal antibodies exhibited 
preference towards the -anomer of NeuGc confirmed by the recognition of NeuGc -linked 
trisaccharides. 
-Enzymatical synthesis of sialylated glycans of different lengths was achieved for further 
molecular recognition studies. The linear synthesized glycans were shown, by STD-NMR, to 
display different affinity towards hemagglutinins (HA) of different influenza strains through the 
terminal Neu5Ac moiety and depending of the regiochemistry of Neu5Ac linkage. By means of 
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docking calculations a 3D model of the binding mode of the glycans was proposed, in 
accordance with the spectroscopic data and displaying an umbrella-like topology for the case 
of Neu5Ac2-6Gal linked glycans. Furthermore, very low affinity was observed when 
Neu5Ac2-6Gal linked glycans were tested against HAs from avian strains specific of 
Neu5Ac2-3Gal linked glycans showing up the importance of local mutations for influenza 
transfection between species. 
- The NMR dynamic analysis (1H-15N hetNOE and R2/R1 relaxation ratio) of a fragment of 53 
amino acids in the N-terminal region of CHOP has revealed evidences of structural order in the 
Ser59 to Glu65. The obtained experimental NMR data (positive hetNOE and large R2/R1 ratios) 
signature of of structured protein domains together with a previous chemical shift index 
analysis, indicate that this region may adopt a -helix motif. Furthermore, 1H-2H chemical 
exchange experiments (CLEANEX-PM) confirmed the structuring propensity of that segment 
displaying a significantly reduced chemical exchange with water solvent in comparison with 
the rest of the peptide.  
- The molecular recognition of a cyclopropane epothilone derivative (EPO-tc) by tubulin (in 
both, dimeric and microtubule states of aggregation) was characterized by combined NMR and 
molecular-modelling approach. The STD-derived epitopes and the obtained bound 
conformations in both states were similar to those described for natural epothilone-A (EPO-A) 
with no significant changes in the binding modes. Therefore, the experimental data suggest 
that EPO-tc may be an efficient epothilone derivative with improved properties and a potential 
candidate for anti-tumor therapy. 
- NMR methodology (STD-NMR, DOSY and tr-NOESY) has been proved to be a versatile tool to 
direct detection of binders in dynamic combinatorial chemistry (DCC). Using a simplified 
aldehyde/hydrazine dynamic combinatorial library (DCL), it was possible to reveal that 
hydrazone 3 is bound and amplified by the frequenin protein, Frq2, in the presence of 
hydrazone 5 validating the role of Frq2 as a selective template. Furthermore, STD-based 
competition studies permitted to assess that the amplified product 3 competes for the same 
binding site than a well-known Frq2-binder, chlorpromazine (CPZ). 
- The interaction of synthetic DNA-minor groove binders has been studied by NMR. The 
specificity towards A/T-rich regions of DNA of ligands 1 and 2 and structure of their complexes 
were characterized by NOESY experiments. The combination of the obtained NMR data with 
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docking calculation have permitted to propose a 3D model of the interaction revealing that 
both ligands establish hydrogen bonding in the minor groove of a dsDNA helix. 
 
 
 
 
 
